No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 4i5bB, 1.0000, 0.00, 1.000, 192, 91, STRUCTURE OF HUMAN MHC CLASS II PROTEIN HLA-DR1 CARRYING AN INFLUENZA HEMAGGLUTININ PEPTIDE PARTIALLY FILLING THE BINDING GROOVE
2, 1t5wB, 0.9957, 0.23, 0.989, 190, 91, HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE (AAYSDQATPLLLSPR)
3, 4i5bE, 0.9955, 0.23, 1.000, 190, 91, STRUCTURE OF HUMAN MHC CLASS II PROTEIN HLA-DR1 CARRYING AN INFLUENZA HEMAGGLUTININ PEPTIDE PARTIALLY FILLING THE BINDING GROOVE
4, 1t5wE, 0.9949, 0.25, 0.989, 190, 91, HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE (AAYSDQATPLLLSPR)
5, 2icwB, 0.9939, 0.27, 0.989, 184, 91, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX BETWEEN TCR SUPERANTIGEN AND PEPTIDE-MHC CLASS II MOLECULE
6, 3qxaE, 0.9938, 0.27, 0.989, 190, 91, HLA-DR1 BOUND WITH CLIP PEPTIDE
7, 2icwE, 0.9938, 0.27, 0.989, 185, 91, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX BETWEEN TCR SUPERANTIGEN AND PEPTIDE-MHC CLASS II MOLECULE
8, 5jlzD, 0.9924, 0.30, 0.890, 190, 91, CRYSTAL STRUCTURE OF HLA-DRB1*04:01 IN COMPLEX WITH MODIFIED ALPHA- ENOLASE PEPTIDE 26-40 WITH CITRULLINE AT THE POSITION 32
9, 1jwuB, 0.9924, 0.30, 0.989, 187, 91, CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1 (HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3 VARIANT 3B2
10, 3qxdE, 0.9922, 0.31, 0.989, 189, 91, F54C HLA-DR1 BOUND WITH CLIP PEPTIDE
11, 1r5iF, 0.9922, 0.31, 0.989, 190, 91, CRYSTAL STRUCTURE OF THE MAM-MHC COMPLEX
12, 1r5iB, 0.9922, 0.31, 0.989, 190, 91, CRYSTAL STRUCTURE OF THE MAM-MHC COMPLEX
13, 2ojeF, 0.9916, 0.32, 0.989, 190, 91, MYCOPLASMA ARTHRITIDIS-DERIVED MITOGEN COMPLEXED WITH CLASS II MHC MOLECULE HLA-DR1/HA COMPLEX IN THE PRESENCE OF EDTA
14, 2ojeB, 0.9915, 0.32, 0.989, 190, 91, MYCOPLASMA ARTHRITIDIS-DERIVED MITOGEN COMPLEXED WITH CLASS II MHC MOLECULE HLA-DR1/HA COMPLEX IN THE PRESENCE OF EDTA
15, 3s5lE, 0.9913, 0.33, 0.989, 191, 91, CRYSTAL STRUCTURE OF CD4 MUTANT BOUND TO HLA-DR1
16, 2xn9E, 0.9911, 0.33, 0.989, 188, 91, CRYSTAL STRUCTURE OF THE TERNARY COMPLEX BETWEEN HUMAN T CELL RECEPTOR STAPHYLOCOCCAL ENTEROTOXIN H AND HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II
17, 1sebF, 0.9907, 0.34, 0.989, 192, 91, COMPLEX OF THE HUMAN MHC CLASS II GLYCOPROTEIN HLA-DR1 AND THE BACTERIAL SUPERANTIGEN SEB
18, 1sebB, 0.9907, 0.34, 0.989, 192, 91, COMPLEX OF THE HUMAN MHC CLASS II GLYCOPROTEIN HLA-DR1 AND THE BACTERIAL SUPERANTIGEN SEB
19, 2ipkB, 0.9906, 0.34, 0.989, 190, 91, CRYSTAL STRUCTURE OF THE MHC CLASS II MOLECULE HLA-DR1 IN COMPLEX WITH THE FLUOROGENIC PEPTIDE ACPKXVKQNTLKLAT (X=3- [5-(DIMETHYLAMINO)-13-DIOXO-13-DIHYDRO-2H-ISOINDOL-2-YL]- L-ALANINE) AND THE SUPERANTIGEN SEC3 VARIANT 3B2
20, 3s5lB, 0.9904, 0.34, 0.989, 191, 91, CRYSTAL STRUCTURE OF CD4 MUTANT BOUND TO HLA-DR1
21, 1jwsB, 0.9902, 0.34, 0.989, 187, 91, CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1 (HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3 VARIANT 3B1
22, 1jwmB, 0.9901, 0.35, 0.989, 187, 91, CRYSTAL STRUCTURE OF THE COMPLEX OF THE MHC CLASS II MOLECULE HLA-DR1(HA PEPTIDE 306-318) WITH THE SUPERANTIGEN SEC3
23, 1d5mB, 0.9900, 0.35, 0.890, 181, 91, X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDE AND SEB
24, 3s4sE, 0.9895, 0.36, 0.989, 185, 91, CRYSTAL STRUCTURE OF CD4 MUTANT BOUND TO HLA-DR1
25, 1t5xB, 0.9895, 0.36, 0.989, 190, 91, HLA-DR1 IN COMPLEX WITH A SYNTHETIC PEPTIDE (AAYSDQATPLLLSPR) AND THE SUPERANTIGEN SEC3-3B2
26, 2g9hB, 0.9891, 0.37, 0.989, 190, 91, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN I (SEI) IN COMPLEX WITH A HUMAN MHC CLASS II MOLECULE
27, 4ov5Q, 0.9890, 0.37, 0.989, 189, 91, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
28, 3s4sB, 0.9887, 0.37, 0.989, 186, 91, CRYSTAL STRUCTURE OF CD4 MUTANT BOUND TO HLA-DR1
29, 6cqjB, 0.9886, 0.37, 0.989, 182, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
30, 4gbxB, 0.9885, 0.38, 1.000, 189, 91, CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX AT PH 6.5
31, 1d5zB, 0.9881, 0.38, 0.890, 181, 91, X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDOMIMETIC AND SEB
32, 4ov5B, 0.9879, 0.39, 0.989, 189, 91, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
33, 6cqjH, 0.9878, 0.39, 0.989, 182, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
34, 1klgB, 0.9878, 0.39, 0.989, 187, 91, CRYSTAL STRUCTURE OF HLA-DR1/TPI(23-37 THR28-->ILE MUTANT) COMPLEXED WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2)
35, 5nigB, 0.9869, 0.41, 0.890, 197, 91, CRYSTAL STRUCTURE OF HLA-DRB1*04:01 WITH MODIFIED ALPHA-ENOLASE PEPTIDE 326-340 (ARGININE 327 TO CITRULLINE) 
36, 4ov5H, 0.9869, 0.40, 0.989, 189, 91, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
37, 1kluB, 0.9869, 0.40, 0.989, 190, 91, CRYSTAL STRUCTURE OF HLA-DR1/TPI(23-37) COMPLEXED WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2)
38, 5ni9B, 0.9867, 0.41, 0.890, 193, 91, CRYSTAL STRUCTURE OF HLA-DRB1*04:01 WITH THE ALPHA-ENOLASE PEPTIDE 326-340 
39, 4ov5E, 0.9867, 0.41, 0.989, 186, 91, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
40, 4ov5N, 0.9866, 0.41, 0.989, 185, 91, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
41, 1sjeB, 0.9865, 0.41, 0.989, 190, 91, HLA-DR1 COMPLEXED WITH A 16 RESIDUE HIV CAPSID PEPTIDE BOUND IN A HAIRPIN CONFORMATION
42, 4md5B, 0.9864, 0.41, 0.890, 190, 91, IMMUNE RECEPTOR
43, 3l6fB, 0.9864, 0.41, 0.989, 191, 91, STRUCTURE OF MHC CLASS II MOLECULE HLA-DR1 COMPLEXED WITH PHOSPHOPEPTIDE MART-1
44, 5laxB, 0.9863, 0.41, 0.890, 193, 91, CRYSTAL STRUCTURE OF HLA_DRB1*04:01 IN COMPLEX WITH ALPHA-ENOLASE PEPTIDE 26-40
45, 5jlzB, 0.9860, 0.42, 0.890, 193, 91, CRYSTAL STRUCTURE OF HLA-DRB1*04:01 IN COMPLEX WITH MODIFIED ALPHA- ENOLASE PEPTIDE 26-40 WITH CITRULLINE AT THE POSITION 32
46, 1pywB, 0.9860, 0.41, 0.989, 190, 91, HUMAN CLASS II MHC PROTEIN HLA-DR1 BOUND TO A DESIGNED PEPTIDE RELATED TO INFLUENZA VIRUS HEMAGGLUTININ FVKQNA(MAA)AL IN COMPLEX WITH STAPHYLOCOCCAL ENTEROTOXIN C3 VARIANT 3B2 (SEC3-3B2)
47, 1sjhB, 0.9857, 0.42, 0.989, 190, 91, HLA-DR1 COMPLEXED WITH A 13 RESIDUE HIV CAPSID PEPTIDE
48, 1fv1B, 0.9857, 0.42, 0.890, 190, 91, STRUCTURAL BASIS FOR THE BINDING OF AN IMMUNODOMINANT PEPTIDE FROM MYELIN BASIC PROTEIN IN DIFFERENT REGISTERS BY TWO HLA-DR2 ALLELES
49, 4c56E, 0.9856, 0.42, 0.989, 184, 91, X-RAY STRUCTURE OF THE COMPLEX BETWEEN STAPHYLOCOCCAL ENTEROTOXIN B T CELL RECEPTOR AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II
50, 6cqrG, 0.9855, 0.42, 0.989, 190, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
51, 6bilB, 0.9853, 0.42, 0.890, 189, 91, HLA-DRB1 IN COMPLEX WITH CITRULLINATED FIBRINOGEN PEPTIDE
52, 4c56K, 0.9853, 0.42, 0.989, 189, 91, X-RAY STRUCTURE OF THE COMPLEX BETWEEN STAPHYLOCOCCAL ENTEROTOXIN B T CELL RECEPTOR AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II
53, 6bijB, 0.9851, 0.43, 0.890, 189, 91, HLA-DRB1 IN COMPLEX WITH CITRULLINATED FIBRINOGEN PEPTIDE
54, 1fv1E, 0.9851, 0.43, 0.890, 190, 91, STRUCTURAL BASIS FOR THE BINDING OF AN IMMUNODOMINANT PEPTIDE FROM MYELIN BASIC PROTEIN IN DIFFERENT REGISTERS BY TWO HLA-DR2 ALLELES
55, 6bivA, 0.9850, 0.43, 0.890, 189, 91, HLA-DRB1 IN COMPLEX WITH CITRULLINATED LL37 PEPTIDE
56, 4x5wB, 0.9850, 0.43, 0.989, 188, 91, HLA-DR1 WITH CLIP102-120(M107W)
57, 4mcyB, 0.9849, 0.43, 0.890, 189, 91, IMMUNE RECEPTOR
58, 6cqrB, 0.9848, 0.43, 0.989, 190, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
59, 3pgdB, 0.9839, 0.45, 0.989, 185, 91, CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP106-120 CANONICAL PEPTIDE ORIENTATION
60, 3pgcB, 0.9839, 0.45, 0.989, 184, 91, CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP106-120 FLIPPED PEPTIDE ORIENTATION
61, 3pgdE, 0.9838, 0.45, 0.989, 185, 91, CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP106-120 CANONICAL PEPTIDE ORIENTATION
62, 6atiE, 0.9837, 0.45, 0.890, 190, 91, HLA-DRB1*1402 IN COMPLEX WITH VIMENTIN-64CIT59-71
63, 4mdjB, 0.9837, 0.45, 0.857, 191, 91, IMMUNE RECEPTOR
64, 6bixB, 0.9835, 0.45, 0.890, 189, 91, HLA-DRB1 IN COMPLEX WITH CITRULLINATED LL37 PEPTIDE
65, 6cpoB, 0.9833, 0.46, 0.901, 189, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
66, 6atiB, 0.9832, 0.45, 0.890, 190, 91, HLA-DRB1*1402 IN COMPLEX WITH VIMENTIN-64CIT59-71
67, 4ov5K, 0.9831, 0.46, 0.989, 187, 91, STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET
68, 6atfB, 0.9830, 0.46, 0.890, 189, 91, HLA-DRB1*1402 IN COMPLEX WITH VIMENTIN59-71
69, 6atfE, 0.9829, 0.46, 0.890, 189, 91, HLA-DRB1*1402 IN COMPLEX WITH VIMENTIN59-71
70, 2ianG, 0.9828, 0.47, 0.989, 182, 91, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
71, 4y19B, 0.9826, 0.48, 0.890, 184, 91, IMMUNE COMPLEX
72, 4x5xB, 0.9826, 0.47, 0.978, 198, 91, HLA-DR1 MUTANT BN82A WITH COVALENTLY LINKED CLIP106-120(M107W)
73, 6cpoE, 0.9825, 0.47, 0.901, 190, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
74, 6binB, 0.9823, 0.47, 0.890, 189, 91, HLA-DRB1 IN COMPLEX WITH TYPE II COLLAGEN PEPTIDE
75, 3pdoB, 0.9823, 0.47, 0.989, 191, 91, CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP102-120
76, 4ah2B, 0.9822, 0.47, 0.989, 198, 91, HLA-DR1 WITH COVALENTLY LINKED CLIP106-120 IN CANONICAL ORIENTATION
77, 6cqqG, 0.9818, 0.47, 0.901, 189, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
78, 6birB, 0.9816, 0.48, 0.890, 186, 91, HLA-DRB1 IN COMPLEX WITH CITRULLINATED VIMENTIN PEPTIDE
79, 4mczB, 0.9816, 0.48, 0.890, 189, 91, IMMUNE RECEPTOR
80, 4md0B, 0.9815, 0.48, 0.890, 189, 91, IMMUNE RECEPTOR
81, 4is6B, 0.9812, 0.48, 0.890, 188, 91, CRYSTAL STRUCTURE OF HLA-DR4 BOUND TO GP100 PEPTIDE
82, 4mdiB, 0.9810, 0.49, 0.857, 189, 91, IMMUNE RECEPTOR
83, 3pgcE, 0.9810, 0.49, 0.989, 180, 91, CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP106-120 FLIPPED PEPTIDE ORIENTATION
84, 6cqqB, 0.9807, 0.49, 0.901, 188, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
85, 2iamB, 0.9802, 0.53, 0.989, 182, 91, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
86, 4md4B, 0.9801, 0.50, 0.890, 189, 91, IMMUNE RECEPTOR
87, 4x5xD, 0.9797, 0.50, 0.978, 198, 91, HLA-DR1 MUTANT BN82A WITH COVALENTLY LINKED CLIP106-120(M107W)
88, 1d5xB, 0.9797, 0.50, 0.890, 183, 91, X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH DIPEPTIDE MIMETIC AND SEB
89, 4aenB, 0.9796, 0.34, 0.989, 181, 90, HLA-DR1 WITH COVALENTLY LINKED CLIP106-120 IN REVERSED ORIENTATION
90, 1kg0B, 0.9796, 0.35, 0.989, 188, 90, STRUCTURE OF THE EPSTEIN-BARR VIRUS GP42 PROTEIN BOUND TO THE MHC CLASS II RECEPTOR HLA-DR1
91, 1hxyB, 0.9792, 0.35, 0.989, 180, 90, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN H IN COMPLEX WITH HUMAN MHC CLASS II
92, 3qxdB, 0.9786, 0.53, 0.989, 189, 91, F54C HLA-DR1 BOUND WITH CLIP PEPTIDE
93, 1hqrB, 0.9779, 0.52, 0.890, 180, 91, CRYSTAL STRUCTURE OF A SUPERANTIGEN BOUND TO THE HIGH- AFFINITY ZINC-DEPENDENT SITE ON MHC CLASS II
94, 2sebB, 0.9777, 0.54, 0.890, 177, 91, X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM HUMAN COLLAGEN II
95, 2wbjF, 0.9775, 0.38, 0.889, 188, 90, TCR COMPLEX
96, 4y1aB, 0.9774, 0.54, 0.890, 184, 91, IMMUNE COMPLEX
97, 2wbjB, 0.9773, 0.38, 0.889, 179, 90, TCR COMPLEX
98, 3o6fB, 0.9769, 0.54, 0.890, 195, 91, CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4
99, 3o6fF, 0.9765, 0.55, 0.890, 210, 91, CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4
100, 2ianQ, 0.9758, 0.41, 0.978, 188, 90, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
101, 1dlhE, 0.9758, 0.42, 0.978, 188, 90, CRYSTAL STRUCTURE OF THE HUMAN CLASS II MHC PROTEIN HLA-DR1 COMPLEXED WITH AN INFLUENZA VIRUS PEPTIDE
102, 1fytB, 0.9755, 0.41, 0.989, 179, 90, CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR INFLUENZA HA ANTIGEN PEPTIDE AND MHC CLASS II MOLECULE HLA-DR1
103, 1h15E, 0.9754, 0.56, 0.890, 189, 91, X-RAY CRYSTAL STRUCTURE OF HLA-DRA1*0101/DRB5*0101 COMPLEXED WITH A PEPTIDE FROM EPSTEIN BARR VIRUS DNA POLYMERASE
104, 6biyB, 0.9750, 0.56, 0.890, 189, 91, HLA-DRB1 IN COMPLEX WITH HISTONE 2B PEPTIDE
105, 6cqnB, 0.9749, 0.57, 0.846, 190, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
106, 6bizB, 0.9749, 0.56, 0.890, 189, 91, HLA-DRB1 IN COMPLEX WITH CITRULLINATED HISTONE 2B PEPTIDE
107, 1d6eB, 0.9749, 0.42, 0.889, 179, 90, CRYSTAL STRUCTURE OF HLA-DR4 COMPLEX WITH PEPTIDOMIMETIC AND SEB
108, 2ianL, 0.9745, 0.43, 0.978, 188, 90, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
109, 1dlhB, 0.9744, 0.44, 0.978, 188, 90, CRYSTAL STRUCTURE OF THE HUMAN CLASS II MHC PROTEIN HLA-DR1 COMPLEXED WITH AN INFLUENZA VIRUS PEPTIDE
110, 3qxaB, 0.9741, 0.58, 0.989, 190, 91, HLA-DR1 BOUND WITH CLIP PEPTIDE
111, 2ianB, 0.9739, 0.44, 0.978, 181, 90, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
112, 6atzB, 0.9736, 0.44, 0.889, 188, 90, HLA-DRB1*1402 IN COMPLEX WITH CITRULLINATED FIBRINOGEN PEPTIDE
113, 6cqlB, 0.9730, 0.59, 0.846, 190, 91, CRYSTAL STRUCTURE OF A TCR 
114, 5v4mF, 0.9730, 0.58, 0.890, 200, 91, STRUCTURE OF HLA-DR15 WITH BOUND ALPHA3(135-145) PEPTIDE
115, 6atzD, 0.9727, 0.45, 0.889, 187, 90, HLA-DRB1*1402 IN COMPLEX WITH CITRULLINATED FIBRINOGEN PEPTIDE
116, 1bx2E, 0.9726, 0.45, 0.889, 189, 90, CRYSTAL STRUCTURE OF HLA-DR2 (DRA*0101DRB1*1501) COMPLEXED WITH A PEPTIDE FROM HUMAN MYELIN BASIC PROTEIN
117, 5v4mL, 0.9725, 0.59, 0.890, 200, 91, STRUCTURE OF HLA-DR15 WITH BOUND ALPHA3(135-145) PEPTIDE
118, 4fqxB, 0.9717, 0.49, 0.956, 187, 90, CRYSTAL STRUCTURE OF HLA-DM BOUND TO HLA-DR1
119, 5v4mI, 0.9715, 0.60, 0.890, 200, 91, STRUCTURE OF HLA-DR15 WITH BOUND ALPHA3(135-145) PEPTIDE
120, 1bx2B, 0.9712, 0.47, 0.889, 191, 90, CRYSTAL STRUCTURE OF HLA-DR2 (DRA*0101DRB1*1501) COMPLEXED WITH A PEPTIDE FROM HUMAN MYELIN BASIC PROTEIN
121, 6cplB, 0.9710, 0.61, 0.846, 189, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
122, 5v4nC, 0.9708, 0.48, 0.989, 200, 90, STRUCTURE OF HLA-DR1 WITH BOUND ALPHA3(135-145) PEPTIDE
123, 5v4mC, 0.9704, 0.61, 0.890, 200, 91, STRUCTURE OF HLA-DR15 WITH BOUND ALPHA3(135-145) PEPTIDE
124, 1lo5B, 0.9698, 0.49, 0.989, 188, 90, CRYSTAL STRUCTURE OF THE D227A VARIANT OF STAPHYLOCOCCAL ENTEROTOXIN A IN COMPLEX WITH HUMAN MHC CLASS II
125, 5laxD, 0.9696, 0.32, 0.888, 188, 89, CRYSTAL STRUCTURE OF HLA_DRB1*04:01 IN COMPLEX WITH ALPHA-ENOLASE PEPTIDE 26-40
126, 1zglH, 0.9689, 0.66, 0.890, 168, 91, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
127, 1aqdE, 0.9689, 0.34, 0.989, 187, 89, HLA-DR1 (DRA DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE
128, 1j8hB, 0.9687, 0.51, 0.889, 180, 90, CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR INFLUENZA HA ANTIGEN PEPTIDE AND MHC CLASS II MOLECULE HLA-DR4
129, 1zglK, 0.9684, 0.67, 0.890, 180, 91, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
130, 6cqjE, 0.9682, 0.35, 0.989, 180, 89, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
131, 4h25E, 0.9677, 0.52, 0.844, 182, 90, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHTS TO NICKEL CONTACT ALLERGY
132, 1aqdK, 0.9671, 0.37, 0.989, 188, 89, HLA-DR1 (DRA DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE
133, 4e41B, 0.9667, 0.38, 0.989, 179, 89, STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
134, 4h26E, 0.9661, 0.55, 0.844, 188, 90, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHT TO NICKEL CONTACT ALLERGY
135, 6cpnB, 0.9659, 0.67, 0.846, 189, 91, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
136, 2q6wE, 0.9656, 0.55, 0.811, 188, 90, THE STRUCTURE OF HLA-DRA DRB3*0101 (DR52A) WITH BOUND PLATELET INTEGRIN PEPTIDE ASSOCIATED WITH FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
137, 1aqdH, 0.9653, 0.40, 0.989, 187, 89, HLA-DR1 (DRA DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE
138, 1aqdB, 0.9651, 0.40, 0.989, 187, 89, HLA-DR1 (DRA DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUS PEPTIDE
139, 3t0eB, 0.9650, 0.67, 0.890, 195, 91, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX OF T CELL RECEPTOR PEPTIDE-MHC AND CD4
140, 2q6wB, 0.9649, 0.55, 0.811, 188, 90, THE STRUCTURE OF HLA-DRA DRB3*0101 (DR52A) WITH BOUND PLATELET INTEGRIN PEPTIDE ASSOCIATED WITH FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
141, 4h26B, 0.9643, 0.56, 0.833, 188, 90, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHT TO NICKEL CONTACT ALLERGY
142, 4h25B, 0.9643, 0.56, 0.844, 188, 90, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHTS TO NICKEL CONTACT ALLERGY
143, 4e41G, 0.9641, 0.42, 0.989, 177, 89, STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
144, 5v4nF, 0.9636, 0.57, 0.989, 197, 90, STRUCTURE OF HLA-DR1 WITH BOUND ALPHA3(135-145) PEPTIDE
145, 1h15B, 0.9617, 0.74, 0.890, 189, 91, X-RAY CRYSTAL STRUCTURE OF HLA-DRA1*0101/DRB5*0101 COMPLEXED WITH A PEPTIDE FROM EPSTEIN BARR VIRUS DNA POLYMERASE
146, 1zglE, 0.9594, 0.84, 0.890, 175, 91, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
147, 1zglB, 0.9588, 0.84, 0.879, 175, 91, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
148, 2fseD, 0.9584, 0.50, 0.989, 186, 89, CRYSTALLOGRAPHIC STRUCTURE OF A RHEUMATOID ARTHRITIS MHC SUSCEPTIBILITY ALLELE HLA-DR1 (DRB1*0101) COMPLEXED WITH THE IMMUNODOMINANT DETERMINANT OF HUMAN TYPE II COLLAGEN
149, 3c5jB, 0.9572, 0.51, 0.831, 182, 89, CRYSTAL STRUCTURE OF HLA DR52C
150, 1ymmB, 0.9561, 0.65, 0.889, 178, 90, TCR/HLA-DR2B/MBP-PEPTIDE COMPLEX
151, 4i0pH, 0.9533, 0.59, 0.573, 189, 89, HLA-DO IN COMPLEX WITH HLA-DM
152, 2fseB, 0.9532, 0.42, 0.989, 186, 88, CRYSTALLOGRAPHIC STRUCTURE OF A RHEUMATOID ARTHRITIS MHC SUSCEPTIBILITY ALLELE HLA-DR1 (DRB1*0101) COMPLEXED WITH THE IMMUNODOMINANT DETERMINANT OF HUMAN TYPE II COLLAGEN
153, 4i0pD, 0.9520, 0.59, 0.573, 188, 89, HLA-DO IN COMPLEX WITH HLA-DM
154, 5ksvB, 0.9514, 0.74, 0.656, 180, 90, CRYSTAL STRUCTURE OF HLA-DQ2.5-CLIP2
155, 4h1lE, 0.9503, 0.60, 0.831, 179, 89, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURAL INSIGHTS IN NICKEL CONTACT ALLERGY
156, 4h1lB, 0.9502, 0.60, 0.831, 179, 89, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURAL INSIGHTS IN NICKEL CONTACT ALLERGY
157, 4d8pD, 0.9476, 0.76, 0.656, 193, 90, STRUCTURAL AND FUNCTIONAL STUDIES OF THE TRANS-ENCODED HLA-DQ2.3 (DQA1*03:01/DQB1*02:01) MOLECULE
158, 1s9vE, 0.9476, 0.77, 0.656, 180, 90, CRYSTAL STRUCTURE OF HLA-DQ2 COMPLEXED WITH DEAMIDATED GLIADIN PEPTIDE
159, 5ksuE, 0.9449, 0.80, 0.656, 179, 90, CRYSTAL STRUCTURE OF HLA-DQ2.5-CLIP1 AT 2.73 RESOLUTION
160, 1a6aB, 0.9442, 0.54, 0.807, 187, 88, THE STRUCTURE OF AN INTERMEDIATE IN CLASS II MHC MATURATION: CLIP BOUND TO HLA-DR3
161, 5ujtE, 0.9441, 0.80, 0.611, 188, 90, CRYSTAL STRUCTURE OF HUMAN HLA-DQ8 IN COMPLEX WITH INSULIN MIMOTOPE BINDING IN REGISTER 3
162, 1jk8B, 0.9441, 0.79, 0.611, 190, 90, CRYSTAL STRUCTURE OF A HUMAN INSULIN PEPTIDE-HLA-DQ8 COMPLEX
163, 5ksuB, 0.9437, 0.81, 0.656, 180, 90, CRYSTAL STRUCTURE OF HLA-DQ2.5-CLIP1 AT 2.73 RESOLUTION
164, 4ozhD, 0.9436, 0.80, 0.656, 181, 90, S16 PROTEIN COMPLEX
165, 4d8pB, 0.9432, 0.82, 0.656, 193, 90, STRUCTURAL AND FUNCTIONAL STUDIES OF THE TRANS-ENCODED HLA-DQ2.3 (DQA1*03:01/DQB1*02:01) MOLECULE
166, 4p2rB, 0.9426, 0.89, 0.678, 171, 90, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK
167, 5ujtH, 0.9424, 0.82, 0.611, 179, 90, CRYSTAL STRUCTURE OF HUMAN HLA-DQ8 IN COMPLEX WITH INSULIN MIMOTOPE BINDING IN REGISTER 3
168, 4ozgD, 0.9420, 0.81, 0.656, 180, 90, D2 PROTEIN COMPLEX
169, 4p2qL, 0.9419, 0.92, 0.678, 171, 90, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK
170, 4p2rQ, 0.9415, 0.92, 0.678, 171, 90, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK
171, 4p2rL, 0.9414, 0.92, 0.678, 171, 90, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK
172, 4p2qB, 0.9413, 0.90, 0.678, 171, 90, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK
173, 4p2rG, 0.9411, 0.93, 0.678, 171, 90, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK
174, 1s9vB, 0.9411, 0.85, 0.656, 181, 90, CRYSTAL STRUCTURE OF HLA-DQ2 COMPLEXED WITH DEAMIDATED GLIADIN PEPTIDE
175, 5ujtB, 0.9403, 0.83, 0.611, 188, 90, CRYSTAL STRUCTURE OF HUMAN HLA-DQ8 IN COMPLEX WITH INSULIN MIMOTOPE BINDING IN REGISTER 3
176, 4p2qQ, 0.9400, 0.94, 0.678, 171, 90, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK
177, 4p2qG, 0.9386, 0.96, 0.678, 171, 90, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK
178, 6bgaB, 0.9375, 0.90, 0.678, 207, 90, 2B4 I-EK TCR-MHC COMPLEX WITH AFFINITY-ENHANCING VELCRO PEPTIDE 
179, 4grlB, 0.9365, 0.76, 0.618, 181, 89, CRYSTAL STRUCTURE OF A AUTOIMMUNE TCR-MHC COMPLEX
180, 1i3rF, 0.9356, 1.33, 0.670, 216, 91, CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE
181, 5ks9D, 0.9355, 1.09, 0.615, 173, 91, BEL502-DQ8-GLIA-ALPHA1 COMPLEX
182, 4oziB, 0.9354, 0.88, 0.656, 180, 90, S2 PROTEIN COMPLEX
183, 3pl6B, 0.9354, 0.77, 0.618, 181, 89, STRUCTURE OF AUTOIMMUNE TCR HY.1B11 IN COMPLEX WITH HLA-DQ1 AND MBP 85-99
184, 1i3rB, 0.9347, 0.96, 0.678, 216, 90, CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE
185, 5ks9B, 0.9342, 1.13, 0.615, 181, 91, BEL502-DQ8-GLIA-ALPHA1 COMPLEX
186, 1i3rD, 0.9342, 0.96, 0.678, 216, 90, CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE
187, 3qiwB, 0.9341, 0.99, 0.678, 165, 90, CRYSTAL STRUCTURE OF THE 226 TCR IN COMPLEX WITH MCC-P5E/I-EK
188, 1i3rH, 0.9340, 0.96, 0.678, 216, 90, CRYSTAL STRUCTURE OF A MUTANT IEK CLASS II MHC MOLECULE
189, 1ktdB, 0.9339, 0.96, 0.678, 215, 90, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO PIGEON CYTOCHROME C PEPTIDE
190, 4ozfB, 0.9334, 0.90, 0.656, 181, 90, JR5.1 PROTEIN COMPLEX
191, 4ozhB, 0.9332, 0.89, 0.656, 181, 90, S16 PROTEIN COMPLEX
192, 1uvqB, 0.9331, 0.79, 0.629, 181, 89, CRYSTAL STRUCTURE OF HLA-DQ0602 IN COMPLEX WITH A HYPOCRETIN PEPTIDE
193, 3qiuB, 0.9326, 1.00, 0.678, 167, 90, CRYSTAL STRUCTURE OF THE 226 TCR IN COMPLEX WITH MCC/I-EK
194, 5ksaB, 0.9324, 1.11, 0.615, 190, 91, BEL602-DQ8.5-GLIA-GAMMA1 COMPLEX
195, 1ktdD, 0.9324, 0.96, 0.678, 215, 90, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO PIGEON CYTOCHROME C PEPTIDE
196, 2nnaB, 0.9320, 1.14, 0.615, 182, 91, STRUCTURE OF THE MHC CLASS II MOLECULE HLA-DQ8 BOUND WITH A DEAMIDATED GLUTEN PEPTIDE
197, 4oziD, 0.9318, 0.92, 0.656, 181, 90, S2 PROTEIN COMPLEX
198, 4z7uD, 0.9313, 1.14, 0.615, 172, 91, S13 COMPLEX
199, 1r5vB, 0.9313, 0.81, 0.674, 185, 89, EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION
200, 1r5vD, 0.9311, 0.81, 0.674, 185, 89, EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION
201, 4z7uB, 0.9310, 1.13, 0.615, 169, 91, S13 COMPLEX
202, 4z7wB, 0.9307, 0.90, 0.611, 180, 90, T316 COMPLEX
203, 4mayB, 0.9306, 0.82, 0.618, 181, 89, CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX
204, 3lqzB, 0.9306, 0.71, 0.625, 198, 88, CRYSTAL STRUCTURE OF HLA-DP2
205, 4z7wD, 0.9300, 0.91, 0.611, 180, 90, T316 COMPLEX
206, 4p2oB, 0.9297, 0.82, 0.685, 176, 89, CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH 2A/I-EK
207, 4ozgB, 0.9296, 0.92, 0.656, 181, 90, D2 PROTEIN COMPLEX
208, 3qibB, 0.9295, 1.03, 0.678, 165, 90, CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH MCC/I-EK
209, 1fneD, 0.9292, 1.01, 0.678, 213, 90, HISTOCOMPATIBILITY ANTIGEN
210, 4gg6D, 0.9291, 1.18, 0.615, 173, 91, PROTEIN COMPLEX
211, 5ksbD, 0.9290, 1.14, 0.615, 178, 91, T15-DQ8.5-GLIA-GAMMA1 COMPLEX
212, 1kt2D, 0.9289, 1.01, 0.678, 213, 90, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO MOTH CYTOCHROME C PEPTIDE
213, 1ieaD, 0.9289, 1.00, 0.678, 214, 90, HISTOCOMPATIBILITY ANTIGEN
214, 1fngD, 0.9288, 1.02, 0.678, 213, 90, HISTOCOMPATIBILITY ANTIGEN
215, 5ksbB, 0.9286, 1.11, 0.615, 179, 91, T15-DQ8.5-GLIA-GAMMA1 COMPLEX
216, 1r5wD, 0.9283, 0.84, 0.674, 185, 89, EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION
217, 1r5wB, 0.9282, 0.84, 0.674, 185, 89, EVIDENCE THAT STRUCTURAL REARRANGEMENTS AND/OR FLEXIBILITY DURING TCR BINDING CAN CONTRIBUTE TO T-CELL ACTIVATION
218, 1fneB, 0.9282, 1.00, 0.678, 213, 90, HISTOCOMPATIBILITY ANTIGEN
219, 1kt2B, 0.9278, 1.01, 0.678, 213, 90, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IEK BOUND TO MOTH CYTOCHROME C PEPTIDE
220, 1iebB, 0.9276, 1.38, 0.670, 214, 91, HISTOCOMPATIBILITY ANTIGEN
221, 1fngB, 0.9272, 1.01, 0.678, 213, 90, HISTOCOMPATIBILITY ANTIGEN
222, 4gg6B, 0.9268, 0.95, 0.611, 163, 90, PROTEIN COMPLEX
223, 4z7vD, 0.9267, 1.10, 0.615, 175, 91, L3-12 COMPLEX
224, 1ieaB, 0.9267, 1.01, 0.678, 214, 90, HISTOCOMPATIBILITY ANTIGEN
225, 4z7vB, 0.9234, 0.97, 0.611, 172, 90, L3-12 COMPLEX
226, 1iebD, 0.9224, 1.38, 0.670, 214, 91, HISTOCOMPATIBILITY ANTIGEN
227, 3c60D, 0.9195, 0.91, 0.584, 201, 89, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62
228, 3c5zD, 0.9192, 0.92, 0.584, 202, 89, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
229, 3c5zH, 0.9191, 0.92, 0.584, 202, 89, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
230, 3c60H, 0.9187, 0.92, 0.584, 201, 89, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62
231, 4p5mH, 0.9152, 0.86, 0.625, 191, 88, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
232, 1lnuB, 0.9131, 1.46, 0.571, 217, 91, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IAB BOUND TO EALPHA3K PEPTIDE
233, 1lnuH, 0.9126, 1.46, 0.571, 217, 91, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IAB BOUND TO EALPHA3K PEPTIDE
234, 1lnuD, 0.9126, 1.14, 0.578, 217, 90, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IAB BOUND TO EALPHA3K PEPTIDE
235, 1lnuF, 0.9124, 1.14, 0.578, 217, 90, CRYSTAL STRUCTURE OF CLASS II MHC MOLECULE IAB BOUND TO EALPHA3K PEPTIDE
236, 4p5mF, 0.9107, 0.80, 0.632, 190, 87, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
237, 4p57D, 0.9107, 0.80, 0.632, 196, 87, MHC TCR PEPTIDE COMPLEX
238, 6blxB, 0.9105, 1.01, 0.573, 197, 89, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH INSULIN MIMOTOPE P8G9E
239, 4p23D, 0.9100, 0.91, 0.580, 200, 88, J809.B5 TCR BOUND TO IAB/3K
240, 4p57B, 0.9096, 0.81, 0.632, 197, 87, MHC TCR PEPTIDE COMPLEX
241, 6blqB, 0.9092, 1.02, 0.573, 200, 89, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH INSULIN MIMOTOPE P8E9E
242, 4p5kB, 0.9086, 0.93, 0.625, 198, 88, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGY AND AUTOIMMUNITY
243, 1mujB, 0.9079, 1.17, 0.596, 184, 89, CRYSTAL STRUCTURE OF MURINE CLASS II MHC I-AB IN COMPLEX WITH A HUMAN CLIP PEPTIDE
244, 1d9kD, 0.9074, 1.02, 0.596, 188, 89, CRYSTAL STRUCTURE OF COMPLEX BETWEEN D10 TCR AND PMHC I-AK/CA
245, 3c6lD, 0.9071, 0.92, 0.591, 192, 88, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR 2W20
246, 2iadB, 0.9067, 0.95, 0.636, 201, 88, CLASS II MHC I-AD IN COMPLEX WITH AN INFLUENZA HEMAGGLUTININ PEPTIDE 126-138
247, 4p4rD, 0.9060, 0.97, 0.625, 199, 88, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
248, 3c6lH, 0.9036, 0.95, 0.591, 192, 88, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR 2W20
249, 4p5tH, 0.9029, 0.88, 0.598, 199, 87, 14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
250, 4p4rB, 0.9025, 1.01, 0.625, 199, 88, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
251, 4p5tD, 0.9006, 0.90, 0.598, 199, 87, 14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
252, 3wexH, 0.8998, 0.94, 0.632, 195, 87, CRYSTAL STRUCTURE OF HLA-DP5 IN COMPLEX WITH CRY J 1-DERIVED PEPTIDE (RESIDUES 214-222)
253, 3rdtD, 0.8995, 0.91, 0.598, 199, 87, CRYSTAL STRUCTURE OF 809.B5 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
254, 3wexB, 0.8994, 0.94, 0.632, 195, 87, CRYSTAL STRUCTURE OF HLA-DP5 IN COMPLEX WITH CRY J 1-DERIVED PEPTIDE (RESIDUES 214-222)
255, 4p46D, 0.8993, 0.91, 0.598, 199, 87, J809.B5 Y31A TCR BOUND TO IAB3K
256, 2pxyD, 0.8986, 1.15, 0.557, 189, 88, CRYSTAL STRUCTURES OF IMMUNE RECEPTOR COMPLEXES
257, 3wexD, 0.8982, 0.95, 0.632, 195, 87, CRYSTAL STRUCTURE OF HLA-DP5 IN COMPLEX WITH CRY J 1-DERIVED PEPTIDE (RESIDUES 214-222)
258, 1d9kH, 0.8981, 1.08, 0.596, 188, 89, CRYSTAL STRUCTURE OF COMPLEX BETWEEN D10 TCR AND PMHC I-AK/CA
259, 1iaoB, 0.8969, 0.93, 0.644, 200, 87, CLASS II MHC I-AD IN COMPLEX WITH OVALBUMIN PEPTIDE 323-339
260, 2z31D, 0.8964, 1.13, 0.557, 188, 88, CRYSTAL STRUCTURE OF IMMUNE RECEPTOR COMPLEX
261, 4p4kB, 0.8962, 1.09, 0.625, 199, 88, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY
262, 4p4kF, 0.8956, 1.10, 0.625, 199, 88, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY
263, 3wexF, 0.8934, 0.99, 0.632, 195, 87, CRYSTAL STRUCTURE OF HLA-DP5 IN COMPLEX WITH CRY J 1-DERIVED PEPTIDE (RESIDUES 214-222)
264, 6blrB, 0.8931, 0.98, 0.586, 198, 87, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH INSULIN MIMOTOPE P8E9E6SS
265, 4p5kE, 0.8926, 1.08, 0.625, 198, 88, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGY AND AUTOIMMUNITY
266, 1u3hH, 0.8914, 1.16, 0.557, 189, 88, CRYSTAL STRUCTURE OF MOUSE TCR 172.10 COMPLEXED WITH MHC CLASS II I-AU MOLECULE AT 2.4 A
267, 4p5mB, 0.8905, 1.04, 0.632, 199, 87, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
268, 5dmkF, 0.8889, 1.02, 0.586, 190, 87, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH RLGL-WE14
269, 4p5mD, 0.8885, 1.05, 0.632, 199, 87, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY
270, 5dmkB, 0.8884, 1.01, 0.586, 190, 87, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH RLGL-WE14
271, 5dmkH, 0.8873, 1.04, 0.598, 189, 87, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH RLGL-WE14
272, 1u3hD, 0.8863, 1.19, 0.557, 189, 88, CRYSTAL STRUCTURE OF MOUSE TCR 172.10 COMPLEXED WITH MHC CLASS II I-AU MOLECULE AT 2.4 A
273, 5dmkD, 0.8860, 1.04, 0.586, 186, 87, CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH RLGL-WE14
274, 1jl4B, 0.8845, 0.94, 0.616, 185, 86, CRYSTAL STRUCTURE OF THE HUMAN CD4 N-TERMINAL TWO DOMAIN FRAGMENT COMPLEXED TO A CLASS II MHC MOLECULE
275, 1iakB, 0.8844, 0.94, 0.616, 185, 86, HISTOCOMPATIBILITY ANTIGEN I-AK
276, 2p24B, 0.8825, 0.97, 0.570, 194, 86, I-AU/MBP125-135
277, 1f3jE, 0.8815, 1.06, 0.586, 187, 87, HISTOCOMPATIBILITY ANTIGEN I-AG7
278, 1f3jB, 0.8797, 1.08, 0.586, 187, 87, HISTOCOMPATIBILITY ANTIGEN I-AG7
279, 1es0B, 0.8773, 1.01, 0.593, 190, 86, CRYSTAL STRUCTURE OF THE MURINE CLASS II ALLELE I-A(G7) COMPLEXED WITH THE GLUTAMIC ACID DECARBOXYLASE (GAD65) PEPTIDE 207-220
280, 3mbeF, 0.8766, 1.02, 0.593, 178, 86, TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27)
281, 3mbeB, 0.8765, 1.03, 0.593, 178, 86, TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27)
282, 1k2dB, 0.8736, 1.04, 0.570, 185, 86, CRYSTAL STRUCTURE OF THE AUTOIMMUNE MHC CLASS II I-AU COMPLEXED WITH MYELIN BASIC PROTEIN 1-11 AT 2.2A
283, 3cupB, 0.8733, 1.25, 0.586, 176, 87, CRYSTAL STRUCTURE OF THE MHC CLASS II MOLECULE I-AG7 IN COMPLEX WITH THE PEPTIDE GAD221-235
284, 5u1rA, 0.7884, 2.21, 0.125, 262, 88, STRUCTURE OF HUMAN MR1-DICLOFENAC IN COMPLEX WITH HUMAN MAIT A-F7 TCR
285, 5u72C, 0.7871, 2.20, 0.125, 263, 88, STRUCTURE OF HUMAN MR1-5OH-DCF IN COMPLEX WITH HUMAN MAIT A-F7 TCR
286, 5d7jC, 0.7845, 2.21, 0.125, 263, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64(Y95ALPHAF) TCR
287, 5u1rC, 0.7827, 2.22, 0.125, 263, 88, STRUCTURE OF HUMAN MR1-DICLOFENAC IN COMPLEX WITH HUMAN MAIT A-F7 TCR
288, 5opiA, 0.7826, 2.15, 0.112, 278, 89, CRYSTAL STRUCTURE OF THE TAPBPR-MHC I PEPTIDE EDITING COMPLEX
289, 4pjcC, 0.7820, 2.22, 0.125, 256, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-A11 TCR
290, 5d7iA, 0.7807, 2.23, 0.125, 263, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT M33.64 TCR
291, 4pjaC, 0.7798, 2.24, 0.125, 256, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-B10 TCR
292, 4pj5A, 0.7784, 2.26, 0.125, 263, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT TRBV6-1 TCR
293, 4pjcA, 0.7783, 2.04, 0.126, 264, 87, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-A11 TCR
294, 5u72A, 0.7777, 2.26, 0.125, 259, 88, STRUCTURE OF HUMAN MR1-5OH-DCF IN COMPLEX WITH HUMAN MAIT A-F7 TCR
295, 4pjfA, 0.7759, 2.28, 0.125, 263, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-C10 TCR
296, 3bevA, 0.7758, 2.12, 0.151, 274, 86, 11MER STRUCTURE OF AN MHC CLASS I MOLECULE FROM B21 CHICKENS ILLUSTRATE PROMISCUOUS PEPTIDE BINDING
297, 5u6qA, 0.7756, 2.07, 0.126, 263, 87, STRUCTURE OF HUMAN MR1-3-F-SA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
298, 5d7jE, 0.7754, 2.26, 0.125, 265, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64(Y95ALPHAF) TCR
299, 4pjaA, 0.7754, 2.06, 0.126, 264, 87, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-B10 TCR
300, 5u16C, 0.7753, 2.29, 0.125, 265, 88, STRUCTURE OF HUMAN MR1-2-OH-1-NA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
301, 4l4vA, 0.7752, 2.05, 0.126, 262, 87, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH
302, 5d5mA, 0.7745, 2.29, 0.125, 264, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64 TCR
303, 5u17A, 0.7743, 2.07, 0.126, 264, 87, STRUCTURE OF HUMAN MR1-DA-6-FP IN COMPLEX WITH HUMAN MAIT A-F7 TCR
304, 5gjyA, 0.7743, 2.04, 0.174, 266, 86, CRYSTAL STRUCTURE OF DUCK MHC CLASS I FOR 1.71 ANGSTROM
305, 4lcwA, 0.7743, 2.08, 0.126, 264, 87, THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH
306, 5u2vA, 0.7742, 2.07, 0.126, 264, 87, STRUCTURE OF HUMAN MR1-HMB IN COMPLEX WITH HUMAN MAIT A-F7 TCR
307, 4cvzA, 0.7741, 2.30, 0.149, 277, 87, COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 10MER CHICKEN PEPTIDE
308, 4pjeA, 0.7738, 2.06, 0.126, 261, 87, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-B10 TCR
309, 5u16A, 0.7737, 2.27, 0.125, 265, 88, STRUCTURE OF HUMAN MR1-2-OH-1-NA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
310, 4lccC, 0.7735, 2.40, 0.114, 341, 88, CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH A BACTERIAL ANTIGEN BOUND TO HUMANIZED BOVINE MR1
311, 4pj7A, 0.7731, 2.08, 0.126, 264, 87, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV6-4 TCR
312, 4l4tA, 0.7730, 2.07, 0.126, 264, 87, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP
313, 4pj5C, 0.7729, 2.27, 0.125, 258, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT TRBV6-1 TCR
314, 4nqdA, 0.7729, 2.08, 0.126, 260, 87, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND NON-COVALENTLY BOUND 5-(2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
315, 4iiqC, 0.7727, 2.32, 0.114, 359, 88, CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH BOVINE MR1
316, 4pjiA, 0.7724, 2.08, 0.126, 262, 87, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-C10 TCR
317, 4pjiC, 0.7722, 2.28, 0.125, 251, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-C10 TCR
318, 5nq1A, 0.7721, 2.25, 0.146, 276, 89, PORCINE (SUS SCROFA) MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS I; WITH HUMAN BETA2 MICRO GLOBULIN; PRESENTING DFEREGYSL 
319, 4pj7C, 0.7720, 2.30, 0.125, 264, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV6-4 TCR
320, 4l9lC, 0.7720, 2.36, 0.114, 328, 88, CRYSTAL STRUCTURE OF A HUMAN VALPHA7.2/VBETA13.2 MAIT TCR IN COMPLEX WITH BOVINE MR1
321, 5d7iC, 0.7719, 2.28, 0.125, 269, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT M33.64 TCR
322, 4pjbC, 0.7719, 2.28, 0.136, 260, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
323, 4l8sC, 0.7719, 2.35, 0.114, 371, 88, CRYSTAL STRUCTURE OF A HUMAN VALPHA7.2/VBETA13.3 MAIT TCR IN COMPLEX WITH BOVINE MR1
324, 4d0cA, 0.7714, 2.31, 0.138, 276, 87, COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 10MER CHICKEN PEPTIDE
325, 4pjxA, 0.7712, 2.08, 0.126, 262, 87, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-A11 TCR
326, 4pjeC, 0.7709, 2.28, 0.125, 252, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-B10 TCR
327, 4pjgA, 0.7707, 2.31, 0.125, 264, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
328, 4lcwC, 0.7704, 2.09, 0.126, 256, 87, THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH
329, 5u2vC, 0.7701, 2.32, 0.124, 262, 89, STRUCTURE OF HUMAN MR1-HMB IN COMPLEX WITH HUMAN MAIT A-F7 TCR
330, 4pjbA, 0.7699, 2.30, 0.136, 264, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
331, 3bewD, 0.7698, 2.13, 0.138, 271, 87, 10MER CRYSTAL STRUCTURE OF CHICKEN MHC CLASS I HAPLOTYPE B21
332, 5u6qC, 0.7695, 2.28, 0.125, 261, 88, STRUCTURE OF HUMAN MR1-3-F-SA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
333, 4pjfC, 0.7694, 2.30, 0.125, 257, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-C10 TCR
334, 4l4vC, 0.7694, 2.29, 0.125, 256, 88, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH
335, 5aczA, 0.7689, 2.34, 0.138, 269, 87, COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 11MER CHICKEN PEPTIDE
336, 5d5mC, 0.7688, 2.10, 0.126, 269, 87, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64 TCR
337, 4nqeA, 0.7688, 2.10, 0.126, 264, 87, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX BOUND TO 5-(2- OXOETHYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
338, 4pj8A, 0.7684, 2.13, 0.116, 260, 86, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV20 TCR
339, 4nqdC, 0.7682, 2.09, 0.126, 248, 87, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND NON-COVALENTLY BOUND 5-(2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
340, 4pjxC, 0.7679, 2.31, 0.136, 250, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-A11 TCR
341, 4pj9A, 0.7677, 2.12, 0.126, 262, 87, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRAJ20 TCR
342, 4pjdA, 0.7676, 2.10, 0.126, 264, 87, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-C10 TCR
343, 4pjhC, 0.7675, 2.31, 0.125, 255, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-G8 TCR
344, 5u17C, 0.7674, 2.09, 0.126, 262, 87, STRUCTURE OF HUMAN MR1-DA-6-FP IN COMPLEX WITH HUMAN MAIT A-F7 TCR
345, 4pjhA, 0.7671, 2.11, 0.126, 262, 87, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-G8 TCR
346, 4pjgC, 0.7671, 2.33, 0.125, 249, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
347, 3bewA, 0.7671, 2.15, 0.138, 271, 87, 10MER CRYSTAL STRUCTURE OF CHICKEN MHC CLASS I HAPLOTYPE B21
348, 5d7lA, 0.7670, 2.29, 0.136, 262, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAV36 TCR
349, 5gjxA, 0.7664, 2.14, 0.172, 266, 87, CRYSTAL STRUCTURE OF DUCK MHC I FOR 2.06 ANGSTROM
350, 4nqcC, 0.7664, 2.13, 0.126, 263, 87, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND COVALENTLY BOUND 5- (2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
351, 4nqcA, 0.7663, 2.33, 0.125, 255, 88, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND COVALENTLY BOUND 5- (2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
352, 4cvxD, 0.7660, 2.35, 0.125, 272, 88, COMPLEX OF A B2 CHICKEN MHC CLASS I MOLECULE AND A 9MER CHICKEN PEPTIDE
353, 4cvxA, 0.7657, 2.35, 0.125, 272, 88, COMPLEX OF A B2 CHICKEN MHC CLASS I MOLECULE AND A 9MER CHICKEN PEPTIDE
354, 4l4tC, 0.7655, 2.10, 0.126, 250, 87, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP
355, 4nqeC, 0.7651, 2.11, 0.126, 249, 87, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX BOUND TO 5-(2- OXOETHYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
356, 5hgbD, 0.7650, 2.14, 0.170, 274, 88, HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE
357, 5hgbG, 0.7647, 2.13, 0.170, 274, 88, HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE
358, 4d0bA, 0.7646, 2.37, 0.136, 276, 88, COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 10MER CHICKEN PEPTIDE
359, 3h9hD, 0.7640, 2.12, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TEL1P PEPTIDE
360, 3p77A, 0.7639, 2.05, 0.149, 272, 87, CRYSTAL STRUCTURES OF THE CHICKEN YF1*7.1 MOLECULE
361, 3h9hA, 0.7638, 2.03, 0.138, 275, 87, HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TEL1P PEPTIDE
362, 4pjdC, 0.7637, 2.29, 0.126, 254, 87, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-C10 TCR
363, 2clrD, 0.7637, 2.09, 0.159, 275, 88, THREE DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING OUT ONE END OF A CLASS I MHC BINDING SITE
364, 1vgkA, 0.7637, 2.19, 0.136, 274, 88, THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KD AT 2.0 A RESOLUTION
365, 5werD, 0.7629, 2.21, 0.125, 265, 88, CRYSTAL STRUCTURE OF TAPBPR AND H2-DD COMPLEX
366, 2dypA, 0.7629, 2.12, 0.159, 275, 88, CRYSTAL STRUCTURE OF LILRB2(LIR2/ILT4/CD85D) COMPLEXED WITH HLA-G
367, 2clrA, 0.7629, 2.11, 0.159, 275, 88, THREE DIMENSIONAL STRUCTURE OF A PEPTIDE EXTENDING OUT ONE END OF A CLASS I MHC BINDING SITE
368, 5werA, 0.7624, 2.40, 0.124, 265, 89, CRYSTAL STRUCTURE OF TAPBPR AND H2-DD COMPLEX
369, 4wdiD, 0.7623, 2.18, 0.136, 277, 88, WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES
370, 4no3A, 0.7623, 2.14, 0.159, 274, 88, CRYSTAL STRUCTURE OF AMPD2 PHOSPHOPEPTIDE BOUND TO HLA-A2
371, 5nq1D, 0.7621, 2.34, 0.146, 276, 89, PORCINE (SUS SCROFA) MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS I; WITH HUMAN BETA2 MICRO GLOBULIN; PRESENTING DFEREGYSL 
372, 5hgaD, 0.7617, 2.15, 0.170, 274, 88, HLA*A2402 COMPLEX WITH HIV NEF138 Y2F-8MER MUTANT EPITOPE
373, 5gsvA, 0.7617, 2.20, 0.148, 274, 88, MOUSE MHC CLASS I H-2KD WITH A MERS-COV-DERIVED PEPTIDE 142-5
374, 4wu5A, 0.7617, 2.14, 0.170, 274, 88, HLA-A24 IN COMPLEX WITH HIV-1 NEF134-8(WT)
375, 4d0dJ, 0.7617, 2.36, 0.136, 274, 88, COMPLEX OF A B2 CHICKEN MHC CLASS I MOLECULE AND A 8MER CHICKEN PEPTIDE
376, 3kynA, 0.7617, 2.16, 0.170, 275, 88, CRYSTAL STRUCTURE OF HLA-G PRESENTING KGPPAALTL PEPTIDE
377, 2yezA, 0.7617, 2.40, 0.138, 278, 87, COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 10MER CHICKEN PEPTIDE
378, 5hgbJ, 0.7615, 2.14, 0.170, 274, 88, HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE
379, 5hgbA, 0.7615, 2.14, 0.170, 274, 88, HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE
380, 5xs3A, 0.7614, 2.14, 0.170, 271, 88, CRYSTAL STRUCTURE OF HLA CLASS I ANTIGEN
381, 4wu5D, 0.7614, 2.15, 0.170, 274, 88, HLA-A24 IN COMPLEX WITH HIV-1 NEF134-8(WT)
382, 5tezA, 0.7613, 2.31, 0.157, 275, 89, TCR F50 RECGONIZING M1-HLA-A2
383, 3kyoA, 0.7609, 2.17, 0.170, 273, 88, CRYSTAL STRUCTURE OF HLA-G PRESENTING KLPAQFYIL PEPTIDE
384, 1ydpA, 0.7606, 2.16, 0.170, 275, 88, 1.9A CRYSTAL STRUCTURE OF HLA-G
385, 1zvsA, 0.7605, 2.19, 0.159, 278, 88, CRYSTAL STRUCTURE OF THE FIRST CLASS MHC MAMU AND TAT-TL8 COMPLEX
386, 5hgdD, 0.7603, 2.18, 0.170, 274, 88, HLA*A2402 COMPLEXED WITH HIV NEF138 Y2F MUTANT 10MER EPITOPE
387, 4wu7D, 0.7603, 2.16, 0.170, 274, 88, HLA-A24 IN COMPLEX WITH HIV-1 NEF134-8(2F)
388, 2v2xD, 0.7596, 2.14, 0.159, 275, 88, T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT.
389, 5hgdA, 0.7594, 2.19, 0.170, 274, 88, HLA*A2402 COMPLEXED WITH HIV NEF138 Y2F MUTANT 10MER EPITOPE
390, 1ogaA, 0.7593, 2.05, 0.163, 276, 86, A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION.
391, 5gsxD, 0.7592, 2.20, 0.136, 274, 88, MOUSE MHC CLASS I H-2KD WITH A MERS-COV-DERIVED PEPTIDE 142-2
392, 3vxoD, 0.7592, 2.17, 0.170, 274, 88, HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(2F)
393, 3vxoA, 0.7592, 2.17, 0.170, 274, 88, HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(2F)
394, 5jhdF, 0.7591, 2.10, 0.172, 276, 87, CRYSTAL STRUCTURE OF LS10-TCR/M1-HLA-A*02 COMPLEX
395, 5hhmA, 0.7590, 2.27, 0.159, 212, 88, CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L
396, 4d0dA, 0.7590, 2.20, 0.138, 275, 87, COMPLEX OF A B2 CHICKEN MHC CLASS I MOLECULE AND A 8MER CHICKEN PEPTIDE
397, 3ixaA, 0.7590, 1.99, 0.151, 275, 86, HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TAX PEPTIDE
398, 4d0dG, 0.7589, 2.19, 0.138, 270, 87, COMPLEX OF A B2 CHICKEN MHC CLASS I MOLECULE AND A 8MER CHICKEN PEPTIDE
399, 5iszA, 0.7588, 2.09, 0.172, 275, 87, CRYSTAL STRUCTURE OF LS01-TCR/M1-HLA-A*02 COMPLEX
400, 5hhmF, 0.7588, 2.27, 0.159, 212, 88, CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L
401, 1a6zA, 0.7587, 2.38, 0.159, 272, 88, HFE (HUMAN) HEMOCHROMATOSIS PROTEIN
402, 3p73A, 0.7586, 2.26, 0.148, 275, 88, CRYSTAL STRUCTURES OF THE CHICKEN YF1*7.1 MOLECULE
403, 1a6zC, 0.7586, 2.37, 0.159, 272, 88, HFE (HUMAN) HEMOCHROMATOSIS PROTEIN
404, 5d7lC, 0.7585, 2.20, 0.128, 242, 86, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAV36 TCR
405, 5ad0A, 0.7582, 2.30, 0.151, 269, 86, COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 11MER CHICKEN PEPTIDE
406, 4wdiA, 0.7582, 2.19, 0.136, 277, 88, WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES
407, 2d31A, 0.7582, 2.19, 0.159, 269, 88, CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER
408, 5nq3A, 0.7579, 2.33, 0.146, 276, 89,  PORCINE (SUS SCROFA) MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS I; WITH HUMAN BETA2 MICRO GLOBULIN; PRESENTING EFEDLTFLA 
409, 4z76D, 0.7579, 2.22, 0.136, 277, 88, WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES
410, 2vllD, 0.7578, 2.14, 0.159, 275, 88, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
411, 5hghA, 0.7576, 2.19, 0.170, 274, 88, HLA*A2402 COMPLEXED WITH HIV NEF138 10MER EPITOPE
412, 3nfnA, 0.7576, 2.19, 0.170, 274, 88, RECOGNITION OF PEPTIDE-MHC BY A V-DELTA/V-BETA TCR
413, 2v2wD, 0.7576, 2.15, 0.159, 275, 88, T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT
414, 4wu7A, 0.7575, 2.18, 0.170, 274, 88, HLA-A24 IN COMPLEX WITH HIV-1 NEF134-8(2F)
415, 3h9sA, 0.7574, 2.05, 0.138, 275, 87, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TEL1P PEPTIDE
416, 5hgaA, 0.7573, 2.19, 0.170, 274, 88, HLA*A2402 COMPLEX WITH HIV NEF138 Y2F-8MER MUTANT EPITOPE
417, 5f1nA, 0.7573, 2.15, 0.136, 275, 88, MHC COMPLEXED TO 11MER PEPTIDE
418, 5iueE, 0.7571, 2.15, 0.125, 275, 88, HUMAN LEUKOCYTE ANTIGEN F (HLA-F) PRESENTS PEPTIDES AND REGULATES IMMUNITY THROUGH INTERACTIONS WITH NK-CELL RECEPTORS
419, 3bzeA, 0.7571, 2.23, 0.148, 273, 88, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA- 2 E
420, 2vllA, 0.7570, 2.16, 0.159, 275, 88, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
421, 2d31D, 0.7569, 2.21, 0.159, 262, 88, CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER
422, 5werG, 0.7568, 2.35, 0.136, 269, 88, CRYSTAL STRUCTURE OF TAPBPR AND H2-DD COMPLEX
423, 4z77D, 0.7568, 2.21, 0.148, 277, 88, WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES
424, 3kyoC, 0.7567, 2.18, 0.170, 273, 88, CRYSTAL STRUCTURE OF HLA-G PRESENTING KLPAQFYIL PEPTIDE
425, 4g43D, 0.7566, 2.41, 0.148, 270, 88, STRUCTURE OF THE CHICKEN MHC CLASS I MOLECULE BF2*0401 COMPLEXED TO P5E
426, 5jhdA, 0.7565, 2.12, 0.172, 276, 87, CRYSTAL STRUCTURE OF LS10-TCR/M1-HLA-A*02 COMPLEX
427, 3vxnA, 0.7565, 2.20, 0.170, 274, 88, HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(WT)
428, 2gtzA, 0.7565, 2.08, 0.161, 275, 87, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A28L SUBSTITUTION
429, 3w0wA, 0.7564, 2.13, 0.172, 279, 87, THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE IN SPACE GROUP P212121
430, 5w1wA, 0.7563, 2.24, 0.148, 272, 88, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
431, 2v2xA, 0.7563, 2.15, 0.159, 275, 88, T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT.
432, 3vxuA, 0.7562, 2.18, 0.170, 274, 88, THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE
433, 5hhpA, 0.7561, 2.12, 0.161, 274, 87, CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH M1-G4E
434, 5degA, 0.7561, 2.19, 0.159, 276, 88, CRYSTAL STRUCTURE OF B*27:06 BOUND TO THE PVIPR PEPTIDE
435, 4mnqA, 0.7561, 2.11, 0.161, 276, 87, TCR-PEPTIDE SPECIFICITY OVERRIDES AFFINITY ENHANCING TCR-MHC INTERACTIONS
436, 1b0gA, 0.7561, 2.18, 0.159, 275, 88, CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)/BETA 2- MICROGLOBULIN/PEPTIDE P1049 COMPLEX
437, 4cw1A, 0.7560, 2.26, 0.138, 271, 87, COMPLEX OF A B14 CHICKEN MHC CLASS I MOLECULE AND A 9MER CHICKEN PEPTIDE
438, 3qfdA, 0.7560, 2.08, 0.161, 275, 87, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH MART-1(27-35) NONAMERIC PEPTIDE
439, 3ixaD, 0.7560, 2.03, 0.140, 275, 86, HUMAN CLASS I MHC HLA-A2(A150P) IN COMPLEX WITH THE TAX PEPTIDE
440, 2a83A, 0.7560, 2.19, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE GLUCAGON RECEPTOR (GR) PEPTIDE (RESIDUES 412-420)
441, 5gsxA, 0.7559, 2.24, 0.136, 274, 88, MOUSE MHC CLASS I H-2KD WITH A MERS-COV-DERIVED PEPTIDE 142-2
442, 5gsbA, 0.7559, 2.21, 0.136, 274, 88, MOUSE MHC CLASS I H-2KD WITH A MERS-COV-DERIVED PEPTIDE 37-3
443, 4z76A, 0.7558, 2.24, 0.136, 277, 88, WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES
444, 4g42D, 0.7558, 2.25, 0.149, 272, 87, STRUCTURE OF THE CHICKEN MHC CLASS I MOLECULE BF2*0401 COMPLEXED TO PEPITDE P8D
445, 3vxuF, 0.7558, 2.18, 0.170, 274, 88, THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE
446, 2esvA, 0.7554, 2.23, 0.159, 268, 88, STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX
447, 3o4lA, 0.7553, 2.13, 0.151, 276, 86, GENETIC AND STRUCTURAL BASIS FOR SELECTION OF A UBIQUITOUS T CELL RECEPTOR DEPLOYED IN EPSTEIN-BARR VIRUS
448, 1b0gD, 0.7553, 2.18, 0.159, 275, 88, CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2.1)/BETA 2- MICROGLOBULIN/PEPTIDE P1049 COMPLEX
449, 4z78A, 0.7552, 2.23, 0.136, 277, 88, WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES
450, 3mgtD, 0.7552, 2.12, 0.161, 275, 87, CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201
451, 3pwvA, 0.7551, 2.21, 0.102, 274, 88, AN IMMMUNODOMINANT CTL EPITOPE FROM RINDERPEST VIRUS PRESENTED BY CATTLE MHC CLASS I MOLECULE N*01801 (BOLA-A11)
452, 5gsrA, 0.7550, 2.21, 0.136, 274, 88, MOUSE MHC CLASS I H-2KD WITH A MERS-COV-DERIVED PEPTIDE I5A
453, 1eezA, 0.7549, 2.17, 0.159, 275, 88, CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TO GP2 PEPTIDE VARIANT(I2L/V5L)
454, 3mrhA, 0.7548, 2.17, 0.159, 274, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE N3S VARIANT
455, 2x4oA, 0.7548, 2.18, 0.159, 275, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 ENVELOPE PEPTIDE ENV120-128
456, 1eezD, 0.7548, 2.17, 0.159, 275, 88, CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TO GP2 PEPTIDE VARIANT(I2L/V5L)
457, 4no5A, 0.7547, 2.21, 0.148, 275, 88, CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF AMPD2 PHOSPHOPEPTIDE BOUND TO HLA-A2
458, 4d0dD, 0.7547, 2.21, 0.138, 272, 87, COMPLEX OF A B2 CHICKEN MHC CLASS I MOLECULE AND A 8MER CHICKEN PEPTIDE
459, 2av7D, 0.7547, 2.13, 0.161, 275, 87, CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE K66A MUTATION IN THE HEAVY CHAIN.
460, 2vlkA, 0.7546, 2.17, 0.159, 276, 88, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
461, 1inqA, 0.7546, 2.25, 0.114, 275, 88, STRUCTURE OF MINOR HISTOCOMPATIBILITY ANTIGEN PEPTIDE H13A COMPLEXED TO H2-DB
462, 4cw1D, 0.7545, 2.25, 0.138, 271, 87, COMPLEX OF A B14 CHICKEN MHC CLASS I MOLECULE AND A 9MER CHICKEN PEPTIDE
463, 3vxpD, 0.7545, 2.13, 0.172, 274, 87, HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(6L)
464, 3czfA, 0.7545, 2.20, 0.159, 275, 88, CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE GLUCAGON RECEPTOR (GR) PEPTIDE (RESIDUES 412-420)
465, 3bp7A, 0.7545, 2.19, 0.159, 276, 88, THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*2709 IN COMPLEX WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE PCATA
466, 1kj2H, 0.7544, 2.30, 0.125, 276, 88, MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
467, 4z78D, 0.7543, 2.18, 0.138, 277, 87, WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES
468, 3d18A, 0.7543, 2.20, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH A VARIANT OF THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2(L)) OF EPSTEIN-BARR VIRUS
469, 3bh9A, 0.7543, 2.17, 0.159, 275, 88, CRYSTAL STRUCTURE OF RTY PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
470, 2j8uH, 0.7543, 2.10, 0.161, 275, 87, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.
471, 5gsrC, 0.7542, 2.22, 0.136, 274, 88, MOUSE MHC CLASS I H-2KD WITH A MERS-COV-DERIVED PEPTIDE I5A
472, 1zvsD, 0.7542, 2.24, 0.159, 278, 88, CRYSTAL STRUCTURE OF THE FIRST CLASS MHC MAMU AND TAT-TL8 COMPLEX
473, 3mgtJ, 0.7541, 2.13, 0.161, 275, 87, CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201
474, 2gitD, 0.7541, 2.13, 0.161, 275, 87, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE MODIFIED HTLV-1 TAX (Y5K- 4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE
475, 1im9E, 0.7541, 2.18, 0.170, 275, 88, CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELL INHIBITORY RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4
476, 4z77A, 0.7540, 2.19, 0.136, 277, 88, WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES
477, 5iueI, 0.7539, 2.11, 0.126, 275, 87, HUMAN LEUKOCYTE ANTIGEN F (HLA-F) PRESENTS PEPTIDES AND REGULATES IMMUNITY THROUGH INTERACTIONS WITH NK-CELL RECEPTORS
478, 1jgdA, 0.7539, 2.19, 0.148, 276, 88, HLA-B*2709 BOUND TO DECA-PEPTIDE S10R
479, 1hhiA, 0.7539, 2.14, 0.161, 275, 87, THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
480, 5nq3D, 0.7538, 2.20, 0.136, 276, 88,  PORCINE (SUS SCROFA) MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS I; WITH HUMAN BETA2 MICRO GLOBULIN; PRESENTING EFEDLTFLA 
481, 3v5kD, 0.7538, 2.19, 0.159, 275, 88, HLA2.1 KVAELVWFL
482, 3kpmA, 0.7538, 2.21, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLKAWTF A MIMOTOPE
483, 2qrtB, 0.7538, 2.38, 0.124, 398, 89, CRYSTAL STRUCTURE OF A DISULFIDE TRAPPED SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB Y84C BETA- 2MICROGLOBULIN AND OVALBUMIN-DERIVED PEPTIDE.
484, 1im3I, 0.7537, 2.21, 0.159, 275, 88, CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX
485, 5werJ, 0.7536, 2.50, 0.135, 270, 89, CRYSTAL STRUCTURE OF TAPBPR AND H2-DD COMPLEX
486, 5w1wK, 0.7536, 2.27, 0.148, 272, 88, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
487, 4u6yA, 0.7536, 2.22, 0.148, 274, 88, CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH FLNDK A 15 MER SELF- PEPTIDE
488, 3wl9A, 0.7536, 2.14, 0.172, 274, 87, HLA-A24 IN COMPLEX WITH HIV-1 NEF126-10(8I10F)
489, 3v5hD, 0.7536, 2.17, 0.159, 275, 88, HLA-A2.1 KVAEIVHFL
490, 3pwnA, 0.7536, 2.15, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L) PEPTIDE VARIANT
491, 3klaA, 0.7536, 2.18, 0.159, 275, 88, CA2+ RELEASE FROM THE ENDOPLASMIC RETICULUM OF NY-ESO-1 SPECIFIC T CELLS IS MODULATED BY THE AFFINITY OF T CELL RECEPTOR AND BY THE USE OF THE CD8 CO-RECEPTOR
492, 1im3E, 0.7536, 2.21, 0.159, 275, 88, CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX
493, 1hhiD, 0.7536, 2.14, 0.161, 275, 87, THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
494, 1t1zA, 0.7535, 2.22, 0.159, 275, 88, STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE VARIANT SL9-6A
495, 4k7fD, 0.7534, 2.17, 0.159, 275, 88, NEWLY IDENTIFIED EPITOPE V60 FROM HBV CORE PROTEIN COMPLEXED WITH HLA- A*0201
496, 4gupA, 0.7534, 2.08, 0.128, 265, 86, STRUCTURE OF MHC-CLASS I RELATED MOLECULE MR1
497, 3o3bA, 0.7533, 2.16, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1.1
498, 1im3M, 0.7533, 2.22, 0.159, 275, 88, CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX
499, 1im3A, 0.7533, 2.22, 0.159, 275, 88, CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2 BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX
500, 3hpjD, 0.7532, 2.14, 0.161, 275, 87, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) PEPTIDE
501, 1i7uD, 0.7532, 2.13, 0.161, 275, 87, CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-6V
502, 4zezA, 0.7531, 2.32, 0.157, 261, 89, CRYSTAL STRUCTURE OF HCV 1406 TCR/HCV NS3: 1406-1415/HLA-A2 COMPLEX
503, 3v5dD, 0.7531, 2.19, 0.159, 275, 88, HLA-A2.1 KVAELVHFL
504, 2clzA, 0.7531, 2.26, 0.125, 278, 88, MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM1 PEPTIDE
505, 1hhgD, 0.7531, 2.15, 0.161, 275, 87, THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
506, 5nmkA, 0.7530, 2.20, 0.159, 276, 88, HLA A02 PRESENTING SLFNTIAVL
507, 5iueG, 0.7530, 2.12, 0.126, 274, 87, HUMAN LEUKOCYTE ANTIGEN F (HLA-F) PRESENTS PEPTIDES AND REGULATES IMMUNITY THROUGH INTERACTIONS WITH NK-CELL RECEPTORS
508, 3v5dA, 0.7530, 2.19, 0.159, 275, 88, HLA-A2.1 KVAELVHFL
509, 3qzwD, 0.7530, 2.24, 0.170, 274, 88, PLASTICITY OF HUMAN CD8 BINDING TO PEPTIDE-HLA-A*2402
510, 3i6gA, 0.7530, 2.14, 0.138, 275, 87, NEWLY IDENTIFIED EPITOPE MN2 FROM SARS-COV M PROTEIN COMPLEXED WITHHLA-A*0201
511, 2v2wA, 0.7530, 2.18, 0.159, 275, 88, T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT
512, 5wliJ, 0.7529, 2.15, 0.114, 276, 88, CRYSTAL STRUCTURE OF H-2DB WITH THE GAP501 PEPTIDE (SQL)
513, 5oqgA, 0.7529, 2.39, 0.124, 388, 89, CRYSTAL STRUCTURE OF A SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB W167A; BETA-2MICROGLOBULIN; AND AND OVALBUMIN-DERIVED PEPTIDE. 
514, 3haeP, 0.7529, 2.21, 0.159, 276, 88, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
515, 3am8B, 0.7529, 2.24, 0.148, 276, 88, CRYSTAL STRUCTURE OF A HUMAN MAJOR HISTOCOMPATIBILTY COMPLEX
516, 1s7vA, 0.7529, 2.13, 0.125, 276, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
517, 1i7tD, 0.7529, 2.15, 0.161, 275, 87, CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V
518, 1i7tA, 0.7529, 2.15, 0.161, 275, 87, CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-5V
519, 6gl1G, 0.7528, 2.17, 0.149, 249, 87, HLA-E*01:03 IN COMPLEX WITH THE HIV EPITOPE; RL9HIV 
520, 3pwlA, 0.7528, 2.14, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD PEPTIDE
521, 1s7vD, 0.7528, 2.13, 0.125, 276, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
522, 3klaD, 0.7527, 2.19, 0.159, 275, 88, CA2+ RELEASE FROM THE ENDOPLASMIC RETICULUM OF NY-ESO-1 SPECIFIC T CELLS IS MODULATED BY THE AFFINITY OF T CELL RECEPTOR AND BY THE USE OF THE CD8 CO-RECEPTOR
523, 2ve6D, 0.7527, 2.18, 0.114, 276, 88, CRYSTAL STRUCTURE OF A MURINE MHC CLASS I H2-DB MOLECULE IN COMPLEX WITH A PHOTOCLEAVABLE PEPTIDE
524, 5mepD, 0.7526, 2.12, 0.161, 276, 87, HUMAN LEUKOCYTE ANTIGEN A02 PRESENTING ILGKFLHWL
525, 3wlbA, 0.7526, 2.18, 0.170, 274, 88, HLA-A24 IN COMPLEX WITH HIV-1 NEF126-10(8T10F)
526, 5wxdA, 0.7525, 2.15, 0.172, 274, 87, CRYSTAL STRUCTURE OF HLA-A*2402 IN COMPLEX WITH AVIAN INFLUENZA A(H7N9) VIRUS-DERIVED PEPTIDE H7-25 (DATA SET 1)
527, 3bp4A, 0.7525, 2.21, 0.159, 276, 88, THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*2705 IN COMPLEX WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE PCATA
528, 1i7uA, 0.7525, 2.14, 0.161, 275, 87, CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1049-6V
529, 5menA, 0.7524, 2.12, 0.161, 276, 87, HUMAN LEUKOCYTE ANTIGEN A02 PRESENTING ILAKFLHWL IN COMPLEX WITH COGNATE T-CELL RECEPTOR
530, 3haeD, 0.7524, 2.21, 0.159, 276, 88, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
531, 2av1A, 0.7524, 2.19, 0.159, 275, 88, CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THE HEAVY CHAIN.
532, 5im7C, 0.7523, 2.19, 0.170, 277, 88, CRYSTAL STRUCTURE OF HLA-B5801 A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION
533, 4f7tA, 0.7523, 2.21, 0.170, 274, 88, CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009 H1N1 PB1 (498-505)
534, 3uttA, 0.7523, 2.14, 0.138, 275, 87, 1E6-A*0201-ALWGPDPAAA COMPLEX TRICLINIC
535, 3haeJ, 0.7523, 2.21, 0.159, 276, 88, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
536, 3bhbA, 0.7523, 2.22, 0.159, 274, 88, CRYSTAL STRUCTURE OF KMD PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
537, 5w1wP, 0.7522, 2.25, 0.148, 272, 88, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
538, 4e0rD, 0.7522, 2.23, 0.149, 272, 87, STRUCTURE OF THE CHICKEN MHC CLASS I MOLECULE BF2*0401
539, 3mgoD, 0.7522, 2.20, 0.159, 275, 88, CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201
540, 3ciiA, 0.7522, 2.22, 0.149, 273, 87, STRUCTURE OF NKG2A/CD94 BOUND TO HLA-E
541, 1rjyD, 0.7522, 2.25, 0.125, 278, 88, MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS GLYCOPROTEIN B PEPTIDE
542, 5meoA, 0.7521, 2.13, 0.161, 276, 87, HUMAN LEUKOCYTE ANTIGEN PRESENTING ILGKFLHRL
543, 1zagD, 0.7520, 2.38, 0.091, 263, 88, HUMAN ZINC-ALPHA-2-GLYCOPROTEIN
544, 1bqhA, 0.7520, 2.30, 0.124, 274, 89, MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8
545, 4g8gA, 0.7519, 2.23, 0.159, 276, 88, CRYSTAL STRUCTURE OF C12C TCR-HA B2705-KK10
546, 2qrsA, 0.7519, 2.30, 0.124, 398, 89, CRYSTAL STRUCTURE OF A SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB Y84A BETA-2MICROGLOBULIN AND OVALBUMIN-DERIVED PEPTIDE.
547, 1duyD, 0.7519, 2.18, 0.159, 275, 88, CRYSTAL STRUCTURE OF HLA-A*0201/OCTAMERIC TAX PEPTIDE COMPLEX
548, 5wliG, 0.7518, 2.16, 0.114, 276, 88, CRYSTAL STRUCTURE OF H-2DB WITH THE GAP501 PEPTIDE (SQL)
549, 5hhoA, 0.7518, 2.18, 0.159, 276, 88, CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-G4E
550, 3ciiD, 0.7518, 2.22, 0.149, 273, 87, STRUCTURE OF NKG2A/CD94 BOUND TO HLA-E
551, 1t1yA, 0.7518, 2.22, 0.148, 275, 88, STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE VARIANT SL9-5V
552, 5oqiA, 0.7517, 2.39, 0.124, 388, 89, CRYSTAL STRUCTURE OF A DISULFIDE TRAPPED SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB Y84C E63A MUTANT; BETA-2MICROGLOBULIN; AND OVALBUMIN-DERIVED PEPTIDE 
553, 3ov6A, 0.7517, 2.49, 0.141, 376, 85, CD1C IN COMPLEX WITH MPM (MANNOSYL-BETA1-PHOSPHOMYCOKETIDE)
554, 3mgoG, 0.7517, 2.20, 0.159, 275, 88, CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201
555, 2av1D, 0.7517, 2.20, 0.159, 275, 88, CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THE HEAVY CHAIN.
556, 5w1vF, 0.7516, 2.26, 0.159, 272, 88, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
557, 3qzwA, 0.7516, 2.25, 0.170, 274, 88, PLASTICITY OF HUMAN CD8 BINDING TO PEPTIDE-HLA-A*2402
558, 3haeA, 0.7515, 2.21, 0.159, 276, 88, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
559, 3bzeG, 0.7515, 2.25, 0.148, 273, 88, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA- 2 E
560, 2f54A, 0.7515, 2.14, 0.161, 274, 87, DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
561, 2av7A, 0.7515, 2.20, 0.159, 275, 88, CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2 WITH THE K66A MUTATION IN THE HEAVY CHAIN.
562, 1t1xA, 0.7515, 2.23, 0.148, 275, 88, STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE VARIANT SL9-4L
563, 1jhtA, 0.7515, 2.13, 0.172, 273, 87, CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A NONAMERIC ALTERED PEPTIDE LIGAND (ALGIGILTV) FROM THE MART- 1/MELAN-A.
564, 5wxcA, 0.7514, 2.23, 0.170, 274, 88, CRYSTAL STRUCTURE OF HLA-A*2402 IN COMPLEX WITH AVIAN INFLUENZA A(H7N9) VIRUS-DERIVED PEPTIDE H7-25 (DATA SET 2)
565, 3i6gD, 0.7514, 2.14, 0.163, 275, 86, NEWLY IDENTIFIED EPITOPE MN2 FROM SARS-COV M PROTEIN COMPLEXED WITHHLA-A*0201
566, 2gt9A, 0.7514, 2.15, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE DECAMERIC MELAN-A/MART- 1(26-35) PEPTIDE
567, 1tvhA, 0.7514, 2.17, 0.159, 275, 88, CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND TO HUMAN CLASS I MHC HLA-A2
568, 4f7mA, 0.7513, 2.21, 0.170, 274, 88, CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009 H1N1 PA (649-658)
569, 2gitA, 0.7513, 2.20, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE MODIFIED HTLV-1 TAX (Y5K- 4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE
570, 5c0bF, 0.7512, 2.10, 0.161, 275, 87, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDFPTI
571, 3mgtG, 0.7512, 2.13, 0.161, 275, 87, CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201
572, 3hpjA, 0.7512, 2.14, 0.161, 275, 87, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) PEPTIDE
573, 5v5lA, 0.7511, 2.24, 0.159, 278, 88, CRYSTAL STRUCTURE OF HLA-B*5801 COMPLEX WITH HIV-1 GAG DERIVED PEPTIDE TW10
574, 3o3aA, 0.7511, 2.21, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1
575, 2qrtA, 0.7511, 2.38, 0.124, 398, 89, CRYSTAL STRUCTURE OF A DISULFIDE TRAPPED SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB Y84C BETA- 2MICROGLOBULIN AND OVALBUMIN-DERIVED PEPTIDE.
576, 2mhaC, 0.7511, 2.27, 0.115, 270, 87, CRYSTAL STRUCTURE OF THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I H-2KB MOLECULE CONTAINING A SINGLE VIRAL PEPTIDE: IMPLICATIONS FOR PEPTIDE BINDING AND T-CELL RECEPTOR RECOGNITION
577, 2jccA, 0.7511, 2.13, 0.161, 275, 87, AH3 RECOGNITION OF MUTANT HLA-A2 W167A
578, 1t21A, 0.7511, 2.23, 0.159, 275, 88, STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE VARIANT SL9 MONOCLINIC CRYSTAL
579, 3o3eA, 0.7510, 2.18, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2.1
580, 3kpqA, 0.7510, 2.20, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLKAWTF A MIMOTOPE
581, 2x4oD, 0.7510, 2.19, 0.159, 275, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 ENVELOPE PEPTIDE ENV120-128
582, 1w0vA, 0.7510, 2.22, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1
583, 5wliA, 0.7509, 2.21, 0.114, 276, 88, CRYSTAL STRUCTURE OF H-2DB WITH THE GAP501 PEPTIDE (SQL)
584, 5oqiB, 0.7509, 2.38, 0.124, 388, 89, CRYSTAL STRUCTURE OF A DISULFIDE TRAPPED SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB Y84C E63A MUTANT; BETA-2MICROGLOBULIN; AND OVALBUMIN-DERIVED PEPTIDE 
585, 5eu3A, 0.7509, 2.19, 0.159, 276, 88, HLA CLASS I ANTIGEN
586, 3v5hA, 0.7509, 2.20, 0.159, 275, 88, HLA-A2.1 KVAEIVHFL
587, 5wwjA, 0.7508, 2.23, 0.170, 274, 88, CRYSTAL STRUCTURE OF HLA-A*2402 IN COMPLEX WITH AVIAN INFLUENZA A(H7N9) VIRUS-DERIVED PEPTIDE H7-25 (DATA SET 1)
588, 5hhnA, 0.7508, 2.20, 0.159, 274, 88, CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH M1-F5L
589, 5euoA, 0.7508, 2.18, 0.159, 274, 88, PF6-M1-HLA-A2
590, 3gjfA, 0.7508, 2.20, 0.159, 276, 88, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
591, 2guoA, 0.7508, 2.18, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NATIVE NONAMERIC MELAN- A/MART-1(27-35) PEPTIDE
592, 1uxsA, 0.7508, 2.21, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS
593, 1hhgA, 0.7508, 2.16, 0.161, 275, 87, THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
594, 1eeyA, 0.7508, 2.14, 0.161, 275, 87, CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TO PEPTIDE GP2 WITH THE SUBSTITUTION (I2L/V5L/L9V)
595, 5oqfA, 0.7507, 2.41, 0.124, 388, 89, CRYSTAL STRUCTURE OF A SINGLE CHAIN TRIMER COMPOSED OF THE MHC 1 HEAVY CHAIN H2-KB WT; BETA-2MICROGLOBULIN; AND OVALBUMIN DERIVED PEPTIDE 
596, 3myjA, 0.7507, 2.15, 0.161, 275, 87, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) (R1Y) PEPTIDE VARIANT.
597, 3b6sA, 0.7507, 2.22, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)
598, 5iueA, 0.7506, 2.18, 0.125, 275, 88, HUMAN LEUKOCYTE ANTIGEN F (HLA-F) PRESENTS PEPTIDES AND REGULATES IMMUNITY THROUGH INTERACTIONS WITH NK-CELL RECEPTORS
599, 5im7A, 0.7506, 2.23, 0.159, 277, 88, CRYSTAL STRUCTURE OF HLA-B5801 A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION
600, 4u6xA, 0.7506, 2.24, 0.148, 274, 88, CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH ALQDA A 15 MER SELF- PEPTIDE
601, 4l29I, 0.7506, 2.21, 0.161, 276, 87, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
602, 4f7pA, 0.7506, 2.24, 0.170, 274, 88, CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009H1N1 PB1 (496-505)
603, 3kprF, 0.7506, 2.38, 0.157, 276, 89, CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE
604, 3dx6A, 0.7506, 2.23, 0.159, 276, 88, CRYSTAL STRUCTURE OF B*4402 PRESENTING A 10MER EBV EPITOPE
605, 3bgmA, 0.7506, 2.21, 0.159, 274, 88, CRYSTAL STRUCTURE OF PKD2 PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
606, 2j8uA, 0.7506, 2.13, 0.161, 275, 87, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.
607, 1uxwA, 0.7506, 2.22, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS
608, 1rjzD, 0.7506, 2.28, 0.125, 278, 88, MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPIES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE
609, 1eeyD, 0.7506, 2.14, 0.161, 275, 87, CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TO PEPTIDE GP2 WITH THE SUBSTITUTION (I2L/V5L/L9V)
610, 1duyA, 0.7506, 2.20, 0.159, 275, 88, CRYSTAL STRUCTURE OF HLA-A*0201/OCTAMERIC TAX PEPTIDE COMPLEX
611, 6gl1A, 0.7505, 2.15, 0.163, 274, 86, HLA-E*01:03 IN COMPLEX WITH THE HIV EPITOPE; RL9HIV 
612, 5e8oD, 0.7505, 2.54, 0.111, 274, 90, THE STRUCTURE OF THE TEIPP ASSOCIATED ALTERED PEPTIDE LIGAND TRH4- P2ABU IN COMPLEX WITH H-2D(B)
613, 3p4nD, 0.7505, 2.29, 0.125, 277, 88, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE NP205-PV EPITOPE YTVKFPNM AN 8-MER PEPTIDE FROM PV
614, 2qrsB, 0.7505, 2.38, 0.124, 398, 89, CRYSTAL STRUCTURE OF A SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB Y84A BETA-2MICROGLOBULIN AND OVALBUMIN-DERIVED PEPTIDE.
615, 1t0nA, 0.7505, 2.26, 0.125, 278, 88, CONFORMATIONAL SWITCH IN POLYMORPHIC H-2K MOLECULES CONTAINING AN HSV PEPTIDE
616, 5ib5A, 0.7504, 2.21, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*27:09 COMPLEXED WITH THE SELF-PEPTIDE PVIPR AND COPPER
617, 2x4sD, 0.7504, 2.17, 0.161, 275, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEPTIDE REPRESENTING THE EPITOPE OF THE H5N1 (AVIAN FLU) NUCLEOPROTEIN
618, 5nmgF, 0.7503, 2.12, 0.163, 276, 86, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYFNTIAVL
619, 3p4oD, 0.7503, 2.29, 0.125, 277, 88, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE MUTANT NP205-LCMV-V3A EPITOPE YTAKYPNL AN 8-MER MODIFIED PEPTIDE FROM THE LCMV
620, 3am8A, 0.7503, 2.21, 0.161, 276, 87, CRYSTAL STRUCTURE OF A HUMAN MAJOR HISTOCOMPATIBILTY COMPLEX
621, 2vljA, 0.7503, 2.14, 0.161, 276, 87, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
622, 5fdwA, 0.7502, 2.22, 0.148, 274, 88, STRUCTURE OF HLA-A2:01 WITH PEPTIDE Y10L
623, 3bxnA, 0.7502, 2.23, 0.159, 276, 88, THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 COMPLEXED WITH A CATHEPSIN A SIGNAL SEQUENCE PEPTIDE PCATA
624, 2bvpA, 0.7502, 2.23, 0.159, 274, 88, STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION
625, 1hhkA, 0.7502, 2.20, 0.159, 275, 88, THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
626, 5wxcC, 0.7501, 2.26, 0.170, 274, 88, CRYSTAL STRUCTURE OF HLA-A*2402 IN COMPLEX WITH AVIAN INFLUENZA A(H7N9) VIRUS-DERIVED PEPTIDE H7-25 (DATA SET 2)
627, 4l3cW, 0.7501, 2.19, 0.161, 276, 87, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
628, 4f7mD, 0.7501, 2.22, 0.170, 274, 88, CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009 H1N1 PA (649-658)
629, 3o3dA, 0.7501, 2.19, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2
630, 3h7bD, 0.7501, 2.13, 0.161, 275, 87, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE TEL1P PEPTIDE
631, 1zagB, 0.7501, 2.22, 0.092, 274, 87, HUMAN ZINC-ALPHA-2-GLYCOPROTEIN
632, 1duzD, 0.7501, 2.16, 0.161, 275, 87, HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) IN COMPLEX WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN
633, 1jufA, 0.7500, 2.30, 0.114, 276, 88, STRUCTURE OF MINOR HISTOCOMPATIBILITY ANTIGEN PEPTIDE H13B COMPLEXED TO H2-DB
634, 1hhjD, 0.7500, 2.13, 0.161, 275, 87, THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
635, 5xovD, 0.7499, 2.22, 0.170, 274, 88, CRYSTAL STRUCTURE OF PEPTIDE-HLA-A24 BOUND TO S19-2 V-DELTA/V-BETA TCR
636, 2xpgA, 0.7499, 2.17, 0.161, 274, 87, CRYSTAL STRUCTURE OF A MHC CLASS I-PEPTIDE COMPLEX
637, 1qqdA, 0.7499, 2.19, 0.182, 273, 88, CRYSTAL STRUCTURE OF HLA-CW4 A LIGAND FOR THE KIR2D NATURAL KILLER CELL INHIBITORY RECEPTOR
638, 5w1vA, 0.7498, 2.24, 0.159, 272, 88, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
639, 5meqA, 0.7498, 2.13, 0.161, 276, 87, HUMAN LEUKOCYTE ANTIGEN A02 PRESENTING ILAKFLHTL
640, 3myjD, 0.7498, 2.14, 0.161, 275, 87, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) (R1Y) PEPTIDE VARIANT.
641, 3bh8A, 0.7498, 2.21, 0.159, 274, 88, CRYSTAL STRUCTURE OF RQA_M PHOSPHOPEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
642, 5w69C, 0.7497, 2.29, 0.170, 273, 88, HLA-C*06:02 PRESENTING ARFNDLRFV
643, 5oqhA, 0.7497, 2.41, 0.124, 388, 89, CRYSTAL STRUCTURE OF A DISULFIDE TRAPPED SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB Y84C K66A MUTANT; BETA-2MICROGLOBULIN; AND OVALBUMIN-DERIVED PEPTIDE 
644, 2gtwA, 0.7497, 2.16, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A27L SUBSTITUTION
645, 1tvbA, 0.7497, 2.20, 0.159, 275, 88, CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100(209-217) BOUND TO HUMAN CLASS I MHC HLA-A2
646, 6bxpA, 0.7496, 2.23, 0.170, 275, 88, CRYSTAL STRUCTURE OF HLA-B*57:01 WITH A MODIFIED HIV PEPTIDE RKV-KYN
647, 5w6aA, 0.7496, 2.25, 0.161, 273, 87, HLA-C*06:02 PRESENTING ARTELYRSL
648, 3mgtA, 0.7496, 2.15, 0.161, 275, 87, CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201
649, 3kpoA, 0.7496, 2.23, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLKAWTF A MIMOTOPE
650, 3fonC, 0.7496, 2.25, 0.125, 274, 88, CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE VNDIFEAI
651, 3bzfA, 0.7496, 2.26, 0.148, 276, 88, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
652, 2uweA, 0.7496, 2.12, 0.161, 275, 87, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION
653, 6am5A, 0.7495, 2.31, 0.157, 275, 89, CRYSTAL STRUCTURE OF DMF5 TCR BOUND TO HLA-A2 PRESENTING SYNTHETIC PEPTIDE SMLGIGIVPV 
654, 5wwiA, 0.7495, 2.17, 0.172, 274, 87, CRYSTAL STRUCTURE OF HLA-A*2402 IN COMPLEX WITH AVIAN INFLUENZA A(H7N9) VIRUS-DERIVED PEPTIDE H7-25 (DATA SET 1)
655, 5oqgB, 0.7495, 2.39, 0.124, 388, 89, CRYSTAL STRUCTURE OF A SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB W167A; BETA-2MICROGLOBULIN; AND AND OVALBUMIN-DERIVED PEPTIDE. 
656, 5c0cF, 0.7495, 2.12, 0.161, 277, 87, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDWIVA
657, 5c0bA, 0.7495, 2.14, 0.161, 275, 87, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDFPTI
658, 3rewD, 0.7495, 2.21, 0.159, 271, 88, CRYSTAL STRUCTURE OF AN LMP2A-DERIVED PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
659, 1a1mA, 0.7495, 2.21, 0.170, 278, 88, MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE TPYDINQML FROM GAG PROTEIN OF HIV2
660, 3dmmA, 0.7494, 2.23, 0.125, 274, 88, CRYSTAL STRUCTURE OF THE CD8 ALPHA BETA/H-2DD COMPLEX
661, 4uq3C, 0.7493, 2.21, 0.159, 275, 88, CRYSTAL STRUCTURE OF HLA-A0201 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE
662, 3l3dA, 0.7493, 2.24, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201
663, 2qriA, 0.7493, 2.41, 0.124, 398, 89, CRYSTAL STRUCTURE OF A SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB WT BETA-2MICROGLOBULIN AND OVALBUMIN-DERIVED PEPTIDE.
664, 1i1fA, 0.7493, 2.12, 0.174, 275, 86, CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y
665, 1hhjA, 0.7493, 2.14, 0.161, 275, 87, THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
666, 1duzA, 0.7493, 2.22, 0.159, 275, 88, HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) IN COMPLEX WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN
667, 5eotA, 0.7492, 2.23, 0.159, 273, 88, STRUCTURE OF HLA-A2:01 WITH PEPTIDE G13E
668, 4k7fA, 0.7492, 2.21, 0.159, 274, 88, NEWLY IDENTIFIED EPITOPE V60 FROM HBV CORE PROTEIN COMPLEXED WITH HLA- A*0201
669, 2x4sA, 0.7492, 2.22, 0.159, 275, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEPTIDE REPRESENTING THE EPITOPE OF THE H5N1 (AVIAN FLU) NUCLEOPROTEIN
670, 5c0gA, 0.7491, 2.21, 0.159, 276, 88, HLA-A02 CARRYING YLGGPDFPTI
671, 4uq3A, 0.7491, 2.21, 0.159, 275, 88, CRYSTAL STRUCTURE OF HLA-A0201 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE
672, 4i4wA, 0.7491, 2.20, 0.159, 276, 88, PEPTIDE LENGTH DETERMINES THE OUTCOME OF T CELL RECEPTOR/PEPTIDE-MHCI ENGAGEMENT
673, 3pwjA, 0.7491, 2.20, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2LI9V) PEPTIDE VARIANT
674, 3i6lD, 0.7491, 2.22, 0.170, 274, 88, NEWLY IDENTIFIED EPITOPE N1 DERIVED FROM SARS-COV N PROTEIN COMPLEXED WITH HLA-A*2402
675, 3h7bA, 0.7491, 2.21, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE TEL1P PEPTIDE
676, 3ecbA, 0.7491, 2.17, 0.126, 273, 87, CRYSTAL STRUCTURE OF MOUSE H-2DD IN COMPLEX WITH PEPTIDE P18-I10 DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN 120
677, 3bzeE, 0.7491, 2.40, 0.146, 267, 89, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA- 2 E
678, 5wwuA, 0.7490, 2.17, 0.161, 274, 87, CRYSTAL STRUCTURE OF HLA-A*2402 IN COMPLEX WITH 2009 PANDEMIC INFLUENZA A(H1N1) VIRUS AND AVIAN INFLUENZA A(H5N1) VIRUS-DERIVED PEPTIDE H1-25
679, 5v5mA, 0.7490, 2.23, 0.170, 278, 88, CRYSTAL STRUCTURE OF HLA-B*5701 COMPLEX WITH HIV-1 GAG DERIVED PEPTIDE TW10
680, 5gr7A, 0.7490, 2.27, 0.136, 274, 88, MOUSE MHC CLASS I H-2KD WITH A MERS-COV-DERIVED PEPTIDE 37-1
681, 3rgvC, 0.7490, 2.24, 0.125, 275, 88, A SINGLE TCR BOUND TO MHCI AND MHC II REVEALS SWITCHABLE TCR CONFORMERS
682, 3fonA, 0.7490, 2.26, 0.125, 274, 88, CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE VNDIFEAI
683, 3cdgC, 0.7490, 2.28, 0.159, 273, 88, HUMAN CD94/NKG2A IN COMPLEX WITH HLA-E
684, 3cdgA, 0.7490, 2.28, 0.159, 273, 88, HUMAN CD94/NKG2A IN COMPLEX WITH HLA-E
685, 2x70D, 0.7490, 2.20, 0.159, 275, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE
686, 5euoC, 0.7489, 2.26, 0.159, 275, 88, PF6-M1-HLA-A2
687, 5defA, 0.7489, 2.24, 0.159, 276, 88, CRYSTAL STRUCTURE OF B*27:04 COMPLEX BOUND TO THE PVIPR PEPTIDE
688, 4pgcD, 0.7489, 2.20, 0.125, 278, 88, MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGN(35-DIIODOTYROSINE)PAL
689, 3vxpA, 0.7489, 2.17, 0.172, 274, 87, HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(6L)
690, 3v5kA, 0.7489, 2.23, 0.159, 275, 88, HLA2.1 KVAELVWFL
691, 1nanH, 0.7489, 2.27, 0.125, 278, 88, MCH CLASS I H-2KB MOLECULE COMPLEXED WITH PBM1 PEPTIDE
692, 5oqhB, 0.7488, 2.41, 0.135, 388, 89, CRYSTAL STRUCTURE OF A DISULFIDE TRAPPED SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB Y84C K66A MUTANT; BETA-2MICROGLOBULIN; AND OVALBUMIN-DERIVED PEPTIDE 
693, 5jziA, 0.7488, 2.35, 0.157, 260, 89, CRYSTAL STRUCTURE OF 1406 TCR BOUND TO HLA-A2 WITH HCV 1406-1415 ANTIGEN PEPTIDE
694, 5indA, 0.7488, 2.23, 0.159, 277, 88, CRYSTAL STRUCTURE OF HLA-B5801 A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION
695, 5c0iA, 0.7488, 2.15, 0.161, 277, 87, HAL-A02 CARRYING RQFGPDFPTI
696, 2bnqA, 0.7488, 2.20, 0.159, 276, 88, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
697, 1b0rA, 0.7488, 2.21, 0.159, 269, 88, CRYSTAL STRUCTURE OF HLA-A*0201 COMPLEXED WITH A PEPTIDE WITH THE CARBOXYL-TERMINAL GROUP SUBSTITUTED BY A METHYL GROUP
698, 5ivxA, 0.7487, 2.25, 0.125, 274, 88, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR AND H2-DD P18-I10 COMPLEX
699, 5wliD, 0.7486, 2.24, 0.114, 277, 88, CRYSTAL STRUCTURE OF H-2DB WITH THE GAP501 PEPTIDE (SQL)
700, 5hhqA, 0.7486, 2.21, 0.159, 274, 88, CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH M1-L3W
701, 1t1wA, 0.7486, 2.24, 0.159, 275, 88, STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE VARIANT SL9-3F6I8V
702, 4l3cU, 0.7485, 2.22, 0.161, 276, 87, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
703, 3kplA, 0.7485, 2.23, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
704, 3givA, 0.7485, 2.21, 0.159, 275, 88, ANTIGEN PROCESSING INFLUENCES HIV-SPECIFIC CYTOTOXIC T LYMPHOCYTE IMMUNODOMINANCE
705, 3dxaA, 0.7485, 2.22, 0.148, 276, 88, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
706, 3dx8A, 0.7485, 2.22, 0.159, 276, 88, CRYSTAL STRUCTURE OF B*4405 PRESENTING A 10MER EBV EPITOPE
707, 1zagC, 0.7485, 2.40, 0.091, 273, 88, HUMAN ZINC-ALPHA-2-GLYCOPROTEIN
708, 1qrnA, 0.7485, 2.10, 0.174, 274, 86, CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A
709, 5wwjC, 0.7484, 2.26, 0.170, 274, 88, CRYSTAL STRUCTURE OF HLA-A*2402 IN COMPLEX WITH AVIAN INFLUENZA A(H7N9) VIRUS-DERIVED PEPTIDE H7-25 (DATA SET 1)
710, 5indC, 0.7484, 2.24, 0.159, 277, 88, CRYSTAL STRUCTURE OF HLA-B5801 A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION
711, 3hcvA, 0.7484, 2.23, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE DOUBLE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)
712, 3folA, 0.7484, 2.18, 0.125, 274, 88, CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE VNDIFERI
713, 3dxaK, 0.7484, 2.22, 0.148, 276, 88, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
714, 3dxaF, 0.7484, 2.22, 0.148, 276, 88, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
715, 3bzfC, 0.7484, 2.27, 0.148, 276, 88, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
716, 1m6oA, 0.7484, 2.26, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLA DPA*0201 PEPTIDE
717, 5xovA, 0.7483, 2.23, 0.170, 274, 88, CRYSTAL STRUCTURE OF PEPTIDE-HLA-A24 BOUND TO S19-2 V-DELTA/V-BETA TCR
718, 5v5mC, 0.7483, 2.25, 0.170, 276, 88, CRYSTAL STRUCTURE OF HLA-B*5701 COMPLEX WITH HIV-1 GAG DERIVED PEPTIDE TW10
719, 3p9lD, 0.7483, 2.20, 0.125, 278, 88, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE CHICKEN OVALBUMIN EPITOPE OVA
720, 1ce6A, 0.7483, 2.24, 0.114, 274, 88, MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUS NUCLEOPROTEIN PEPTIDE
721, 5ib5D, 0.7482, 2.24, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*27:09 COMPLEXED WITH THE SELF-PEPTIDE PVIPR AND COPPER
722, 3kpnA, 0.7482, 2.23, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
723, 3gsoA, 0.7482, 2.16, 0.161, 274, 87, CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV PEPTIDE
724, 1t20A, 0.7481, 2.24, 0.148, 275, 88, STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE VARIANT SL9-6I
725, 1im9A, 0.7481, 2.21, 0.182, 275, 88, CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELL INHIBITORY RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4
726, 4l29W, 0.7480, 2.21, 0.161, 276, 87, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
727, 4e5xA, 0.7480, 2.19, 0.161, 275, 87, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 2 E3- 19K PROTEIN AND MHC CLASS I MOLECULE HLA-A2/TAX
728, 3to2A, 0.7480, 2.14, 0.161, 275, 87, STRUCTURE OF HLA-A*0201 COMPLEXED WITH PEPTIDE MD3-C9 DERIVED FROM A CLUSTERING REGION OF RESTRICTED CYTOTOXIC T LYMPHOCYTE EPITOPE FROM SARS-COV M PROTEIN
729, 3l3iA, 0.7480, 2.25, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F7A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201
730, 3gsuA, 0.7480, 2.17, 0.161, 275, 87, CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5T PEPTIDE VARIANT
731, 3cchD, 0.7480, 2.27, 0.114, 276, 88, H-2DB COMPLEX WITH MURINE GP100
732, 2jccH, 0.7480, 2.16, 0.161, 275, 87, AH3 RECOGNITION OF MUTANT HLA-A2 W167A
733, 1nanL, 0.7480, 2.29, 0.125, 278, 88, MCH CLASS I H-2KB MOLECULE COMPLEXED WITH PBM1 PEPTIDE
734, 1kj3I, 0.7480, 2.31, 0.125, 278, 88, MHC CLASS I H-2KB MOLECULE COMPLEXED WITH PKB1 PEPTIDE
735, 1k8dA, 0.7480, 2.19, 0.126, 274, 87, CRYSTAL STRUCTURE OF THE NON-CLASSICAL MHC CLASS IB QA-2 COMPLEXED WITH A SELF PEPTIDE
736, 5jweG, 0.7479, 2.24, 0.114, 273, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP92-101 PEPTIDE
737, 5c0aF, 0.7479, 2.15, 0.161, 276, 87, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE
738, 1hhkD, 0.7479, 2.21, 0.159, 275, 88, THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
739, 5w1wF, 0.7478, 2.27, 0.148, 272, 88, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
740, 1zagA, 0.7478, 2.05, 0.093, 273, 86, HUMAN ZINC-ALPHA-2-GLYCOPROTEIN
741, 5nq0A, 0.7477, 2.31, 0.125, 275, 88, PORCINE (SUS SCROFA) MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS I; PRESENTING DFEREGYSL 
742, 5jweE, 0.7477, 2.30, 0.114, 268, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP92-101 PEPTIDE
743, 4onoA, 0.7477, 2.53, 0.141, 374, 85, CD1C IN COMPLEX WITH PM (PHOSPHOMYCOKETIDE)
744, 4jfqA, 0.7477, 2.20, 0.159, 275, 88, A2 HLA COMPLEX WITH L8A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE
745, 3l3kA, 0.7477, 2.24, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE R5A/F7A DOUBLE MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201
746, 3gswA, 0.7477, 2.26, 0.159, 274, 88, CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-T8A PEPTIDE VARIANT
747, 3gsrA, 0.7477, 2.17, 0.161, 274, 87, CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5V PEPTIDE VARIANT
748, 3fomA, 0.7477, 2.25, 0.125, 274, 88, CRYSTAL STRUCTURE OF THE CLASS I MHC MOLECULE H-2KWM7 WITH A SINGLE SELF PEPTIDE IQQSIERL
749, 1lp9H, 0.7477, 2.15, 0.161, 275, 87, XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1
750, 1i7rA, 0.7477, 2.15, 0.161, 275, 87, CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058
751, 5oqfB, 0.7476, 2.40, 0.124, 388, 89, CRYSTAL STRUCTURE OF A SINGLE CHAIN TRIMER COMPOSED OF THE MHC 1 HEAVY CHAIN H2-KB WT; BETA-2MICROGLOBULIN; AND OVALBUMIN DERIVED PEPTIDE 
752, 5fa3A, 0.7476, 2.26, 0.148, 273, 88, STRUCTURE OF HLA-A2:01 WITH PEPTIDE G9V
753, 5eu4D, 0.7476, 2.23, 0.159, 276, 88, HLA CLASS I ANTIGEN
754, 4zfzD, 0.7476, 2.32, 0.159, 277, 88, CRYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*098 COMPLEXED WITH MYRISTOYLATED 5-MER LIPOPEPTIDE DERIVED FROM SIV NEF PROTEIN
755, 3mrrA, 0.7476, 2.15, 0.161, 275, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HUMAN PROSTAGLANDIN TRANSPORTER DECAPEPTIDE
756, 3gjfD, 0.7476, 2.24, 0.159, 276, 88, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
757, 4wj5A, 0.7475, 2.15, 0.161, 275, 87, STRUCTURE OF HLA-A2 IN COMPLEX WITH AN ALTERED PEPTIDE LIGANDS BASED ON MART-1 VARIANT EPITOPE
758, 3vxsA, 0.7475, 2.28, 0.159, 274, 88, THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(6L) PEPTIDE
759, 1p7qA, 0.7475, 2.16, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR-1 A HOST AND VIRAL MHC RECEPTOR
760, 5w67A, 0.7474, 2.32, 0.170, 273, 88, HLA-C*06:02 PRESENTING VRSRR(ABA)LRL
761, 5w1vK, 0.7474, 2.29, 0.159, 272, 88, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
762, 3ln5A, 0.7474, 2.23, 0.148, 274, 88, CRYSTAL STRUCTURE OF HLA-B*4104 IN COMPLEX WITH A 11MER SELF-PEPTIDE DERIVED FROM S-METHYL-5-THIOADENOSINE PHOSPHORYLASE
763, 3dtxA, 0.7474, 2.24, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE DOUBLE CITRULLINATED VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)
764, 5jweC, 0.7473, 2.21, 0.114, 276, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP92-101 PEPTIDE
765, 3pwjD, 0.7473, 2.21, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2LI9V) PEPTIDE VARIANT
766, 1agfA, 0.7473, 2.27, 0.136, 276, 88, ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKRYKL-5R MUTATION)
767, 5w69A, 0.7472, 2.29, 0.159, 273, 88, HLA-C*06:02 PRESENTING ARFNDLRFV
768, 5c09A, 0.7472, 2.19, 0.159, 276, 88, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN
769, 3l3jA, 0.7472, 2.24, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A/R5A DOUBLE MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201
770, 5ib3A, 0.7471, 2.25, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*27:05 COMPLEXED WITH THE SELF-PEPTIDE PVIPR AND COPPER
771, 4jqxA, 0.7471, 2.28, 0.159, 276, 88, HLA-B*44:03 IN COMPLEX WITH EPSTEIN-BARR VIRUS BZLF1-DERIVED PEPTIDE (RESIDUES 169-180)
772, 3rewA, 0.7471, 2.23, 0.159, 271, 88, CRYSTAL STRUCTURE OF AN LMP2A-DERIVED PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2
773, 3cchA, 0.7471, 2.28, 0.114, 276, 88, H-2DB COMPLEX WITH MURINE GP100
774, 5eu6A, 0.7470, 2.17, 0.161, 276, 87, HLA CLASS I ANTIGEN
775, 4zfzA, 0.7470, 2.32, 0.159, 277, 88, CRYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*098 COMPLEXED WITH MYRISTOYLATED 5-MER LIPOPEPTIDE DERIVED FROM SIV NEF PROTEIN
776, 3l3gA, 0.7470, 2.28, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE R5A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201
777, 1kj2I, 0.7470, 2.25, 0.125, 277, 88, MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
778, 5weuA, 0.7469, 2.22, 0.126, 273, 87, CRYSTAL STRUCTURE OF H2-DD WITH DISULFIDE-LINKED 10MER PEPTIDE
779, 5eu5A, 0.7469, 2.20, 0.161, 276, 87, HLA CLASS I ANTIGEN
780, 4pgbD, 0.7469, 2.29, 0.125, 278, 88, MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGNWPAL
781, 4e5xD, 0.7469, 2.24, 0.159, 275, 88, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 2 E3- 19K PROTEIN AND MHC CLASS I MOLECULE HLA-A2/TAX
782, 3mgoA, 0.7469, 2.16, 0.161, 275, 87, CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201
783, 1s8dA, 0.7469, 2.25, 0.159, 275, 88, STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE VARIANT SL9-3A
784, 4l29O, 0.7468, 2.24, 0.159, 276, 88, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
785, 4jfoD, 0.7468, 2.13, 0.163, 275, 86, A2 HLA COMPLEX WITH E1A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE
786, 2x4pD, 0.7468, 2.22, 0.159, 275, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE
787, 5nmhA, 0.7467, 2.19, 0.161, 276, 87, HLA A02 PRESENTING SLYNTIATL
788, 3pwvD, 0.7467, 2.27, 0.102, 274, 88, AN IMMMUNODOMINANT CTL EPITOPE FROM RINDERPEST VIRUS PRESENTED BY CATTLE MHC CLASS I MOLECULE N*01801 (BOLA-A11)
789, 3hlaA, 0.7467, 2.23, 0.159, 270, 88, HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2.1
790, 3gsxA, 0.7467, 2.17, 0.161, 274, 87, CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-T8V PEPTIDE VARIANT
791, 2x4tA, 0.7467, 2.23, 0.159, 275, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEIODATE-CLEAVABLE PEPTIDE
792, 1namH, 0.7467, 2.32, 0.125, 275, 88, MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
793, 1ed3D, 0.7467, 2.24, 0.125, 275, 88, CRYSTAL STRUCTURE OF RAT MINOR HISTOCOMPATIBILITY ANTIGEN COMPLEX RT1-AA/MTF-E.
794, 5c0fA, 0.7466, 2.26, 0.159, 277, 88, HLA-A02 CARRYING RQWGPDPAAV
795, 4pgcA, 0.7466, 2.21, 0.125, 278, 88, MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGN(35-DIIODOTYROSINE)PAL
796, 3i6kE, 0.7466, 2.22, 0.159, 273, 88, NEWLY IDENTIFIED EPITOPE FROM SARS-COV MEMBRANE PROTEIN COMPLEXED WITH HLA-A*0201
797, 1n2rA, 0.7466, 2.24, 0.159, 276, 88, A NATURAL SELECTED DIMORPHISM IN HLA B*44 ALTERS SELF PEPTIDE REPORTOIRE AND T CELL RECOGNITION.
798, 1kjmA, 0.7466, 2.24, 0.125, 277, 88, TAP-A-ASSOCIATED RAT MHC CLASS I MOLECULE
799, 1ed3A, 0.7466, 2.26, 0.125, 275, 88, CRYSTAL STRUCTURE OF RAT MINOR HISTOCOMPATIBILITY ANTIGEN COMPLEX RT1-AA/MTF-E.
800, 5ts1E, 0.7465, 2.26, 0.136, 273, 88, CRYSTAL STRUCTURE OF MHC-I H2-KD COMPLEXED WITH PEPTIDES OF MYCOBACTERIAL TUBERCULOSIS (YYQSGLSIV) 
801, 3qq3A, 0.7465, 2.27, 0.136, 275, 88, CRYSTAL STRUCTURE OF SWINE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I SLA-1 0401 AND IDENTIFICATION OF 2009 PANDEMIC SWINE-ORIGIN INFLUENZA A H1N1 VIRUS CYTOTOXIC T LYMPHOCYTE EPITOPE PEPTIDES
802, 3mgoJ, 0.7465, 2.16, 0.161, 275, 87, CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201
803, 2qriB, 0.7465, 2.34, 0.124, 398, 89, CRYSTAL STRUCTURE OF A SINGLE CHAIN TRIMER COMPOSED OF THE MHC I HEAVY CHAIN H-2KB WT BETA-2MICROGLOBULIN AND OVALBUMIN-DERIVED PEPTIDE.
804, 1ddhA, 0.7465, 2.27, 0.125, 274, 88, MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND AN IMMUNODOMINANT PEPTIDE P18-I10 FROM THE HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN 120
805, 4zusA, 0.7464, 2.20, 0.125, 274, 88, CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE REV-QW11
806, 3mr9A, 0.7464, 2.17, 0.161, 274, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE M5A VARIANT
807, 3bvnD, 0.7464, 2.23, 0.148, 277, 88, HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 IN COMPLEX WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS
808, 1k5nA, 0.7464, 2.27, 0.159, 276, 88, HLA-B*2709 BOUND TO NONA-PEPTIDE M9
809, 5ddhA, 0.7463, 2.16, 0.161, 274, 87, STRUCTURE OF HLA-A2:01 WITH THE 12-MER PEPTIDE F12K
810, 3mrgA, 0.7463, 2.17, 0.161, 274, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE
811, 5eu4A, 0.7462, 2.23, 0.159, 276, 88, HLA CLASS I ANTIGEN
812, 4l29a, 0.7462, 2.19, 0.161, 276, 87, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
813, 3mrjA, 0.7462, 2.20, 0.161, 275, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE V5M VARIANT
814, 1bqhD, 0.7462, 2.26, 0.126, 274, 87, MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8
815, 3qdjA, 0.7461, 2.20, 0.159, 275, 88, THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
816, 3i6kA, 0.7461, 2.22, 0.159, 273, 88, NEWLY IDENTIFIED EPITOPE FROM SARS-COV MEMBRANE PROTEIN COMPLEXED WITH HLA-A*0201
817, 3d25A, 0.7461, 2.24, 0.159, 274, 88, CRYSTAL STRUCTURE OF HA-1 MINOR HISTOCOMPATIBILITY ANTIGEN BOUND TO HUMAN CLASS I MHC HLA-A2
818, 1s7tD, 0.7461, 2.26, 0.125, 276, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
819, 1of2A, 0.7461, 2.25, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)
820, 1lp9A, 0.7461, 2.16, 0.161, 275, 87, XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1
821, 1biiA, 0.7461, 2.24, 0.125, 274, 88, THE CRYSTAL STRUCTURE OF H-2DD MHC CLASS I IN COMPLEX WITH THE HIV-1 DERIVED PEPTIDE P18-110
822, 5enwA, 0.7460, 2.24, 0.159, 274, 88, STRUCTURE OF HLA-A2:01 WITH PEPTIDE G9L
823, 3mrfA, 0.7460, 2.26, 0.159, 274, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH EBV BMLF1-280-288 NONAPEPTIDE T4P VARIANT
824, 3kprA, 0.7460, 2.30, 0.159, 276, 88, CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE
825, 1i7rD, 0.7460, 2.17, 0.161, 275, 87, CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDE P1058
826, 4z78G, 0.7459, 2.23, 0.136, 277, 88, WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES
827, 4l29U, 0.7459, 2.23, 0.161, 276, 87, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
828, 3vxrA, 0.7459, 2.29, 0.170, 274, 88, THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(WT) PEPTIDE
829, 3qdgA, 0.7459, 2.19, 0.159, 275, 88, THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
830, 3mreA, 0.7459, 2.26, 0.159, 274, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH EBV BMLF1-280-288 NONAPEPTIDE
831, 3jtsG, 0.7459, 2.49, 0.146, 276, 89, GY9-MAMU-A*02-HB2M
832, 2x4tD, 0.7459, 2.25, 0.159, 275, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEIODATE-CLEAVABLE PEPTIDE
833, 2uweH, 0.7459, 2.14, 0.161, 275, 87, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION
834, 4wuuA, 0.7458, 2.16, 0.161, 275, 87, STRUCTURE OF ESK1 IN COMPLEX WITH HLA-A*0201/WT1
835, 3dx7A, 0.7458, 2.26, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*4403 PRESENTING 10MER EBV ANTIGEN
836, 1zt7A, 0.7458, 2.39, 0.136, 275, 88, CRYSTAL STRUCTURE OF CLASS I MHC H-2KK IN COMPLEX WITH A NONAPEPTIDE
837, 6gl1C, 0.7457, 2.19, 0.115, 273, 87, HLA-E*01:03 IN COMPLEX WITH THE HIV EPITOPE; RL9HIV 
838, 5f1nD, 0.7457, 2.34, 0.136, 275, 88, MHC COMPLEXED TO 11MER PEPTIDE
839, 5d2nA, 0.7457, 2.26, 0.159, 273, 88, CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX
840, 4g42A, 0.7457, 2.28, 0.149, 271, 87, STRUCTURE OF THE CHICKEN MHC CLASS I MOLECULE BF2*0401 COMPLEXED TO PEPITDE P8D
841, 4e0rA, 0.7457, 2.29, 0.149, 272, 87, STRUCTURE OF THE CHICKEN MHC CLASS I MOLECULE BF2*0401
842, 1i1fD, 0.7457, 2.19, 0.161, 275, 87, CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y
843, 5t6yA, 0.7456, 2.24, 0.170, 276, 88, HLA-B*57:01 PRESENTING TSTFEDVKILAF
844, 5merD, 0.7456, 2.17, 0.161, 276, 87, HUMAN LEUKOCYTE ANTIGEN A02 PRESENTING ILAKFLHEL
845, 4zutA, 0.7456, 2.21, 0.125, 274, 88, CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE GAG-GW12
846, 4wj5D, 0.7456, 2.22, 0.159, 275, 88, STRUCTURE OF HLA-A2 IN COMPLEX WITH AN ALTERED PEPTIDE LIGANDS BASED ON MART-1 VARIANT EPITOPE
847, 4pgbA, 0.7456, 2.30, 0.125, 278, 88, MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGNWPAL
848, 4pg2A, 0.7456, 2.25, 0.114, 254, 88, THE CRYSTAL STRUCTURE OF H-2DB WITH A S-GLUTATHIONYLATED PEPTIDE
849, 3skoA, 0.7456, 2.25, 0.148, 273, 88, CRYSTAL STRUCTURE OF THE HLA-B8-A66-FLR MUTANT A66 OF THE HLA B8
850, 1w0wA, 0.7456, 2.26, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1
851, 1ogtA, 0.7456, 2.25, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408)
852, 1jpfA, 0.7456, 2.28, 0.114, 275, 88, CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP276 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB
853, 4pv8A, 0.7455, 2.29, 0.125, 278, 88, CRYSTAL STRUCTURE OF H2KB-Q600F COMPLEX
854, 4l3cO, 0.7455, 2.27, 0.159, 276, 88, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
855, 3vxmA, 0.7455, 2.34, 0.170, 274, 88, THE COMPLEX BETWEEN C1-28 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE
856, 3buyA, 0.7455, 2.25, 0.114, 275, 88, MHC-I IN COMPLEX WITH PEPTIDE
857, 2bsrA, 0.7455, 2.27, 0.159, 276, 88, CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705
858, 1zt7C, 0.7455, 2.39, 0.136, 275, 88, CRYSTAL STRUCTURE OF CLASS I MHC H-2KK IN COMPLEX WITH A NONAPEPTIDE
859, 1rjyA, 0.7455, 2.29, 0.125, 278, 88, MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS GLYCOPROTEIN B PEPTIDE
860, 1hocA, 0.7455, 2.25, 0.125, 272, 88, THE THREE-DIMENSIONAL STRUCTURE OF H-2DB AT 2.4 ANGSTROMS RESOLUTION: IMPLICATIONS FOR ANTIGEN-DETERMINANT SELECTION
861, 3tieA, 0.7454, 2.31, 0.125, 277, 88, CRYSTAL STRUCTURE OF THE VACCINIA DERIVED PEPTIDE A11R IN COMPLEX WITH THE MURINE MHC CLASS I H-2 KB
862, 3pabD, 0.7454, 2.31, 0.125, 278, 88, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH A MUTANT OF THE CHICKEN OVALBUMIN EPITOPE OVA-E1
863, 3lv3A, 0.7454, 2.24, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH A PEPTIDE DERIVED FROM THE HUMAN VOLTAGE-DEPENDENT CALCIUM CHANNEL ALPHA1 SUBUNIT (RESIDUES 513-521)
864, 3b3iA, 0.7454, 2.24, 0.161, 276, 87, CITRULLINATION-DEPENDENT DIFFERENTIAL PRESENTATION OF A SELF-PEPTIDE BY HLA-B27 SUBTYPES
865, 2bnrA, 0.7454, 2.23, 0.159, 276, 88, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
866, 1i1yA, 0.7454, 2.18, 0.161, 275, 87, CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y
867, 1hlaA, 0.7454, 2.17, 0.136, 270, 88, STRUCTURE OF THE HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-A2
868, 1e27A, 0.7454, 2.27, 0.170, 276, 88, NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM1(LPPVVAKEI)
869, 5ib1A, 0.7453, 2.26, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*27:05 COMPLEXED WITH THE SELF-PEPTIDE PVIPR MEASURED AT 295 K
870, 4jfoA, 0.7453, 2.21, 0.159, 275, 88, A2 HLA COMPLEX WITH E1A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE
871, 1rjzA, 0.7453, 2.23, 0.125, 278, 88, MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPIES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE
872, 6gl1E, 0.7452, 2.23, 0.138, 274, 87, HLA-E*01:03 IN COMPLEX WITH THE HIV EPITOPE; RL9HIV 
873, 5ib4A, 0.7452, 2.26, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*27:05 COMPLEXED WITH THE SELF-PEPTIDE PVIPR AND NICKEL
874, 4l29M, 0.7452, 2.28, 0.159, 276, 88, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
875, 4hx1A, 0.7452, 2.21, 0.161, 274, 87, STRUCTURE OF HLA-A68 COMPLEXED WITH A TUMOR ANTIGEN DERIVED PEPTIDE
876, 3mrbA, 0.7452, 2.18, 0.161, 275, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE A7H VARIANT
877, 3gsvA, 0.7452, 2.18, 0.161, 275, 87, CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5Q PEPTIDE VARIANT
878, 3gsqA, 0.7452, 2.18, 0.161, 274, 87, CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5S PEPTIDE VARIANT
879, 3givD, 0.7452, 2.21, 0.159, 275, 88, ANTIGEN PROCESSING INFLUENCES HIV-SPECIFIC CYTOTOXIC T LYMPHOCYTE IMMUNODOMINANCE
880, 2bssA, 0.7452, 2.25, 0.159, 276, 88, CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705
881, 1kj3H, 0.7452, 2.24, 0.125, 279, 88, MHC CLASS I H-2KB MOLECULE COMPLEXED WITH PKB1 PEPTIDE
882, 1i1yD, 0.7452, 2.17, 0.161, 275, 87, CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y
883, 4l3cM, 0.7451, 2.28, 0.159, 276, 88, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
884, 4l3cK, 0.7451, 2.29, 0.159, 276, 88, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
885, 3ws3A, 0.7451, 2.34, 0.114, 266, 88, CRYSTAL STRUCTURE OF H-2D IN COMPLEX WITH AN INSULIN DERIVED PEPTIDE
886, 5fa4A, 0.7450, 2.26, 0.159, 273, 88, STRUCTURE OF HLA-A2:01 WITH PEPTIDE Y16R
887, 5e8pA, 0.7450, 2.32, 0.114, 272, 88, THE STRUCTURE OF THE TEIPP ASSOCIATED ALTERED PEPTIDE LIGAND TRH4- P5NLE IN COMPLEX WITH H-2D(B)
888, 3p4mD, 0.7450, 2.30, 0.125, 277, 88, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE NP205-LCMV EPITOPE YTVKYPNL AN 8-MER PEPTIDE FROM THE LCMV
889, 3dbxA, 0.7450, 2.20, 0.047, 279, 86, STRUCTURE OF CHICKEN CD1-2 WITH BOUND FATTY ACID
890, 2bstA, 0.7450, 2.27, 0.159, 276, 88, CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705
891, 1vacA, 0.7450, 2.26, 0.125, 274, 88, MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND CHICKEN OVALBUMIN
892, 1qlfA, 0.7450, 2.26, 0.114, 276, 88, MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G
893, 5w6aC, 0.7449, 2.31, 0.159, 273, 88, HLA-C*06:02 PRESENTING ARTELYRSL
894, 5merA, 0.7449, 2.17, 0.161, 276, 87, HUMAN LEUKOCYTE ANTIGEN A02 PRESENTING ILAKFLHEL
895, 5jweA, 0.7449, 2.25, 0.114, 276, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP92-101 PEPTIDE
896, 5c0cA, 0.7449, 2.18, 0.161, 276, 87, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDWIVA
897, 4l3cC, 0.7449, 2.25, 0.161, 276, 87, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
898, 3e6fA, 0.7449, 2.21, 0.126, 273, 87, MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND A VARIANT PEPTIDE PA9 FROM THE HUMAN IMMUNODEFICIENCY VIRUS (BAL) ENVELOPE GLYCOPROTEIN 120
899, 1qo3A, 0.7449, 2.31, 0.125, 274, 88, COMPLEX BETWEEN NK CELL RECEPTOR LY49A AND ITS MHC CLASS I LIGAND H-2DD
900, 5trzA, 0.7448, 2.27, 0.136, 275, 88, CRYSTAL STRUCTURE OF MHC-I H2-KD COMPLEXED WITH PEPTIDES OF MYCOBACTERIAL TUBERCULOSIS (YQSGLSIVM) 
901, 5e8nA, 0.7448, 2.37, 0.114, 272, 88, THE STRUCTURE OF THE TEIPP ASSOCIATED TRH4 PEPTIDE IN COMPLEX WITH H- 2D(B)
902, 4no2A, 0.7448, 2.23, 0.159, 274, 88, CRYSTAL STRUCTURE OF RQA_V PHOSPHOPEPTIDE BOUND TO HLA-A2
903, 2x4qA, 0.7448, 2.26, 0.159, 275, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE
904, 4l3cA, 0.7447, 2.24, 0.161, 276, 87, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
905, 3tjhA, 0.7447, 2.30, 0.138, 175, 87, 42F3-P3A1/H2-LD COMPLEX
906, 3pwuA, 0.7447, 2.30, 0.102, 274, 88, AN IMMMUNODOMINANT CTL EPITOPE FROM RINDERPEST VIRUS PRESENTED BY CATTLE MHC CLASS I MOLECULE N*01801(BOLA-A11)
907, 3pwpA, 0.7447, 2.22, 0.159, 275, 88, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE
908, 1jpgA, 0.7447, 2.32, 0.114, 275, 88, CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE NP396 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB
909, 1bz9A, 0.7447, 2.32, 0.114, 273, 88, CRYSTAL STRUCTURE OF MURINE CLASS I MHC H2-DB COMPLEXED WITH A SYNTHETIC PEPTIDE P1027
910, 1a1oA, 0.7447, 2.27, 0.170, 276, 88, MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA PARASITE P. FALCIPARUM
911, 5npzA, 0.7446, 2.30, 0.126, 277, 87, PORCINE (SUS SCROFA) MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS I; PRESENTING EFEDLTFLA 
912, 5ib2A, 0.7446, 2.26, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA-B*27:05 COMPLEXED WITH THE SELF-PEPTIDE PVIPR
913, 5c07A, 0.7446, 2.16, 0.161, 276, 87, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA
914, 4g8iA, 0.7446, 2.26, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA B2705-KK10-L6M
915, 3tieD, 0.7446, 2.30, 0.125, 277, 88, CRYSTAL STRUCTURE OF THE VACCINIA DERIVED PEPTIDE A11R IN COMPLEX WITH THE MURINE MHC CLASS I H-2 KB
916, 2ciiA, 0.7446, 2.26, 0.114, 275, 88, THE CRYSTAL STRUCTURE OF H-2DB COMPLEXED WITH A PARTIAL PEPTIDE EPITOPE SUGGESTS AN MHC CLASS I ASSEMBLY- INTERMEDIATE
917, 1syvA, 0.7446, 2.26, 0.159, 276, 88, HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF
918, 1jf1A, 0.7446, 2.21, 0.159, 273, 88, CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A DECAMERIC ALTERED PEPTIDE LIGAND FROM THE MART-1/MELAN-A
919, 5wshA, 0.7445, 2.17, 0.163, 275, 86, STRUCTURE OF HLA-A2 P130
920, 3pwnD, 0.7445, 2.24, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L) PEPTIDE VARIANT
921, 5c0eA, 0.7444, 2.22, 0.149, 277, 87, HLA-A02 CARRYING YLGGPDFPTI
922, 5t6zA, 0.7443, 2.29, 0.159, 275, 88, KIR3DL1 IN COMPLEX WITH HLA-B*57:01-TW10
923, 5c08A, 0.7443, 2.18, 0.161, 276, 87, 1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV
924, 4zuwA, 0.7443, 2.21, 0.125, 274, 88, CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00601) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE GAG-GW12
925, 4l3ca, 0.7443, 2.21, 0.161, 276, 87, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
926, 4l29E, 0.7443, 2.24, 0.161, 276, 87, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
927, 3ox8D, 0.7443, 2.24, 0.159, 275, 88, CRYSTAL STRUCTURE OF HLA A*02:03 BOUND TO HBV CORE 18-27
928, 2x4uA, 0.7443, 2.24, 0.159, 275, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 PEPTIDE RT468-476
929, 2clzH, 0.7443, 2.33, 0.125, 278, 88, MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM1 PEPTIDE
930, 1tvhD, 0.7443, 2.24, 0.159, 275, 88, CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND TO HUMAN CLASS I MHC HLA-A2
931, 1mwaH, 0.7443, 2.35, 0.125, 274, 88, 2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX
932, 5eo0A, 0.7442, 2.29, 0.148, 275, 88, CRYSTAL STRUCTURE OF HLA-B0702-RFL9
933, 4jfqD, 0.7442, 2.24, 0.159, 276, 88, A2 HLA COMPLEX WITH L8A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE
934, 3o3aD, 0.7442, 2.26, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1
935, 3mrlA, 0.7442, 2.23, 0.159, 274, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE C6V VARIANT
936, 5iehA, 0.7441, 2.28, 0.159, 276, 88, STRUCTURE OF HLA-B*40:02 IN COMPLEX WITH THE PHOSPHORYLATED ENDOGENOUS PEPTIDE REF(P)SKEPEL
937, 5d2nH, 0.7441, 2.19, 0.161, 273, 87, CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX
938, 3rooC, 0.7441, 2.27, 0.136, 271, 88, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH IMMUNODOMINANT LCMV-DERIVED GP34-41 PEPTIDE
939, 5wmoA, 0.7440, 2.28, 0.148, 276, 88, CRYSTAL STRUCTURE OF HLA-B7 IN COMPLEX WITH RPP; AN EBV PEPTIDE 
940, 5e6iC, 0.7440, 2.27, 0.149, 258, 87, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
941, 5c09F, 0.7440, 2.22, 0.159, 276, 88, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN
942, 4l29K, 0.7440, 2.26, 0.159, 276, 88, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
943, 3utqA, 0.7440, 2.21, 0.172, 276, 87, HUMAN HLA-A*0201-ALWGPDPAAA
944, 3pqyF, 0.7440, 2.15, 0.115, 267, 87, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
945, 2fwoA, 0.7440, 2.28, 0.136, 275, 88, MHC CLASS I H-2KD HEAVY CHAIN IN COMPLEX WITH BETA- 2MICROGLOBULIN AND PEPTIDE DERIVED FROM INFLUENZA NUCLEOPROTEIN
946, 2bckD, 0.7440, 2.20, 0.172, 286, 87, CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASE PEPTIDE
947, 5ts1C, 0.7439, 2.28, 0.136, 273, 88, CRYSTAL STRUCTURE OF MHC-I H2-KD COMPLEXED WITH PEPTIDES OF MYCOBACTERIAL TUBERCULOSIS (YYQSGLSIV) 
948, 5t7gA, 0.7439, 2.29, 0.125, 273, 88, CRYSTAL STRUCTURE OF MURINE MHC-I H-2DD IN COMPLEX WITH MURINE BETA2- MICROGLOBULIN AND A VARIANT OF PEPTIDE (PT9) OF HIV GP120 MN ISOLATE (IGPGRAFYT)
949, 5nqkH, 0.7439, 2.17, 0.161, 275, 87, HUMAN 199.16 TCR IN COMPLEX WITH MELAN-A/MART-1 (26-35) PEPTIDE AND HLA-A2 
950, 5incC, 0.7439, 2.24, 0.170, 277, 88, CRYSTAL STRUCTURE OF HLA-B5801 A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION
951, 4g9dA, 0.7439, 2.26, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA B2705-KK10
952, 1akjA, 0.7439, 2.22, 0.159, 276, 88, COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 AND THE T CELL CORECEPTOR CD8
953, 3utsA, 0.7438, 2.25, 0.159, 276, 88, 1E6-A*0201-ALWGPDPAAA COMPLEX MONOCLINIC
954, 3ox8A, 0.7438, 2.24, 0.159, 275, 88, CRYSTAL STRUCTURE OF HLA A*02:03 BOUND TO HBV CORE 18-27
955, 6gh4A, 0.7437, 2.20, 0.149, 274, 87, HLA-E*01:03 IN COMPLEX WITH THE MTB44 PEPTIDE VARIANT: MTB44*P2-GLN. 
956, 5w1vP, 0.7437, 2.33, 0.148, 272, 88, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
957, 1de4G, 0.7437, 2.36, 0.161, 272, 87, HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR
958, 1de4D, 0.7437, 2.36, 0.161, 272, 87, HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR
959, 1de4A, 0.7437, 2.36, 0.161, 272, 87, HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR
960, 6bxqB, 0.7436, 2.27, 0.170, 276, 88, CRYSTAL STRUCTURE OF HLA-B*57:01 WITH AN HIV PEPTIDE RKV
961, 2ol3H, 0.7436, 2.35, 0.125, 276, 88, CRYSTAL STRUCTURE OF BM3.3 SCFV TCR IN COMPLEX WITH PBM8-H-2KBM8 MHC CLASS I MOLECULE
962, 1n3nG, 0.7436, 2.40, 0.124, 276, 89, CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB
963, 5n1yA, 0.7435, 2.23, 0.159, 277, 88, HLA-A02 CARRYING MVWGPDPLYV
964, 5c0aA, 0.7435, 2.18, 0.161, 276, 87, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE
965, 3vj6A, 0.7435, 2.22, 0.126, 277, 87, STRUCTURE OF THE MHC CLASS IB MOLECULE QA-1B
966, 3utsF, 0.7435, 2.23, 0.161, 276, 87, 1E6-A*0201-ALWGPDPAAA COMPLEX MONOCLINIC
967, 3p9mD, 0.7435, 2.31, 0.125, 277, 88, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH A MUTANT OF THE CHICKEN OVALBUMIN EPITOPE OVA-G4
968, 2guoD, 0.7435, 2.23, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NATIVE NONAMERIC MELAN- A/MART-1(27-35) PEPTIDE
969, 5t6wA, 0.7434, 2.26, 0.170, 275, 88, HLA-B*57:01 PRESENTING SSTRGISQLW
970, 4l29S, 0.7434, 2.27, 0.161, 276, 87, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
971, 4g43A, 0.7434, 2.46, 0.149, 272, 87, STRUCTURE OF THE CHICKEN MHC CLASS I MOLECULE BF2*0401 COMPLEXED TO P5E
972, 4qrpA, 0.7433, 2.26, 0.148, 276, 88, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR
973, 3ws6B, 0.7433, 2.29, 0.114, 270, 88, CRYSTAL STRUCTURE OF H-2D IN COMPLEX WITH A MIMOTOPIC PEPTIDE
974, 2x4uD, 0.7433, 2.24, 0.159, 275, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 PEPTIDE RT468-476
975, 5jwdA, 0.7432, 2.40, 0.114, 258, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP392-401 PEPTIDE
976, 5d9sA, 0.7432, 2.24, 0.159, 274, 88, STRUCTURE OF HLA-A2:01 WITH THE 11-MER PEPTIDE F11V
977, 4qokA, 0.7432, 2.16, 0.161, 276, 87, STRUCTURAL BASIS FOR INEFFECTIVE T-CELL RESPONSES TO MHC ANCHOR RESIDUE IMPROVED HETEROCLITIC PEPTIDES
978, 4no0A, 0.7432, 2.24, 0.159, 276, 88, CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF RQA_V PHOSPHOPEPTIDE BOUND TO HLA-A2 IN COMPLEX WITH LILRB1
979, 3o3eD, 0.7432, 2.25, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2.1
980, 3cchG, 0.7432, 2.35, 0.114, 272, 88, H-2DB COMPLEX WITH MURINE GP100
981, 2hjkA, 0.7432, 2.28, 0.170, 274, 88, CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE
982, 6gh1A, 0.7431, 2.22, 0.138, 274, 87, HLA-E*01:03 IN COMPLEX WITH MTB44 
983, 6at5A, 0.7431, 2.30, 0.148, 275, 88, CRYSTAL STRUCTURE OF HLA-B*07:02 IN COMPLEX WITH AN NY-ESO-1 PEPTIDE
984, 5vz5A, 0.7431, 2.16, 0.140, 277, 86, CRYSTAL STRUCTURE OF AN ANAPLASTIC LYMPHOMA KINASE-DERIVED NEUROBLASTOMA TUMOR ANTIGEN BOUND TO THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULE HLA-B*1501
985, 5f1iS, 0.7431, 2.31, 0.136, 271, 88, MHC WITH 9-MER PEPTIDE
986, 3mrcA, 0.7431, 2.29, 0.159, 274, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE V6C VARIANT
987, 1fo0H, 0.7431, 2.30, 0.125, 276, 88, MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
988, 1bd2A, 0.7431, 2.21, 0.161, 275, 87, COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7 VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201
989, 1ao7A, 0.7431, 2.14, 0.174, 274, 86, COMPLEX BETWEEN HUMAN T-CELL RECEPTOR VIRAL PEPTIDE (TAX) AND HLA-A 0201
990, 5ts1A, 0.7430, 2.29, 0.136, 273, 88, CRYSTAL STRUCTURE OF MHC-I H2-KD COMPLEXED WITH PEPTIDES OF MYCOBACTERIAL TUBERCULOSIS (YYQSGLSIV) 
991, 5f7dA, 0.7430, 2.23, 0.161, 273, 87, STRUCTURE OF HLA-A2:01 WITH PEPTIDE G11N
992, 4o2cA, 0.7430, 2.29, 0.148, 274, 88, AN NT-ACETYLATED PEPTIDE COMPLEXED WITH HLA-B*3901
993, 3qdmA, 0.7430, 2.24, 0.159, 275, 88, THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) DECAMERIC PEPTIDE
994, 3e6hA, 0.7430, 2.29, 0.125, 274, 88, MHC CLASS I H-2DD HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND A VARIANT PEPTIDE PI10 FROM THE HUMAN IMMUNODEFICIENCY VIRUS (BAL) ENVELOPE GLYCOPROTEIN 120
995, 3cchJ, 0.7430, 2.35, 0.114, 272, 88, H-2DB COMPLEX WITH MURINE GP100
996, 2rfxA, 0.7430, 2.27, 0.159, 275, 88, CRYSTAL STRUCTURE OF HLA-B*5701 PRESENTING THE SELF PEPTIDE LSSPVTKSF
997, 1yn7A, 0.7430, 2.31, 0.114, 273, 88, CRYSTAL STRUCTURE OF A MOUSE MHC CLASS I PROTEIN H2-DB IN COMPLEX WITH A MUTATED PEPTIDE (R7A) OF THE INFLUENZA A ACID POLYMERASE
998, 2x4rD, 0.7429, 2.27, 0.159, 275, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO CYTOMEGALOVIRUS (CMV) PP65 EPITOPE
999, 1agcA, 0.7429, 2.29, 0.148, 276, 88, ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYQL-7Q MUTATION)
1000, 5ts1G, 0.7428, 2.29, 0.136, 273, 88, CRYSTAL STRUCTURE OF MHC-I H2-KD COMPLEXED WITH PEPTIDES OF MYCOBACTERIAL TUBERCULOSIS (YYQSGLSIV) 
1001, 4l29G, 0.7428, 2.29, 0.159, 276, 88, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
1002, 3ft2A, 0.7428, 2.24, 0.161, 275, 87, CRYSTAL STRUCTURE OF A CITRULLINE PEPTIDE VARIANT OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1 IN COMPLEX WITH HLA- A2
1003, 2zokG, 0.7428, 2.30, 0.114, 263, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH JHMV EPITOPE S510
1004, 2x4nA, 0.7428, 2.26, 0.159, 275, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO RESIDUAL FRAGMENTS OF A PHOTOCLEAVABLE PEPTIDE THAT IS CLEAVED UPON UV-LIGHT TREATMENT
1005, 1tvbD, 0.7428, 2.25, 0.159, 275, 88, CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100(209-217) BOUND TO HUMAN CLASS I MHC HLA-A2
1006, 5incA, 0.7427, 2.26, 0.170, 277, 88, CRYSTAL STRUCTURE OF HLA-B5801 A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION
1007, 5d2lC, 0.7427, 2.24, 0.159, 274, 88, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
1008, 3mrpA, 0.7427, 2.24, 0.159, 275, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN- A MART1 DECAPEPTIDE VARIANT
1009, 3kppA, 0.7427, 2.27, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
1010, 2bvoA, 0.7427, 2.29, 0.159, 274, 88, STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION
1011, 4zuvD, 0.7426, 2.24, 0.136, 274, 88, CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE ENV-RW12
1012, 4l3cE, 0.7426, 2.29, 0.159, 276, 88, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
1013, 3w39A, 0.7426, 2.27, 0.170, 277, 88, CRYSTAL STRUCTURE OF HLA-B*5201 IN COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE (TAFTIPSI)
1014, 1w72A, 0.7426, 2.25, 0.159, 274, 88, CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB- HYB3
1015, 5nhtH, 0.7425, 2.19, 0.161, 275, 87, HUMAN 199.54-16 TCR IN COMPLEX WITH MELAN-A/MART-1 (26-35) PEPTIDE AND HLA-A2 
1016, 4u1jA, 0.7425, 2.30, 0.148, 278, 88, HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES
1017, 4qrrA, 0.7425, 2.21, 0.148, 276, 88, CRYSTAL STRUCTURE OF HLA B*3501-IPS IN COMPLEX WITH A DELTA-BETA TCR CLONE 12 TCR
1018, 3pqyK, 0.7425, 2.17, 0.115, 275, 87, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
1019, 3mrmA, 0.7425, 2.19, 0.161, 275, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1406-1415 DECAPEPTIDE
1020, 1s7rA, 0.7425, 2.28, 0.136, 276, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1021, 1qr1A, 0.7425, 2.19, 0.161, 275, 87, POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE
1022, 1qewA, 0.7425, 2.25, 0.136, 275, 88, HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) COMPLEX WITH A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATED ANTIGEN 3 (RESIDUES 271-279)
1023, 1agdA, 0.7425, 2.29, 0.148, 276, 88, ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYKL-INDEX PEPTIDE)
1024, 5t70A, 0.7424, 2.29, 0.159, 275, 88, KIR3DL1 IN COMPLEX WITH HLA-B*57:01 PRESENTING TSNLQEQIGW
1025, 5t6xA, 0.7424, 2.27, 0.170, 275, 88, HLA-B*57:01 PRESENTING TSTTSVASSW
1026, 4l3cI, 0.7424, 2.30, 0.159, 276, 88, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
1027, 4l29A, 0.7424, 2.32, 0.159, 276, 88, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
1028, 4g9fA, 0.7424, 2.30, 0.159, 276, 88, CRYSTAL STRUCTURE OF C12C TCR-HLAB2705-KK10-L6M
1029, 3p4nA, 0.7424, 2.32, 0.125, 278, 88, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE NP205-PV EPITOPE YTVKFPNM AN 8-MER PEPTIDE FROM PV
1030, 2zsvC, 0.7424, 2.29, 0.126, 277, 87, CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH JHMV EPITOPE S598
1031, 1wbxA, 0.7424, 2.31, 0.114, 275, 88, CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1032, 1n3nE, 0.7424, 2.44, 0.112, 276, 89, CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1033, 4l3cG, 0.7423, 2.29, 0.159, 276, 88, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
1034, 3mrdA, 0.7423, 2.25, 0.159, 274, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE V6G VARIANT
1035, 1t22A, 0.7423, 2.27, 0.159, 275, 88, STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE VARIANT SL9 ORTHORHOMBIC CRYSTAL
1036, 1qr1D, 0.7423, 2.19, 0.161, 275, 87, POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE
1037, 5swqA, 0.7422, 2.29, 0.159, 275, 88, CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH NA231 AN INFLUENZA EPITOPE
1038, 4zuvA, 0.7422, 2.24, 0.125, 274, 88, CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE ENV-RW12
1039, 3oxrA, 0.7422, 2.27, 0.159, 275, 88, CRYSTAL STRUCTURE OF HLA A*02:06 BOUND TO HBV CORE 18-27
1040, 2zokA, 0.7422, 2.27, 0.114, 252, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH JHMV EPITOPE S510
1041, 2yplA, 0.7422, 2.28, 0.148, 274, 88, STRUCTURAL FEATURES UNDERLYING T-CELL RECEPTOR SENSITIVITY TO CONCEALED MHC CLASS I MICROPOLYMORPHISMS
1042, 2p5eA, 0.7422, 2.18, 0.163, 276, 86, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
1043, 1s7rD, 0.7422, 2.28, 0.136, 276, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1044, 1rk1A, 0.7422, 2.29, 0.136, 274, 88, MHC CLASS I NATURAL H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE
1045, 1kpvA, 0.7422, 2.26, 0.136, 274, 88, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE MHC CLASS I COMPLEX H- 2KB/SEV9
1046, 5w69E, 0.7421, 2.35, 0.170, 273, 88, HLA-C*06:02 PRESENTING ARFNDLRFV
1047, 5trzC, 0.7421, 2.28, 0.136, 275, 88, CRYSTAL STRUCTURE OF MHC-I H2-KD COMPLEXED WITH PEPTIDES OF MYCOBACTERIAL TUBERCULOSIS (YQSGLSIVM) 
1048, 5n6bD, 0.7421, 2.18, 0.161, 276, 87, HUMAN LEUKOCYTE ANTIGEN CLASS I A02 CARRYING LLWNPGMAV
1049, 5c0dA, 0.7421, 2.21, 0.172, 276, 87, HLA-A02 CARRYING AQWGPDPAAA
1050, 4l3eA, 0.7420, 2.21, 0.159, 275, 88, THE COMPLEX BETWEEN HIGH AFFINITY TCR DMF5(ALPHA-D26YBETA-L98W) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
1051, 2x70A, 0.7420, 2.24, 0.159, 275, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE
1052, 2hjlA, 0.7420, 2.30, 0.170, 274, 88, CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE
1053, 1t0mA, 0.7420, 2.30, 0.125, 278, 88, CONFORMATIONAL SWITCH IN POLYMORPHIC H-2K MOLECULES CONTAINING AN HSV PEPTIDE
1054, 5e6iM, 0.7419, 2.18, 0.138, 268, 87, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
1055, 3bvnA, 0.7419, 2.25, 0.159, 277, 88, HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-B*1402 IN COMPLEX WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS
1056, 1t0nD, 0.7419, 2.23, 0.125, 278, 88, CONFORMATIONAL SWITCH IN POLYMORPHIC H-2K MOLECULES CONTAINING AN HSV PEPTIDE
1057, 1n5aJ, 0.7419, 2.41, 0.124, 273, 89, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB B2-MICROGLOBULIN AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV
1058, 5nmgA, 0.7418, 2.17, 0.163, 276, 86, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYFNTIAVL
1059, 5kd4A, 0.7418, 2.26, 0.125, 273, 88, CRYSTAL STRUCTURE OF MURINE MHC-I H-2DD IN COMPLEX WITH MURINE BETA2- MICROGLOBULIN AND A VARIANT OF PEPTIDE (PVI10) OF HIV GP120 MN ISOLATE (IGPGRAFYVI)
1060, 5d2lM, 0.7418, 2.24, 0.138, 273, 87, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
1061, 5c0jA, 0.7418, 2.28, 0.148, 277, 88, HLA-A02 CARRYING RQFGPDWIVA
1062, 3w39D, 0.7418, 2.27, 0.170, 277, 88, CRYSTAL STRUCTURE OF HLA-B*5201 IN COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE (TAFTIPSI)
1063, 3ft4A, 0.7418, 2.29, 0.148, 275, 88, CRYSTAL STRUCTURE OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1ARG IN COMPLEX WITH HLA-A2
1064, 2x4rA, 0.7418, 2.26, 0.159, 275, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO CYTOMEGALOVIRUS (CMV) PP65 EPITOPE
1065, 1fg2J, 0.7418, 2.42, 0.124, 273, 89, CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1066, 6avfH, 0.7417, 2.35, 0.148, 269, 88, CRYSTAL STRUCTURE OF THE KFJ5 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
1067, 4zfzG, 0.7417, 2.33, 0.170, 277, 88, CRYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*098 COMPLEXED WITH MYRISTOYLATED 5-MER LIPOPEPTIDE DERIVED FROM SIV NEF PROTEIN
1068, 4prbA, 0.7417, 2.25, 0.182, 276, 88, CRYSTAL STRUCTURE OF A HLA-B*35:08-HPVG-A4
1069, 4hkjM, 0.7417, 2.35, 0.125, 277, 88, STRUCTURE OF COWPOX CPXV203 IN COMPLEX WITH MHCI (H-2KB)
1070, 4hkjI, 0.7417, 2.35, 0.125, 277, 88, STRUCTURE OF COWPOX CPXV203 IN COMPLEX WITH MHCI (H-2KB)
1071, 4hkjE, 0.7417, 2.35, 0.125, 277, 88, STRUCTURE OF COWPOX CPXV203 IN COMPLEX WITH MHCI (H-2KB)
1072, 4hkjA, 0.7417, 2.35, 0.125, 277, 88, STRUCTURE OF COWPOX CPXV203 IN COMPLEX WITH MHCI (H-2KB)
1073, 3tidA, 0.7417, 2.30, 0.126, 277, 87, CRYSTAL STRUCTURE OF THE LCMV DERIVED PEPTIDE GP34 IN COMPLEX WITH THE MURINE MHC CLASS I H-2 KB
1074, 3tbsA, 0.7417, 2.43, 0.112, 272, 89, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX THE WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3PY4A)
1075, 3o3dD, 0.7417, 2.26, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2
1076, 3o3bD, 0.7417, 2.27, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1.1
1077, 3hg1A, 0.7417, 2.23, 0.159, 276, 88, GERMLINE-GOVERNED RECOGNITION OF A CANCER EPITOPE BY AN IMMUNODOMINANT HUMAN T CELL RECEPTOR
1078, 1yn6A, 0.7417, 2.32, 0.114, 273, 88, CRYSTAL STRUCTURE OF A MOUSE MHC CLASS I PROTEIN H2-DB IN COMPLEX WITH A PEPTIDE FROM THE INFLUENZA A ACID POLYMERASE
1079, 1n5aG, 0.7417, 2.42, 0.124, 273, 89, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB B2-MICROGLOBULIN AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV
1080, 4ihoA, 0.7416, 2.55, 0.112, 272, 89, CRYSTAL STRUCTURE OF H-2DB Y159F IN COMPLEX WITH CHIMERIC GP100
1081, 3uprC, 0.7416, 2.30, 0.170, 275, 88, HLA-B*57:01 COMPLEXED TO PEP-V AND ABACAVIR
1082, 5c08F, 0.7415, 2.21, 0.161, 276, 87, 1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV
1083, 3ft3A, 0.7415, 2.29, 0.159, 275, 88, CRYSTAL STRUCTURE OF THE MINOR HISTOCOMPATIBILITY PEPTIDE HA-1HIS IN COMPLEX WITH HLA-A2
1084, 2zokE, 0.7415, 2.28, 0.114, 253, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH JHMV EPITOPE S510
1085, 1wbyA, 0.7415, 2.31, 0.114, 275, 88, CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1086, 1q94D, 0.7415, 2.25, 0.159, 275, 88, STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE
1087, 5mepA, 0.7414, 2.20, 0.161, 276, 87, HUMAN LEUKOCYTE ANTIGEN A02 PRESENTING ILGKFLHWL
1088, 2x4qD, 0.7414, 2.25, 0.159, 275, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE
1089, 1sysA, 0.7414, 2.26, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA B*4403 AND PEPTIDE EEPTVIKKY
1090, 6gh1E, 0.7413, 2.23, 0.138, 274, 87, HLA-E*01:03 IN COMPLEX WITH MTB44 
1091, 6ggmC, 0.7413, 2.29, 0.159, 270, 88, HLA-E*01:03 IN COMPLEX WITH THE MTB44 PEPTIDE VARIANT: MTB44*P2-PHE. 
1092, 5t7gC, 0.7413, 2.30, 0.125, 273, 88, CRYSTAL STRUCTURE OF MURINE MHC-I H-2DD IN COMPLEX WITH MURINE BETA2- MICROGLOBULIN AND A VARIANT OF PEPTIDE (PT9) OF HIV GP120 MN ISOLATE (IGPGRAFYT)
1093, 5f1iJ, 0.7413, 2.34, 0.136, 270, 88, MHC WITH 9-MER PEPTIDE
1094, 5eo1A, 0.7413, 2.30, 0.148, 275, 88, CRYSTAL STRUCTURE OF HLA-B0702-RL9
1095, 4zuuA, 0.7413, 2.23, 0.125, 274, 88, CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE GAG-CF9
1096, 4lcyA, 0.7413, 2.32, 0.170, 274, 88, CRYSTAL STRUCTURE OF HLA-B46 AT 1.6 ANGSTROM RESOLUTION
1097, 4l29C, 0.7413, 2.32, 0.159, 276, 88, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
1098, 4jfpA, 0.7413, 2.17, 0.161, 276, 87, A2 HLA COMPLEX WITH G4A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE
1099, 3bwaA, 0.7413, 2.28, 0.182, 276, 88, CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 8- MER PEPTIDE FROM THE PP65 PROTEIN
1100, 2hlaA, 0.7413, 2.29, 0.159, 270, 88, SPECIFICITY POCKETS FOR THE SIDE CHAINS OF PEPTIDE ANTIGENS IN HLA-AW68
1101, 1mheA, 0.7413, 2.30, 0.148, 273, 88, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1102, 1ageA, 0.7413, 2.31, 0.148, 276, 88, ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYRL-7R MUTATION)
1103, 3tbsD, 0.7412, 2.42, 0.124, 271, 89, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX THE WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3PY4A)
1104, 3rolA, 0.7412, 2.27, 0.136, 271, 88, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH POST-TRANSLATIONALLY MODIFIED LCMV-DERIVED GP34-41 PEPTIDE COMPRISING A NITROTYROSINE AT POSITION 3
1105, 3fqtA, 0.7412, 2.24, 0.161, 275, 87, PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES
1106, 2x4nD, 0.7412, 2.25, 0.159, 275, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO RESIDUAL FRAGMENTS OF A PHOTOCLEAVABLE PEPTIDE THAT IS CLEAVED UPON UV-LIGHT TREATMENT
1107, 1rk0A, 0.7412, 2.29, 0.136, 274, 88, MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS GLYCOPROTEIN B PEPTIDE
1108, 1qsfA, 0.7412, 2.16, 0.174, 274, 86, STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A
1109, 1jgeA, 0.7412, 2.27, 0.159, 276, 88, HLA-B*2705 BOUND TO NONA-PEPTIDE M9
1110, 1fg2D, 0.7412, 2.42, 0.124, 273, 89, CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1111, 6gh4G, 0.7411, 2.24, 0.138, 274, 87, HLA-E*01:03 IN COMPLEX WITH THE MTB44 PEPTIDE VARIANT: MTB44*P2-GLN. 
1112, 5kd7A, 0.7411, 2.32, 0.125, 273, 88, CRYSTAL STRUCTURE OF MURINE MHC-I H-2DD IN COMPLEX WITH MURINE BETA2- MICROGLOBULIN AND A VARIANT OF PEPTIDE (PV9) OF HIV GP120 MN ISOLATE (IGPGRAFYV)
1113, 4zfzJ, 0.7411, 2.33, 0.170, 277, 88, CRYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*098 COMPLEXED WITH MYRISTOYLATED 5-MER LIPOPEPTIDE DERIVED FROM SIV NEF PROTEIN
1114, 4prdA, 0.7411, 2.26, 0.182, 275, 88, CRYSTAL STRUCTURE OF A HLA-B*35:08-HPVG-D5
1115, 4lcyF, 0.7411, 2.28, 0.170, 274, 88, CRYSTAL STRUCTURE OF HLA-B46 AT 1.6 ANGSTROM RESOLUTION
1116, 3tpuE, 0.7411, 2.35, 0.138, 175, 87, 42F3 P5E8/H2-LD COMPLEX
1117, 3spvA, 0.7411, 2.27, 0.148, 276, 88, CRYSTAL STRUCTURE OF A PEPTIDE-HLA COMPLEX
1118, 3rwfA, 0.7411, 2.31, 0.159, 276, 88, RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-QW9
1119, 3nwmA, 0.7411, 2.27, 0.141, 384, 85, CRYSTAL STRUCTURE OF A SINGLE CHAIN CONSTRUCT COMPOSED OF MHC CLASS I H-2KD BETA-2MICROGLOBULIN AND A PEPTIDE WHICH IS AN AUTOANTIGEN FOR TYPE 1 DIABETES
1120, 4l29Q, 0.7410, 2.28, 0.159, 276, 88, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
1121, 3rolC, 0.7410, 2.27, 0.136, 272, 88, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH POST-TRANSLATIONALLY MODIFIED LCMV-DERIVED GP34-41 PEPTIDE COMPRISING A NITROTYROSINE AT POSITION 3
1122, 3ln4A, 0.7410, 2.28, 0.148, 274, 88, CRYSTAL STRUCTURE OF HLA-B*4103 IN COMPLEX WITH A 16MER SELF-PEPTIDE DERIVED FROM HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS C1/C2
1123, 2zolA, 0.7410, 2.30, 0.114, 258, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE W513S VARIANT OF JHMV EPITOPE S510
1124, 1fg2G, 0.7410, 2.43, 0.124, 273, 89, CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1125, 1fg2A, 0.7410, 2.43, 0.124, 273, 89, CRYSTAL STRUCTURE OF THE LCMV PEPTIDIC EPITOPE GP33 IN COMPLEX WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1126, 3vh8A, 0.7409, 2.30, 0.159, 275, 88, KIR3DL1 IN COMPLEX WITH HLA-B*5701
1127, 2zolC, 0.7409, 2.31, 0.114, 256, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE W513S VARIANT OF JHMV EPITOPE S510
1128, 4ihoD, 0.7408, 2.59, 0.112, 272, 89, CRYSTAL STRUCTURE OF H-2DB Y159F IN COMPLEX WITH CHIMERIC GP100
1129, 3jvgB, 0.7408, 2.30, 0.174, 267, 86, CRYSTAL STRUCTURE OF CHICKEN CD1-1
1130, 1zhbG, 0.7408, 2.41, 0.124, 273, 89, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB B2-MICROGLOBULIN AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA- MONOOXIGENASE
1131, 5v5lC, 0.7407, 2.35, 0.159, 277, 88, CRYSTAL STRUCTURE OF HLA-B*5801 COMPLEX WITH HIV-1 GAG DERIVED PEPTIDE TW10
1132, 4f7tD, 0.7407, 2.30, 0.172, 274, 87, CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009 H1N1 PB1 (498-505)
1133, 3p4mA, 0.7407, 2.33, 0.125, 278, 88, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE NP205-LCMV EPITOPE YTVKYPNL AN 8-MER PEPTIDE FROM THE LCMV
1134, 3jvgA, 0.7407, 2.32, 0.174, 264, 86, CRYSTAL STRUCTURE OF CHICKEN CD1-1
1135, 1agbA, 0.7407, 2.31, 0.148, 276, 88, ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGRKKYKL-3R MUTATION)
1136, 5iekA, 0.7406, 2.31, 0.148, 276, 88, STRUCTURE OF HLA-B*40:02 IN COMPLEX WITH THE ENDOGENOUS PEPTIDE REFSKEPEL
1137, 3mroA, 0.7406, 2.25, 0.159, 275, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN- A MART1 DECAPEPTIDE VARIANT
1138, 1zhbJ, 0.7406, 2.41, 0.112, 273, 89, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB B2-MICROGLOBULIN AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA- MONOOXIGENASE
1139, 1hsaA, 0.7406, 2.34, 0.148, 276, 88, THE THREE-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 ANGSTROMS RESOLUTION SUGGESTS A GENERAL MECHANISM FOR TIGHT PEPTIDE BINDING TO MHC
1140, 5txsA, 0.7405, 2.28, 0.148, 276, 88, CRYSTAL STRUCTURE OF AN ANAPLASTIC LYMPHOMA KINASE-DERIVED NEUROBLASTOMA TUMOR ANTIGEN BOUND TO THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULE HLA-B*1501
1141, 4o2fD, 0.7405, 2.24, 0.138, 274, 87, A PEPTIDE COMPLEXED WITH HLA-B*3901
1142, 3d3vA, 0.7405, 2.26, 0.159, 275, 88, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(34-DIFLUOROPHENYLALANINE)) PEPTIDE
1143, 1zhbD, 0.7405, 2.41, 0.124, 273, 89, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB B2-MICROGLOBULIN AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA- MONOOXIGENASE
1144, 1qseA, 0.7405, 2.22, 0.161, 274, 87, STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R
1145, 1n5aD, 0.7405, 2.27, 0.125, 274, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB B2-MICROGLOBULIN AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV
1146, 4qrqA, 0.7404, 2.28, 0.148, 269, 88, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL
1147, 3qfjA, 0.7404, 2.22, 0.161, 275, 87, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE
1148, 5wmnA, 0.7402, 2.31, 0.148, 276, 88, CRYSTAL STRUCTURE OF HLA-B7 IN COMPLEX WITH SPI; AN INFLUENZA PEPTIDE 
1149, 5f1iV, 0.7402, 2.34, 0.136, 271, 88, MHC WITH 9-MER PEPTIDE
1150, 5c07F, 0.7402, 2.23, 0.149, 277, 87, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA
1151, 2p5wA, 0.7402, 2.20, 0.163, 276, 86, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
1152, 2gtzD, 0.7402, 2.28, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A28L SUBSTITUTION
1153, 2c7uD, 0.7402, 2.28, 0.159, 275, 88, CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE.
1154, 1xr8A, 0.7402, 2.29, 0.170, 276, 88, CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3
1155, 1e28A, 0.7402, 2.28, 0.172, 276, 87, NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM2(TAFTIPSI)
1156, 5e00A, 0.7401, 2.21, 0.161, 275, 87, STRUCTURE OF HLA-A2 P130
1157, 4u1kA, 0.7401, 2.32, 0.148, 277, 88, HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES
1158, 1lk2A, 0.7401, 2.29, 0.136, 274, 88, 1.35A CRYSTAL STRUCTURE OF H-2KB COMPLEXED WITH THE GNYSFYAL PEPTIDE
1159, 5f9jA, 0.7400, 2.26, 0.159, 274, 88, STRUCTURE OF HLA-A2:01 WITH PEPTIDE Y9L
1160, 4u1kD, 0.7400, 2.31, 0.148, 277, 88, HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES
1161, 4l3cQ, 0.7400, 2.29, 0.159, 276, 88, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
1162, 3pqyA, 0.7400, 2.16, 0.115, 275, 87, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
1163, 3fquA, 0.7400, 2.25, 0.161, 275, 87, PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES
1164, 1n5aA, 0.7400, 2.28, 0.125, 276, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB B2-MICROGLOBULIN AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV
1165, 2ckbI, 0.7399, 2.27, 0.126, 274, 87, STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
1166, 2ckbH, 0.7399, 2.27, 0.126, 274, 87, STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
1167, 1ffoA, 0.7399, 2.30, 0.114, 273, 88, CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH SYNTHETIC PEPTIDE GP33 (C9M/K1A)
1168, 5m00A, 0.7398, 2.37, 0.114, 276, 88, CRYSTAL STRUCTURE OF MURINE P14 TCR COMPLEX WITH H-2DB AND Y4A MODIFIED GP33 PEPTIDE FROM LCMV
1169, 4u1nA, 0.7398, 2.31, 0.136, 278, 88, HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES
1170, 3qfdD, 0.7398, 2.28, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH MART-1(27-35) NONAMERIC PEPTIDE
1171, 3p9mA, 0.7398, 2.33, 0.125, 277, 88, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH A MUTANT OF THE CHICKEN OVALBUMIN EPITOPE OVA-G4
1172, 3kpsA, 0.7398, 2.25, 0.149, 276, 87, CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
1173, 2e7lF, 0.7398, 2.15, 0.140, 175, 86, STRUCTURE OF A HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1174, 1s7tA, 0.7398, 2.28, 0.136, 276, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1175, 4l29Y, 0.7397, 2.31, 0.159, 276, 88, STRUCTURE OF WTMHC CLASS I WITH NY-ESO1 DOUBLE MUTANT
1176, 3cplC, 0.7397, 2.33, 0.114, 275, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH A VARIANT M6A OF THE NP366 PEPTIDE FROM INFLUENZA A VIRUS
1177, 4u1mA, 0.7396, 2.31, 0.148, 277, 88, HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES
1178, 4nskA, 0.7396, 2.36, 0.114, 274, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND V3P
1179, 4nqxG, 0.7396, 2.28, 0.159, 274, 88, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N AN 9-MER INFLUENZA EPITOPE
1180, 4jfeA, 0.7396, 2.21, 0.161, 276, 87, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
1181, 3pwlD, 0.7396, 2.28, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD PEPTIDE
1182, 2ve6G, 0.7396, 2.32, 0.125, 276, 88, CRYSTAL STRUCTURE OF A MURINE MHC CLASS I H2-DB MOLECULE IN COMPLEX WITH A PHOTOCLEAVABLE PEPTIDE
1183, 2mhaA, 0.7396, 2.31, 0.125, 270, 88, CRYSTAL STRUCTURE OF THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I H-2KB MOLECULE CONTAINING A SINGLE VIRAL PEPTIDE: IMPLICATIONS FOR PEPTIDE BINDING AND T-CELL RECEPTOR RECOGNITION
1184, 1t0mD, 0.7396, 2.25, 0.125, 278, 88, CONFORMATIONAL SWITCH IN POLYMORPHIC H-2K MOLECULES CONTAINING AN HSV PEPTIDE
1185, 1n3nA, 0.7396, 2.29, 0.114, 276, 88, CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1186, 1ffoD, 0.7396, 2.30, 0.114, 273, 88, CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH SYNTHETIC PEPTIDE GP33 (C9M/K1A)
1187, 5wesA, 0.7395, 2.33, 0.125, 273, 88, CRYSTAL STRUCTURE H2-DD WITH DISULFIDE-LINKED 5MER PEPTIDE
1188, 4gksA, 0.7395, 2.19, 0.161, 276, 87, A2-MHC COMPLEX CARRYING FLTGIGIITV
1189, 3ch1A, 0.7395, 2.32, 0.114, 274, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH CHIMERIC GP100
1190, 1wbzC, 0.7395, 2.33, 0.125, 274, 88, CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1191, 1p4lA, 0.7395, 2.31, 0.125, 273, 88, CRYSTAL STRUCTURE OF NK RECEPTOR LY49C MUTANT WITH ITS MHC CLASS I LIGAND H-2KB
1192, 5wetA, 0.7394, 2.33, 0.125, 273, 88, CRYSTAL STRUCTURE OF H2-DD WITH DISULFIDE-LINKED 6MER PEPTIDE
1193, 2clvA, 0.7394, 2.31, 0.125, 278, 88, MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM8 PEPTIDE
1194, 5b38A, 0.7393, 2.27, 0.161, 275, 87, KIR3DL1*005 IN COMPLEX WITH HLA-B*57:01
1195, 4preA, 0.7393, 2.27, 0.182, 275, 88, CRYSTAL STRUCTURE OF A HLA-B*35:08-HPVG-Q5
1196, 3tbwA, 0.7393, 2.41, 0.124, 274, 89, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G V3P Y4S)
1197, 3p9lA, 0.7393, 2.26, 0.125, 278, 88, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE CHICKEN OVALBUMIN EPITOPE OVA
1198, 5nmfF, 0.7392, 2.18, 0.163, 276, 86, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTIATL
1199, 4pg9A, 0.7392, 2.28, 0.136, 276, 88, MHC CLASS I IN COMPLEX WITH SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGNYPAL
1200, 4nqvI, 0.7392, 2.29, 0.159, 274, 88, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44 AN 9-MER INFLUENZA EPITOPE
1201, 3x12A, 0.7392, 2.32, 0.159, 275, 88, CRYSTAL STRUCTURE OF HLA-B*57:01.I80N
1202, 3cplA, 0.7392, 2.33, 0.114, 275, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH A VARIANT M6A OF THE NP366 PEPTIDE FROM INFLUENZA A VIRUS
1203, 3vh8D, 0.7391, 2.32, 0.159, 275, 88, KIR3DL1 IN COMPLEX WITH HLA-B*5701
1204, 3vclA, 0.7391, 2.34, 0.148, 275, 88, CRYSTAL STRUCTURE OF HLA-B7 WITH THE HCMV PP65 PEPTIDE RPHERNGFTVL
1205, 3uprA, 0.7391, 2.34, 0.170, 275, 88, HLA-B*57:01 COMPLEXED TO PEP-V AND ABACAVIR
1206, 3tpuK, 0.7391, 2.17, 0.140, 175, 86, 42F3 P5E8/H2-LD COMPLEX
1207, 3tf7E, 0.7391, 2.43, 0.136, 175, 88, 42F3 QL9/H2-LD COMPLEX
1208, 3mriA, 0.7391, 2.27, 0.161, 274, 87, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE G4M-V5W VARIANT
1209, 2vlrF, 0.7391, 2.22, 0.161, 276, 87, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
1210, 1mheC, 0.7391, 2.30, 0.148, 273, 88, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1211, 5n6bA, 0.7390, 2.21, 0.161, 276, 87, HUMAN LEUKOCYTE ANTIGEN CLASS I A02 CARRYING LLWNPGMAV
1212, 5e8nD, 0.7390, 2.37, 0.114, 272, 88, THE STRUCTURE OF THE TEIPP ASSOCIATED TRH4 PEPTIDE IN COMPLEX WITH H- 2D(B)
1213, 4qrpF, 0.7390, 2.26, 0.136, 276, 88, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR
1214, 2f54F, 0.7390, 2.27, 0.159, 274, 88, DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
1215, 1s7xD, 0.7390, 2.26, 0.125, 276, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1216, 1oszA, 0.7390, 2.29, 0.136, 274, 88, MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND AN (L4V) MUTANT OF THE VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
1217, 5wmpA, 0.7389, 2.32, 0.148, 276, 88, CRYSTAL STRUCTURE OF HLA-B7 IN COMPLEX WITH TPR; A CMV PEPTIDE 
1218, 3rooA, 0.7389, 2.29, 0.125, 275, 88, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH IMMUNODOMINANT LCMV-DERIVED GP34-41 PEPTIDE
1219, 3d39A, 0.7389, 2.24, 0.161, 275, 87, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(4-FLUOROPHENYLALANINE)) PEPTIDE
1220, 1kbgH, 0.7389, 2.30, 0.136, 274, 88, MHC CLASS I H-2KB PRESENTED GLYCOPEPTIDE RGY8-6H-GAL2
1221, 6enyF, 0.7388, 2.29, 0.170, 274, 88, STRUCTURE OF THE HUMAN PLC EDITING MODULE
1222, 4nqvA, 0.7388, 2.28, 0.159, 274, 88, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44 AN 9-MER INFLUENZA EPITOPE
1223, 3ws3C, 0.7388, 2.25, 0.114, 271, 88, CRYSTAL STRUCTURE OF H-2D IN COMPLEX WITH AN INSULIN DERIVED PEPTIDE
1224, 2c7uA, 0.7388, 2.28, 0.159, 275, 88, CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE.
1225, 5vgdA, 0.7387, 2.36, 0.170, 273, 88, CRYSTAL STRUCTURE OF HLA-C*0501 IN COMPLEX WITH SAE
1226, 5e9dF, 0.7387, 2.19, 0.161, 272, 87, RD-1 MART-1 HIGH BOUND TO MART-1 DECAMERIC PEPTIDE (ELA) IN COMPLEX WITH HLA-A2
1227, 4nqvG, 0.7387, 2.26, 0.159, 274, 88, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44 AN 9-MER INFLUENZA EPITOPE
1228, 4jqvA, 0.7387, 2.31, 0.170, 276, 88, HLA-B*18:01 IN COMPLEX WITH EPSTEIN-BARR VIRUS BZLF1-DERIVED PEPTIDE (RESIDUES 173-180)
1229, 2xfxA, 0.7387, 2.32, 0.115, 277, 87, CATTLE MHC CLASS I N01301 PRESENTING AN 11MER FROM THEILERIA PARVA
1230, 2pyeA, 0.7387, 2.23, 0.161, 276, 87, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY TCR CLONE C5C1 COMPLEXED WITH MHC
1231, 1q94A, 0.7387, 2.22, 0.161, 275, 87, STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE
1232, 4jffA, 0.7386, 2.26, 0.159, 276, 88, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
1233, 4huxA, 0.7386, 2.42, 0.114, 273, 88, CRYSTAL STRUCTURE OF H2DB-H155A-NP
1234, 3tpuQ, 0.7386, 2.27, 0.138, 176, 87, 42F3 P5E8/H2-LD COMPLEX
1235, 3jtsD, 0.7386, 2.38, 0.136, 276, 88, GY9-MAMU-A*02-HB2M
1236, 3bw9A, 0.7386, 2.29, 0.182, 276, 88, CRYSTAL STRUCTURE OF HLA B*3508 IN COMPLEX WITH A HCMV 12- MER PEPTIDE FROM THE PP65 PROTEIN
1237, 2gt9D, 0.7386, 2.28, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE DECAMERIC MELAN-A/MART- 1(26-35) PEPTIDE
1238, 1s7uD, 0.7386, 2.28, 0.114, 274, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1239, 1ffpA, 0.7386, 2.31, 0.114, 273, 88, CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33 (C9M/K1S)
1240, 5wmnC, 0.7385, 2.32, 0.148, 276, 88, CRYSTAL STRUCTURE OF HLA-B7 IN COMPLEX WITH SPI; AN INFLUENZA PEPTIDE 
1241, 5vclA, 0.7385, 2.18, 0.126, 277, 87, STRUCTURE OF THE QDM PEPTIDE BOUND TO QA-1A
1242, 5m01A, 0.7385, 2.40, 0.114, 276, 88, CRYSTAL STRUCTURE OF MURINE P14 TCR/ H-2DB COMPLEX WITH PA MODIFIED GP33 PEPTIDE FROM LCMV
1243, 4nqvK, 0.7385, 2.28, 0.159, 274, 88, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44 AN 9-MER INFLUENZA EPITOPE
1244, 4jfdA, 0.7385, 2.23, 0.161, 276, 87, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
1245, 4huuA, 0.7385, 2.32, 0.114, 278, 88, CRYSTAL STRUCTURE OF H2DB-NPM6I
1246, 2ve6A, 0.7385, 2.35, 0.114, 276, 88, CRYSTAL STRUCTURE OF A MURINE MHC CLASS I H2-DB MOLECULE IN COMPLEX WITH A PHOTOCLEAVABLE PEPTIDE
1247, 2fz3A, 0.7385, 2.28, 0.182, 276, 88, THE ROLE OF T CELL RECEPTOR ALPHA GENES IN DIRECTING HUMAN MHC RESTRICTION
1248, 4u1hA, 0.7384, 2.33, 0.148, 277, 88, HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES
1249, 4l3cS, 0.7384, 2.29, 0.161, 276, 87, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
1250, 2bvqA, 0.7384, 2.32, 0.159, 274, 88, STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION
1251, 1xh3A, 0.7384, 2.28, 0.170, 276, 88, CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14-MERIC PEPTIDES IN COMPLEX WITH HLA-B*3501
1252, 1ffpD, 0.7384, 2.31, 0.114, 273, 88, CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33 (C9M/K1S)
1253, 4zezD, 0.7383, 2.26, 0.159, 262, 88, CRYSTAL STRUCTURE OF HCV 1406 TCR/HCV NS3: 1406-1415/HLA-A2 COMPLEX
1254, 4nqxA, 0.7383, 2.27, 0.159, 274, 88, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N AN 9-MER INFLUENZA EPITOPE
1255, 2ypkA, 0.7383, 2.31, 0.170, 274, 88, STRUCTURAL FEATURES UNDERLYING T-CELL RECEPTOR SENSITIVITY TO CONCEALED MHC CLASS I MICROPOLYMORPHISMS
1256, 2nw3A, 0.7383, 2.28, 0.182, 276, 88, CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
1257, 5h94A, 0.7382, 2.38, 0.125, 275, 88, CRYSTAL STRUCTURE OF SWINE MHC CLASSI FOR 1.48 ANGSTROMS
1258, 4huwA, 0.7382, 2.29, 0.114, 277, 88, CRYSTAL STRUCTURE OF H2DB-NPM6T
1259, 4huuD, 0.7382, 2.32, 0.114, 276, 88, CRYSTAL STRUCTURE OF H2DB-NPM6I
1260, 5kd7F, 0.7381, 2.33, 0.125, 275, 88, CRYSTAL STRUCTURE OF MURINE MHC-I H-2DD IN COMPLEX WITH MURINE BETA2- MICROGLOBULIN AND A VARIANT OF PEPTIDE (PV9) OF HIV GP120 MN ISOLATE (IGPGRAFYV)
1261, 5b39A, 0.7381, 2.27, 0.161, 275, 87, KIR3DL1*015 IN COMPLEX WITH HLA-B*57:01
1262, 3x14A, 0.7381, 2.30, 0.148, 276, 88, CRYSTAL STRUCTURE OF HLA-B*0801.N80I.R82L.G83R
1263, 3tbwC, 0.7380, 2.45, 0.112, 274, 89, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G V3P Y4S)
1264, 2ak4Q, 0.7380, 2.27, 0.182, 276, 88, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE
1265, 5nmfA, 0.7379, 2.18, 0.163, 276, 86, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTIATL
1266, 5nmeF, 0.7379, 2.23, 0.161, 276, 87, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTVATL
1267, 2f74D, 0.7379, 2.37, 0.125, 276, 88, MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33
1268, 1zhbA, 0.7379, 2.45, 0.124, 273, 89, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2DB B2-MICROGLOBULIN AND A 9-RESIDUE PEPTIDE DERIVED FROM RAT DOPAMINE BETA- MONOOXIGENASE
1269, 1g7qA, 0.7379, 2.31, 0.136, 274, 88, CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND MUC1 VNTR PEPTIDE SAPDTRPA
1270, 5y91A, 0.7378, 2.32, 0.149, 273, 87, THE STRUCTURE OF THE MHC CLASS I MOLECULE OF BONY FISHES PROVIDES INSIGHTS INTO THE CONSERVED NATURE OF THE ANTIGEN-PRESENTING SYSTEM
1271, 5xosA, 0.7378, 2.28, 0.170, 276, 88, CRYSTAL STRUCTURE OF HLA-B35 IN COMPLEX WITH A PEPETIDE ANTIGEN
1272, 5swzA, 0.7378, 2.36, 0.114, 277, 88, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1273, 3qeqA, 0.7378, 2.22, 0.161, 275, 87, THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
1274, 3l3hA, 0.7378, 2.33, 0.114, 275, 88, X-RAY CRYSTAL STRUCTURE OF THE F6A MUTANT OF INFLUENZA A ACID POLYMERASE EPITOPE PA224 BOUND TO MURINE H2-DB MHC
1275, 3c8kA, 0.7378, 2.36, 0.125, 274, 88, THE CRYSTAL STRUCTURE OF LY49C BOUND TO H-2KB
1276, 2hn7A, 0.7378, 2.27, 0.149, 274, 87, HLA-A*1101 IN COMPLEX WITH HBV PEPTIDE HOMOLOGUE
1277, 1s7xA, 0.7378, 2.29, 0.125, 276, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1278, 6at9A, 0.7377, 2.31, 0.159, 274, 88, CRYSTAL STRUCTURE OF AN ANAPLASTIC LYMPHOMA KINASE-DERIVED NEUROBLASTOMA TUMOR ANTIGEN BOUND TO THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULE HLA-A*0101
1279, 5e8pD, 0.7377, 2.38, 0.115, 271, 87, THE STRUCTURE OF THE TEIPP ASSOCIATED ALTERED PEPTIDE LIGAND TRH4- P5NLE IN COMPLEX WITH H-2D(B)
1280, 4qruA, 0.7377, 2.29, 0.148, 275, 88, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH ELR_MYM ELRRKMMYM
1281, 4prnA, 0.7377, 2.28, 0.170, 276, 88, CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-A4
1282, 3wuwA, 0.7377, 2.32, 0.159, 275, 88, KIR3DL1 IN COMPLEX WITH HLA-B*57:01.I80T
1283, 1s7xG, 0.7377, 2.43, 0.112, 276, 89, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1284, 4pr5A, 0.7376, 2.28, 0.170, 276, 88, CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-D5
1285, 4huwC, 0.7376, 2.32, 0.114, 277, 88, CRYSTAL STRUCTURE OF H2DB-NPM6T
1286, 3vfrA, 0.7376, 2.28, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA B*3508LPEP-P4ALA PEPTIDE MUTANT P4-ALA
1287, 1s9xA, 0.7376, 2.28, 0.161, 274, 87, CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE SLLMWITQA IN COMPLEX WITH HLA-A2
1288, 1s7uJ, 0.7376, 2.43, 0.112, 273, 89, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1289, 1mhcA, 0.7376, 2.24, 0.115, 276, 87, MODEL OF MHC CLASS I H2-M3 WITH NONAPEPTIDE FROM RAT ND1 REFINED AT 2.3 ANGSTROMS RESOLUTION
1290, 4nnxA, 0.7375, 2.24, 0.161, 274, 87, CRYSTAL STRUCTURE OF PKD2 PHOSPHOPEPTIDE BOUND TO HLA-A2
1291, 3x11A, 0.7375, 2.29, 0.170, 276, 88, CRYSTAL STRUCTURE OF HLA-B*57:01.I80N.L82R.R83G
1292, 2axgA, 0.7375, 2.29, 0.170, 276, 88, THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION
1293, 1wbzA, 0.7375, 2.35, 0.125, 275, 88, CRYSTAL STRUCTURES OF MURINE MHC CLASS I H-2 DB AND KB MOLECULES IN COMPLEX WITH CTL EPITOPES FROM INFLUENZA A VIRUS: IMPLICATIONS FOR TCR REPERTOIRE SELECTION AND IMMUNODOMINANCE
1294, 5swzP, 0.7374, 2.34, 0.114, 238, 88, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1295, 4huwG, 0.7374, 2.32, 0.114, 277, 88, CRYSTAL STRUCTURE OF H2DB-NPM6T
1296, 1s7wG, 0.7374, 2.40, 0.124, 276, 89, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1297, 5e8oA, 0.7373, 2.39, 0.114, 272, 88, THE STRUCTURE OF THE TEIPP ASSOCIATED ALTERED PEPTIDE LIGAND TRH4- P2ABU IN COMPLEX WITH H-2D(B)
1298, 1n59A, 0.7373, 2.32, 0.125, 276, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2KB B2-MICROGLOBULIN AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV
1299, 5wmrA, 0.7372, 2.28, 0.148, 267, 88, CRYSTAL STRUCTURE OF HLA-B8 IN COMPLEX WITH QIK; A CMV PEPTIDE 
1300, 3c9nA, 0.7372, 2.30, 0.148, 276, 88, CRYSTAL STRUCTURE OF A SARS CORONA VIRUS DERIVED PEPTIDE BOUND TO THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULE HLA-B*1501
1301, 4nqxI, 0.7371, 2.29, 0.159, 274, 88, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N AN 9-MER INFLUENZA EPITOPE
1302, 3fqrA, 0.7371, 2.29, 0.159, 274, 88, PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES
1303, 2zswC, 0.7371, 2.38, 0.125, 277, 88, CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598
1304, 2x4pA, 0.7371, 2.29, 0.159, 275, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE
1305, 1s7xJ, 0.7371, 2.47, 0.112, 276, 89, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1306, 1ld9D, 0.7371, 2.28, 0.138, 268, 87, THE THREE-DIMENSIONAL STRUCTURE OF AN H-2LD PEPTIDE COMPLEX EXPLAINS THE UNIQUE INTERACTION OF LD WITH BETA2M AND PEPTIDE
1307, 1ld9A, 0.7371, 2.28, 0.138, 268, 87, THE THREE-DIMENSIONAL STRUCTURE OF AN H-2LD PEPTIDE COMPLEX EXPLAINS THE UNIQUE INTERACTION OF LD WITH BETA2M AND PEPTIDE
1308, 5e6iI, 0.7370, 2.24, 0.138, 261, 87, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
1309, 3e3qY, 0.7370, 2.31, 0.149, 175, 87, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1310, 2zswE, 0.7370, 2.37, 0.125, 277, 88, CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598
1311, 2zswA, 0.7370, 2.37, 0.125, 277, 88, CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598
1312, 6ei2A, 0.7369, 2.27, 0.159, 275, 88, CRYSTAL STRUCTURE OF HLA-A68 PRESENTING A C-TERMINALLY EXTENDED PEPTIDE
1313, 5wkhA, 0.7369, 2.29, 0.159, 274, 88, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS3
1314, 5hyjF, 0.7369, 2.15, 0.163, 276, 86, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA
1315, 5h5zA, 0.7369, 2.29, 0.138, 275, 87, CRYSTAL STRUCTURE OF BONY FISH MHC CLASS I PEPTIDE AND B2M II
1316, 5cnzA, 0.7369, 2.29, 0.138, 275, 87, CRYSTAL STRUCTURE OF BONY FISH MHC CLASS I PEPTIDE AND B2M II
1317, 4pgdA, 0.7369, 2.31, 0.136, 274, 88, MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGNYPAF
1318, 3oxsA, 0.7369, 2.24, 0.161, 275, 87, CRYSTAL STRUCTURE OF HLA A*02:07 BOUND TO HBV CORE 18-27
1319, 2fo4A, 0.7369, 2.32, 0.136, 274, 88, ENHANCED MHC CLASS I BINDING AND IMMUNE RESPONSES THROUGH ANCHOR MODIFICATION OF THE NON-CANONICAL TUMOR ASSOCIATED MUC1-8 PEPTIDE
1320, 2f74A, 0.7369, 2.40, 0.114, 275, 88, MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33
1321, 4nqxE, 0.7368, 2.28, 0.159, 275, 88, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N AN 9-MER INFLUENZA EPITOPE
1322, 4nqvE, 0.7368, 2.28, 0.159, 274, 88, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44 AN 9-MER INFLUENZA EPITOPE
1323, 4lnrA, 0.7368, 2.29, 0.170, 276, 88, THE STRUCTURE OF HLA-B*35:01 IN COMPLEX WITH THE PEPTIDE (RPQVPLRPMTY)
1324, 4huwE, 0.7368, 2.30, 0.114, 277, 88, CRYSTAL STRUCTURE OF H2DB-NPM6T
1325, 3e3qU, 0.7368, 2.32, 0.149, 175, 87, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1326, 3e3qP, 0.7368, 2.32, 0.149, 175, 87, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1327, 2ak4K, 0.7368, 2.28, 0.182, 276, 88, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE
1328, 1s7wD, 0.7368, 2.28, 0.125, 276, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1329, 1s7uA, 0.7368, 2.31, 0.114, 276, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1330, 5wjlA, 0.7367, 2.31, 0.159, 274, 88, CRYSTAL STRUCTURE OF HLA-A*11:01 WITH GTS1 PEPTIDE
1331, 3qulA, 0.7367, 2.40, 0.114, 264, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (Y4S)
1332, 1s9yA, 0.7367, 2.28, 0.161, 274, 87, CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE SLLMWITQS IN COMPLEX WITH HLA-A2
1333, 1n59C, 0.7367, 2.32, 0.125, 276, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX OF H-2KB B2-MICROGLOBULIN AND A 9-RESIDUE IMMUNODOMINANT PEPTIDE EPITOPE GP33 DERIVED FROM LCMV
1334, 3mrnA, 0.7366, 2.26, 0.159, 274, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS4B-1807-1816 DECAPEPTIDE
1335, 3e3qc, 0.7366, 2.32, 0.149, 175, 87, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1336, 2bckA, 0.7366, 2.31, 0.170, 286, 88, CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASE PEPTIDE
1337, 5mzmA, 0.7365, 2.12, 0.115, 271, 87, STRUCTURE OF H-2DB IN COMPLEX WITH TEIPP APL TRH4 P3P
1338, 5hyjA, 0.7365, 2.26, 0.159, 276, 88, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA
1339, 5e6iR, 0.7365, 2.25, 0.161, 251, 87, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
1340, 3mrqA, 0.7365, 2.29, 0.159, 274, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN- A MART1 DECAPEPTIDE VARIANT
1341, 5e8nJ, 0.7364, 2.27, 0.115, 258, 87, THE STRUCTURE OF THE TEIPP ASSOCIATED TRH4 PEPTIDE IN COMPLEX WITH H- 2D(B)
1342, 5e8nG, 0.7364, 2.34, 0.115, 269, 87, THE STRUCTURE OF THE TEIPP ASSOCIATED TRH4 PEPTIDE IN COMPLEX WITH H- 2D(B)
1343, 5bs0A, 0.7364, 2.26, 0.161, 275, 87, MAGE-A3 REACTIVE TCR IN COMPLEX WITH TITIN EPITOPE IN HLA-A1
1344, 2clvH, 0.7364, 2.35, 0.125, 278, 88, MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND PBM8 PEPTIDE
1345, 1g6rH, 0.7364, 2.33, 0.126, 274, 87, A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
1346, 3e3qH, 0.7363, 2.32, 0.149, 175, 87, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1347, 3ch1J, 0.7363, 2.50, 0.114, 272, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH CHIMERIC GP100
1348, 1s7sA, 0.7363, 2.31, 0.136, 276, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1349, 5f1iD, 0.7362, 2.43, 0.136, 271, 88, MHC WITH 9-MER PEPTIDE
1350, 3fqwA, 0.7362, 2.29, 0.159, 275, 88, PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES
1351, 3e3qB, 0.7362, 2.33, 0.149, 175, 87, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1352, 2zswG, 0.7362, 2.38, 0.125, 277, 88, CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH THE Q600Y VARIANT OF JHMV EPITOPE S598
1353, 2gtwD, 0.7362, 2.30, 0.159, 275, 88, HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE NONAMERIC MELAN-A/MART- 1(27-35) PEPTIDE HAVING A27L SUBSTITUTION
1354, 1g6rI, 0.7362, 2.33, 0.126, 274, 87, A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
1355, 5kd4C, 0.7361, 2.23, 0.126, 273, 87, CRYSTAL STRUCTURE OF MURINE MHC-I H-2DD IN COMPLEX WITH MURINE BETA2- MICROGLOBULIN AND A VARIANT OF PEPTIDE (PVI10) OF HIV GP120 MN ISOLATE (IGPGRAFYVI)
1356, 1s7qA, 0.7361, 2.30, 0.136, 276, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH LCMV- DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1357, 4pgeA, 0.7360, 2.25, 0.138, 274, 87, MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGNYPAW
1358, 3qq3D, 0.7360, 2.39, 0.136, 275, 88, CRYSTAL STRUCTURE OF SWINE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I SLA-1 0401 AND IDENTIFICATION OF 2009 PANDEMIC SWINE-ORIGIN INFLUENZA A H1N1 VIRUS CYTOTOXIC T LYMPHOCYTE EPITOPE PEPTIDES
1359, 2f53A, 0.7360, 2.28, 0.159, 275, 88, DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY
1360, 1ffnD, 0.7360, 2.32, 0.114, 273, 88, CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33(C9M)
1361, 6gh1G, 0.7359, 2.26, 0.138, 274, 87, HLA-E*01:03 IN COMPLEX WITH MTB44 
1362, 5wmqA, 0.7359, 2.26, 0.136, 276, 88, CRYSTAL STRUCTURE OF HLA-B8 IN COMPLEX WITH ELR; AN INFLUENZA A VIRUS PEPTIDE 
1363, 4xxcA, 0.7359, 2.31, 0.170, 276, 88, HLA-B*1801 IN COMPLEX WITH A SELF-PEPTIDE DELEIKAY
1364, 4hv8C, 0.7359, 2.34, 0.114, 278, 88, CRYSTAL STRUCTURE OF H2DB-H155A-NPM6I
1365, 3e3qL, 0.7359, 2.32, 0.149, 175, 87, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1366, 1s7uG, 0.7359, 2.45, 0.112, 274, 89, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1367, 1ffnA, 0.7359, 2.32, 0.114, 273, 88, CRYSTAL STRUCTURE OF MURINE CLASS I H-2DB COMPLEXED WITH PEPTIDE GP33(C9M)
1368, 5u98D, 0.7358, 2.33, 0.170, 273, 88, THE CRYSTAL STRUCTURE OF A SELF-PEPTIDE COMPLEXED TO ABACAVIR AND HLA- B*57:01
1369, 5swsA, 0.7358, 2.37, 0.114, 273, 88, CRYSTAL STRUCTURE OF NP2-B17 TCR-H2DB-NP COMPLEX
1370, 4hv8A, 0.7358, 2.33, 0.114, 276, 88, CRYSTAL STRUCTURE OF H2DB-H155A-NPM6I
1371, 3rl1A, 0.7358, 2.31, 0.170, 274, 88, HIV RT DERIVED PEPTIDE COMPLEXED TO HLA-A*0301
1372, 3ftgA, 0.7358, 2.30, 0.114, 247, 88, CRYSTAL STRUCTURE OF H2DB IN COMPLEX WITH NP366-N3A VARIANT PEPTIDE FROM INFLUENZA
1373, 3tpuI, 0.7357, 2.22, 0.140, 173, 86, 42F3 P5E8/H2-LD COMPLEX
1374, 3gsnH, 0.7357, 2.26, 0.149, 274, 87, CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE
1375, 3fqnA, 0.7357, 2.30, 0.159, 275, 88, PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES
1376, 1a1nA, 0.7357, 2.30, 0.170, 276, 88, MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTY FROM THE NEF PROTEIN (75-82) OF HIV1
1377, 3tbvE, 0.7356, 2.46, 0.124, 276, 89, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2GV3PY4A)
1378, 5knmA, 0.7355, 2.17, 0.103, 276, 87, HUMAN LEUKOCYTE ANTIGEN F (HLA-F) PRESENTS PEPTIDES AND REGULATES IMMUNITY THROUGH INTERACTIONS WITH NK-CELL RECEPTORS
1379, 5f1iP, 0.7355, 2.35, 0.148, 271, 88, MHC WITH 9-MER PEPTIDE
1380, 3e3qA, 0.7355, 2.33, 0.149, 175, 87, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1381, 2gj6A, 0.7355, 2.24, 0.161, 275, 87, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE
1382, 1mhcD, 0.7355, 2.29, 0.115, 276, 87, MODEL OF MHC CLASS I H2-M3 WITH NONAPEPTIDE FROM RAT ND1 REFINED AT 2.3 ANGSTROMS RESOLUTION
1383, 2e7lE, 0.7354, 2.18, 0.140, 175, 86, STRUCTURE OF A HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1384, 1hhhA, 0.7354, 2.24, 0.161, 275, 87, THE ANTIGENIC IDENTITY OF PEPTIDE(SLASH)MHC COMPLEXES: A COMPARISON OF THE CONFORMATION OF FIVE PEPTIDES PRESENTED BY HLA-A2
1385, 5wjnG, 0.7353, 2.32, 0.159, 274, 88, CRYSTAL STRUCTURE OF HLA-A*11:01-GTS3
1386, 3vfuA, 0.7353, 2.30, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA B*3508 LPEP-P7ALA PEPTIDE MUTANT P7-ALA
1387, 5m02A, 0.7352, 2.41, 0.114, 275, 88, CRYSTAL STRUCTURE OF MURINE P14 TCR / H-2DB WITH PF MODIFIED GP33 PEPTIDE FROM LCMV
1388, 5kd7C, 0.7352, 2.36, 0.125, 273, 88, CRYSTAL STRUCTURE OF MURINE MHC-I H-2DD IN COMPLEX WITH MURINE BETA2- MICROGLOBULIN AND A VARIANT OF PEPTIDE (PV9) OF HIV GP120 MN ISOLATE (IGPGRAFYV)
1389, 4u1sA, 0.7352, 2.34, 0.125, 278, 88, HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES
1390, 1s9wA, 0.7352, 2.33, 0.159, 274, 88, CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE SLLMWITQC IN COMPLEX WITH HLA-A2
1391, 5u98A, 0.7351, 2.34, 0.170, 273, 88, THE CRYSTAL STRUCTURE OF A SELF-PEPTIDE COMPLEXED TO ABACAVIR AND HLA- B*57:01
1392, 3vfmA, 0.7351, 2.29, 0.148, 276, 88, CRYSTAL STRUCTURE OF HLA B*3508 LPEP155A HLA MUTANT ALA155
1393, 4prpA, 0.7350, 2.23, 0.172, 276, 87, CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:01-HPVG-Q5 COMPLEX
1394, 4gksD, 0.7350, 2.40, 0.159, 276, 88, A2-MHC COMPLEX CARRYING FLTGIGIITV
1395, 2ve6J, 0.7350, 2.39, 0.114, 276, 88, CRYSTAL STRUCTURE OF A MURINE MHC CLASS I H2-DB MOLECULE IN COMPLEX WITH A PHOTOCLEAVABLE PEPTIDE
1396, 1kpuA, 0.7350, 2.31, 0.136, 274, 88, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE MHC CLASS I COMPLEX H- 2KB/VSV8
1397, 3ws6A, 0.7349, 2.35, 0.114, 273, 88, CRYSTAL STRUCTURE OF H-2D IN COMPLEX WITH A MIMOTOPIC PEPTIDE
1398, 1s7wJ, 0.7349, 2.46, 0.112, 276, 89, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1399, 6avgG, 0.7348, 2.38, 0.148, 272, 88, CRYSTAL STRUCTURE OF THE KFJ37 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
1400, 5wjnD, 0.7348, 2.32, 0.159, 274, 88, CRYSTAL STRUCTURE OF HLA-A*11:01-GTS3
1401, 3tbvA, 0.7348, 2.47, 0.124, 276, 89, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2GV3PY4A)
1402, 1w72D, 0.7348, 2.31, 0.159, 274, 88, CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB- HYB3
1403, 1hsaD, 0.7348, 2.38, 0.148, 276, 88, THE THREE-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 ANGSTROMS RESOLUTION SUGGESTS A GENERAL MECHANISM FOR TIGHT PEPTIDE BINDING TO MHC
1404, 5vgeA, 0.7347, 2.32, 0.138, 275, 87, CRYSTAL STRUCTURE OF HLA-C*07:02 IN COMPLEX WITH RYR PEPTIDE
1405, 3vftA, 0.7347, 2.30, 0.182, 276, 88, CRYSTAL STRUCTURE OF HLA B*3508LPEP-P6ALA PEPTIDE MUTANT P6-ALA
1406, 3qulG, 0.7347, 2.32, 0.114, 270, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (Y4S)
1407, 3lkrA, 0.7347, 2.29, 0.148, 276, 88, CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 2009 H1N1 SWINE ORIGIN STRAIN
1408, 2oi9A, 0.7347, 2.39, 0.138, 175, 87, STRUCTURE OF THE 2C/LD/QL9 ALLOGENEIC COMPLEX
1409, 2axfA, 0.7347, 2.31, 0.182, 276, 88, THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE IS CONTROLLED BY ITS MHC-BOUND CONFORMATION
1410, 3tbvC, 0.7346, 2.31, 0.125, 276, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2GV3PY4A)
1411, 3kxfK, 0.7346, 2.30, 0.170, 276, 88, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE  RESTRICTION TRIAD  MUTANT HLA-B*3508-13MER
1412, 4eupA, 0.7344, 2.25, 0.161, 267, 87, THE COMPLEX BETWEEN TCR JKF6 AND HUMAN CLASS I MHC HLA-A2 PRESENTING THE MART-1(27-35)(A27L) PEPTIDE
1413, 3kxfI, 0.7344, 2.31, 0.170, 276, 88, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE  RESTRICTION TRIAD  MUTANT HLA-B*3508-13MER
1414, 1hsbA, 0.7344, 2.33, 0.148, 270, 88, DIFFERENT LENGTH PEPTIDES BIND TO HLA-AW68 SIMILARLY AT THEIR ENDS BUT BULGE OUT IN THE MIDDLE
1415, 5h94D, 0.7343, 2.39, 0.136, 275, 88, CRYSTAL STRUCTURE OF SWINE MHC CLASSI FOR 1.48 ANGSTROMS
1416, 3fqxA, 0.7343, 2.30, 0.159, 275, 88, PHOSPHORYLATION OF SELF-PEPTIDES ALTERS HUMAN LEUKOCYTE ANTIGEN CLASS I-RESTRICTED ANTIGEN PRESENTATION AND GENERATES TUMOR SPECIFIC EPITOPES
1417, 1n3nC, 0.7343, 2.32, 0.114, 276, 88, CRYSTAL STRUCTURE OF A MYCOBACTERIAL HSP60 EPITOPE WITH THE MURINE CLASS I MHC MOLECULE H-2DB
1418, 6ggmA, 0.7342, 2.30, 0.149, 274, 87, HLA-E*01:03 IN COMPLEX WITH THE MTB44 PEPTIDE VARIANT: MTB44*P2-PHE. 
1419, 5jziF, 0.7342, 2.32, 0.159, 262, 88, CRYSTAL STRUCTURE OF 1406 TCR BOUND TO HLA-A2 WITH HCV 1406-1415 ANTIGEN PEPTIDE
1420, 4pv9A, 0.7342, 2.24, 0.126, 277, 87, CRYSTAL STRUCTURE OF H2KB-Q600V COMPLEX
1421, 4o2eD, 0.7342, 2.35, 0.136, 274, 88, A PEPTIDE COMPLEXED WITH HLA-B*3901
1422, 3vrjA, 0.7342, 2.34, 0.159, 275, 88, HLA-B*57:01-LTTKLTNTNI IN COMPLEX WITH ABACAVIR
1423, 3tbwE, 0.7342, 2.60, 0.112, 274, 89, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G V3P Y4S)
1424, 3mv7A, 0.7342, 2.42, 0.159, 276, 88, CRYSTAL STRUCTURE OF THE TK3 TCR IN COMPLEX WITH HLA-B*3501/HPVG
1425, 5xotA, 0.7341, 2.33, 0.170, 276, 88, CRYSTAL STRUCTURE OF PHLA-B35 IN COMPLEX WITH TU55 T CELL RECEPTOR
1426, 5wjlD, 0.7341, 2.29, 0.161, 274, 87, CRYSTAL STRUCTURE OF HLA-A*11:01 WITH GTS1 PEPTIDE
1427, 5nq2A, 0.7341, 2.43, 0.148, 277, 88,  PORCINE (SUS SCROFA) MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS I; PRESENTING IAYERMCNI 
1428, 3vfnA, 0.7341, 2.31, 0.159, 276, 88, CRYSTAL STRUCTURE OF HLA B*3508LPEP151A HLA MUTANT ALA151
1429, 3skmA, 0.7341, 2.32, 0.148, 270, 88, CRYSTAL STRUCTURE OF THE HLA-B8FLRGRAYVL MUTANT G8V OF THE FLR PEPTIDE
1430, 3lkoA, 0.7341, 2.30, 0.170, 276, 88, CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1934 STRAIN
1431, 1k8iB, 0.7341, 2.18, 0.140, 190, 86, CRYSTAL STRUCTURE OF MOUSE H2-DM
1432, 4hwzA, 0.7340, 2.33, 0.159, 274, 88, STRUCTURE OF HLA-A68 COMPLEXED WITH AN HIV DERIVED PEPTIDE
1433, 1i4fA, 0.7340, 2.33, 0.159, 275, 88, CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4-PEPTIDE COMPLEX
1434, 5kd7I, 0.7339, 2.32, 0.126, 266, 87, CRYSTAL STRUCTURE OF MURINE MHC-I H-2DD IN COMPLEX WITH MURINE BETA2- MICROGLOBULIN AND A VARIANT OF PEPTIDE (PV9) OF HIV GP120 MN ISOLATE (IGPGRAFYV)
1435, 5e9dA, 0.7339, 2.28, 0.159, 266, 88, RD-1 MART-1 HIGH BOUND TO MART-1 DECAMERIC PEPTIDE (ELA) IN COMPLEX WITH HLA-A2
1436, 3tbvG, 0.7339, 2.47, 0.124, 276, 89, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2GV3PY4A)
1437, 3kxfA, 0.7339, 2.38, 0.159, 276, 88, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE  RESTRICTION TRIAD  MUTANT HLA-B*3508-13MER
1438, 1s7wA, 0.7339, 2.31, 0.125, 276, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 INDEX PEPTIDE AND THREE OF ITS ESCAPE VARIANTS
1439, 4u1lD, 0.7338, 2.36, 0.125, 277, 88, HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES
1440, 4l8dC, 0.7338, 2.31, 0.114, 277, 88, CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N5D PEPTIDE
1441, 3x13A, 0.7338, 2.32, 0.148, 276, 88, CRYSTAL STRUCTURE OF HLA-B*0801.N80I
1442, 1zsdA, 0.7338, 2.31, 0.170, 276, 88, CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBV ANTIGEN EPLPQGQLTAY
1443, 1zhlA, 0.7338, 2.31, 0.182, 276, 88, CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY
1444, 5wlgF, 0.7336, 2.44, 0.114, 277, 88, CRYSTAL STRUCTURE OF H-2DB WITH THE GAP501 PEPTIDE (SQL)
1445, 3vfvA, 0.7336, 2.31, 0.182, 275, 88, CRYSTAL STRUCTURE OF HLA B*3508 LPEP-P9ALA PEPTIDE MUTANT P9-ALA
1446, 1x7qA, 0.7336, 2.28, 0.161, 275, 87, CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSID PEPTIDE
1447, 5wjnA, 0.7335, 2.33, 0.159, 274, 88, CRYSTAL STRUCTURE OF HLA-A*11:01-GTS3
1448, 5grgA, 0.7335, 2.32, 0.159, 274, 88, CRYSTAL STRUCTURE OF DUAL PEPTIDE FROM EBV IN COMPLEX WITH HLA-A*11:01
1449, 4praA, 0.7333, 2.30, 0.170, 276, 88, CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-Q5
1450, 3vfsA, 0.7333, 2.31, 0.182, 276, 88, CRYSTAL STRUCTURE OF HLA B*3508LPEP-P5ALA  PEPTIDE MUTANT P5-ALA
1451, 3tbyG, 0.7333, 2.48, 0.112, 264, 89, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P Y4F)
1452, 3e2hA, 0.7333, 2.35, 0.140, 175, 86, STRUCTURE OF THE M67 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1453, 3pqyP, 0.7332, 2.36, 0.114, 273, 88, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
1454, 3ch1G, 0.7332, 2.22, 0.115, 271, 87, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH CHIMERIC GP100
1455, 3bo8A, 0.7332, 2.32, 0.159, 274, 88, THE HIGH RESOLUTION CRYSTAL STRUCTURE OF HLA-A1 COMPLEXED WITH THE MAGE-A1 PEPTIDE
1456, 2vaaA, 0.7332, 2.33, 0.136, 274, 88, MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
1457, 4ftvA, 0.7331, 2.31, 0.159, 275, 88, THE COMPLEX BETWEEN THE HIGH AFFINITY VERSION OF A6 TCR (A6C134) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TAX NONAMERIC PEPTIDE
1458, 3kwwA, 0.7331, 2.32, 0.170, 276, 88, CRYSTAL STRUCTURE OF THE  RESTRICTION TRIAD  MUTANT OF HLA B*3508 BETA-2-MICROGLOBULIN AND EBV PEPTIDE
1459, 1xr9A, 0.7330, 2.33, 0.170, 276, 88, CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3
1460, 4qrsA, 0.7329, 2.32, 0.148, 276, 88, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH ELK_IYM ELKRKMIYM
1461, 4hs3A, 0.7329, 2.31, 0.136, 276, 88, CRYSTAL STRUCTURE OF H-2KB WITH A DISULFIDE STABILIZED F POCKET IN COMPLEX WITH THE LCMV DERIVED PEPTIDE GP34
1462, 4o2eA, 0.7328, 2.36, 0.136, 274, 88, A PEPTIDE COMPLEXED WITH HLA-B*3901
1463, 1qvoA, 0.7328, 2.34, 0.159, 275, 88, STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE
1464, 5f1iG, 0.7327, 2.42, 0.148, 271, 88, MHC WITH 9-MER PEPTIDE
1465, 1m05C, 0.7327, 2.33, 0.148, 269, 88, HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT
1466, 6gh4E, 0.7326, 2.28, 0.138, 273, 87, HLA-E*01:03 IN COMPLEX WITH THE MTB44 PEPTIDE VARIANT: MTB44*P2-GLN. 
1467, 6avgF, 0.7326, 2.38, 0.148, 275, 88, CRYSTAL STRUCTURE OF THE KFJ37 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
1468, 3rwcA, 0.7326, 2.40, 0.159, 276, 88, CRYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-IW9
1469, 3jttA, 0.7326, 2.36, 0.148, 276, 88, CYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I:MAMU-A*02
1470, 3jtsA, 0.7326, 2.34, 0.136, 276, 88, GY9-MAMU-A*02-HB2M
1471, 4nqvC, 0.7325, 2.35, 0.159, 274, 88, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44 AN 9-MER INFLUENZA EPITOPE
1472, 3ch1D, 0.7325, 2.42, 0.114, 273, 88, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH CHIMERIC GP100
1473, 1vadA, 0.7325, 2.35, 0.125, 274, 88, MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA-GLUCOSIDASE
1474, 4u1lA, 0.7324, 2.38, 0.125, 277, 88, HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES
1475, 4huvD, 0.7324, 2.34, 0.114, 275, 88, CRYSTAL STRUCTURE OF H2DB-NPM6W
1476, 3vriA, 0.7324, 2.35, 0.159, 275, 88, HLA-B*57:01-RVAQLENVYI IN COMPLEX WITH ABACAVIR
1477, 1t80A, 0.7324, 2.40, 0.080, 273, 87, ZN-ALPHA-2-GLYCOPROTEIN; CHO-ZAG PEG 200
1478, 4priA, 0.7323, 2.27, 0.184, 276, 87, CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:08-HPVG COMPLEX
1479, 4l3cY, 0.7323, 2.30, 0.161, 276, 87, STRUCTURE OF HLA-A2 IN COMPLEX WITH D76N B2M MUTANT AND NY-ESO1 DOUBLE MUTANT
1480, 2zokC, 0.7323, 2.39, 0.115, 258, 87, CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH JHMV EPITOPE S510
1481, 4u1iA, 0.7322, 2.35, 0.125, 278, 88, HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES
1482, 4pv8C, 0.7322, 2.26, 0.126, 277, 87, CRYSTAL STRUCTURE OF H2KB-Q600F COMPLEX
1483, 3p4oA, 0.7322, 2.39, 0.125, 278, 88, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE MUTANT NP205-LCMV-V3A EPITOPE YTAKYPNL AN 8-MER MODIFIED PEPTIDE FROM THE LCMV
1484, 3mrkA, 0.7321, 2.35, 0.159, 273, 88, CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH AFP137 NONAPEPTIDE
1485, 3eryA, 0.7321, 2.10, 0.153, 174, 85, DIFFERENT THERMODYNAMIC BINDING MECHANISMS AND PEPTIDE FINE SPECIFICITIES ASSOCIATED WITH A PANEL OF STRUCTURALLY SIMILAR HIGH-AFFINITY T CELL RECEPTORS
1486, 2fyyA, 0.7321, 2.32, 0.170, 276, 88, THE ROLE OF T CELL RECEPTOR ALPHA GENES IN DIRECTING HUMAN MHC RESTRICTION
1487, 4nqxK, 0.7320, 2.34, 0.159, 275, 88, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N AN 9-MER INFLUENZA EPITOPE
1488, 3qulJ, 0.7320, 2.41, 0.114, 267, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (Y4S)
1489, 3vfwA, 0.7319, 2.31, 0.182, 276, 88, CRYSTAL STRUCTURE OF HLA B*3508 LPEP-P10ALA PEPTIDE MUTANT P10-ALA
1490, 3vfoA, 0.7319, 2.32, 0.170, 276, 88, CRYSTAL STRUCTURE OF HLA B*3508 LPEP157A HLA MUTANT ALA157
1491, 3tbyA, 0.7319, 2.50, 0.124, 266, 89, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P Y4F)
1492, 5wkfA, 0.7318, 2.32, 0.159, 274, 88, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS1
1493, 5gsdA, 0.7318, 2.34, 0.159, 274, 88, CRYSTAL STRUCTURE OF LMP2 PEPTIDE FROM EBV IN COMPLEX WITH HLA-A*11:01
1494, 5f1iM, 0.7318, 2.41, 0.148, 271, 88, MHC WITH 9-MER PEPTIDE
1495, 3tbwG, 0.7318, 2.50, 0.114, 267, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G V3P Y4S)
1496, 3mv9A, 0.7318, 2.46, 0.159, 276, 88, CRYSTAL STRUCTURE OF THE TK3-GLN55ALA TCR IN COMPLEX WITH HLA- B*3501/HPVG
1497, 1t7yA, 0.7318, 2.47, 0.091, 273, 88, ZN-ALPHA-2-GLYCOPROTEIN; BACULO-ZAG PEG 200 NO GLYCEROL
1498, 1fzoA, 0.7318, 2.26, 0.138, 273, 87, MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN
1499, 1g7pA, 0.7317, 2.34, 0.136, 274, 88, CRYSTAL STRUCTURE OF MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND YEAST ALPHA-GLUCOSIDASE
1500, 4l8bA, 0.7316, 2.41, 0.114, 276, 88, CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N5H PEPTIDE
1501, 3jttD, 0.7316, 2.36, 0.148, 276, 88, CYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I:MAMU-A*02
1502, 5xmmA, 0.7315, 2.30, 0.126, 275, 87, FLA-E*01801-167W/S
1503, 3tbyD, 0.7315, 2.49, 0.124, 266, 89, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P Y4F)
1504, 4nnyA, 0.7314, 2.28, 0.161, 274, 87, CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF PKD2 PHOSPHOPEPTIDE BOUND TO HLA-A2
1505, 4huvA, 0.7314, 2.35, 0.125, 275, 88, CRYSTAL STRUCTURE OF H2DB-NPM6W
1506, 3rl2A, 0.7314, 2.45, 0.148, 274, 88, HIV NEF DERIVED PEPTIDE NEF73 COMPLEXED TO HLA-A*0301
1507, 3mv8A, 0.7314, 2.29, 0.172, 276, 87, CRYSTAL STRUCTURE OF THE TK3-GLN55HIS TCR IN COMPLEX WITH HLA- B*3501/HPVG
1508, 3jttG, 0.7314, 2.36, 0.148, 276, 88, CYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I:MAMU-A*02
1509, 5f1iA, 0.7313, 2.44, 0.148, 270, 88, MHC WITH 9-MER PEPTIDE
1510, 1t7wA, 0.7313, 2.41, 0.080, 273, 87, ZN-ALPHA-2-GLYCOPROTEIN; CHO-ZAG PEG 400
1511, 5tilD, 0.7312, 2.42, 0.114, 275, 88, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2 DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE V3P AND T-CELL RECEPTOR P14
1512, 5d2lA, 0.7312, 2.29, 0.159, 274, 88, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
1513, 4uq2C, 0.7312, 2.33, 0.148, 275, 88, CRYSTAL STRUCTURE OF HLA-A1101 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE
1514, 4nqxC, 0.7312, 2.36, 0.159, 275, 88, CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N AN 9-MER INFLUENZA EPITOPE
1515, 4l8dA, 0.7312, 2.34, 0.114, 277, 88, CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N5D PEPTIDE
1516, 4l8cE, 0.7312, 2.33, 0.114, 275, 88, CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N3D PEPTIDE
1517, 3vfpA, 0.7312, 2.33, 0.170, 276, 88, CRYSTAL STRUCTURE OF HLA B*3508 LPEP158G HLA MUTANT GLY158
1518, 3rweA, 0.7312, 2.40, 0.159, 276, 88, RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-FW9
1519, 3cc5D, 0.7312, 2.39, 0.114, 276, 88, H-2DB COMPLEX WITH HUMAN GP100
1520, 1t7vA, 0.7312, 2.40, 0.080, 273, 87, ZN-ALPHA-2-GLYCOPROTEIN; BACULO-ZAG PEG 200
1521, 4uq2A, 0.7310, 2.35, 0.148, 275, 88, CRYSTAL STRUCTURE OF HLA-A1101 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE
1522, 3cc5A, 0.7310, 2.40, 0.125, 276, 88, H-2DB COMPLEX WITH HUMAN GP100
1523, 2vabA, 0.7310, 2.35, 0.136, 274, 88, MHC CLASS I H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN
1524, 4mj6A, 0.7309, 2.34, 0.159, 274, 88, CRYSTAL STRUCTURE OF HLA-A*1101 IN COMPLEX WITH H7-22 AN INFLUENZA A(H7N9) VIRUS EPITOPE
1525, 2zsvA, 0.7309, 2.22, 0.128, 273, 86, CRYSTAL STRUCTURE OF H-2KB IN COMPLEX WITH JHMV EPITOPE S598
1526, 5grdA, 0.7308, 2.32, 0.159, 274, 88, CRYSTAL STRUCTURE OF 10-MER PEPTIDE FROM EBV IN COMPLEX WITH HLA- A1101.
1527, 4eupD, 0.7307, 2.27, 0.161, 265, 87, THE COMPLEX BETWEEN TCR JKF6 AND HUMAN CLASS I MHC HLA-A2 PRESENTING THE MART-1(27-35)(A27L) PEPTIDE
1528, 5nmeA, 0.7306, 2.29, 0.161, 276, 87, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTVATL
1529, 3qukA, 0.7306, 2.45, 0.114, 262, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (Y4A)
1530, 4jfpD, 0.7305, 2.34, 0.138, 276, 87, A2 HLA COMPLEX WITH G4A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE
1531, 4prhA, 0.7304, 2.27, 0.184, 240, 87, CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:08-HPVG-D5 COMPLEX
1532, 5tilA, 0.7303, 2.44, 0.114, 275, 88, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2 DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE V3P AND T-CELL RECEPTOR P14
1533, 5brzA, 0.7303, 2.30, 0.161, 275, 87, MAGE-A3 REACTIVE TCR IN COMPLEX WITH MAGE-A3 IN HLA-A1
1534, 4mj5A, 0.7303, 2.35, 0.159, 274, 88, CRYSTAL STRUCTURE OF HLA-A*1101 IN COMPLEX WITH H1-22 AN INFLUENZA A(H1N1) VIRUS EPITOPE
1535, 1efxA, 0.7303, 2.39, 0.159, 278, 88, STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3
1536, 4i48A, 0.7302, 2.32, 0.159, 274, 88, STRUCTURE OF HLA-A68 COMPLEXED WITH AN HIV ENV DERIVED PEPTIDE
1537, 4gknD, 0.7302, 2.24, 0.161, 276, 87, A2-MHC COMPLEX CARRYING FATGIGIITV
1538, 2ak4A, 0.7302, 2.39, 0.170, 276, 88, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE
1539, 1mi5A, 0.7302, 2.36, 0.148, 277, 88, THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBV PEPTIDE COMPLEX
1540, 3rwcD, 0.7301, 2.43, 0.159, 276, 88, CRYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-IW9
1541, 3rwhA, 0.7300, 2.43, 0.159, 276, 88, RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-MF8
1542, 2h6pA, 0.7300, 2.29, 0.149, 276, 87, CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING THE HUMAN CYTOCHROME P450 DERIVED PEPTIDE KPIVVLHGY
1543, 1m05A, 0.7300, 2.37, 0.136, 269, 88, HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT
1544, 5wkfF, 0.7299, 2.32, 0.159, 274, 88, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS1
1545, 3lkqA, 0.7299, 2.32, 0.170, 276, 88, CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1977 STRAIN
1546, 3cvhA, 0.7297, 2.30, 0.128, 274, 86, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
1547, 3rwjA, 0.7295, 2.41, 0.161, 276, 87, RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-HW8
1548, 5mzmD, 0.7294, 2.60, 0.112, 271, 89, STRUCTURE OF H-2DB IN COMPLEX WITH TEIPP APL TRH4 P3P
1549, 4pv9C, 0.7294, 2.27, 0.126, 276, 87, CRYSTAL STRUCTURE OF H2KB-Q600V COMPLEX
1550, 3rwgA, 0.7294, 2.47, 0.148, 276, 88, RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-MW9
1551, 3lksA, 0.7293, 2.32, 0.170, 276, 88, CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1980 STRAIN
1552, 3es6A, 0.7293, 2.36, 0.103, 276, 87, CRYSTAL STRUCTURE OF THE NOVEL COMPLEX FORMED BETWEEN ZINC 2- GLYCOPROTEIN (ZAG) AND PROLACTIN INDUCIBLE PROTEIN (PIP) FROM HUMAN SEMINAL PLASMA
1553, 2cikA, 0.7293, 2.29, 0.172, 276, 87, INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM CYTOCHROME P450.
1554, 3tf7A, 0.7291, 2.42, 0.138, 175, 87, 42F3 QL9/H2-LD COMPLEX
1555, 3tbtG, 0.7291, 2.37, 0.114, 269, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P Y4S)
1556, 1t7zA, 0.7291, 2.49, 0.091, 273, 88, ZN-ALPHA-2-GLYCOPROTEIN; BACULO-ZAG NO PEG NO GLYCEROL
1557, 4qrtA, 0.7290, 2.29, 0.149, 275, 87, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH ELN_YYM ELNRKMIYM
1558, 2ak4F, 0.7290, 2.41, 0.170, 276, 88, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE
1559, 2vlrA, 0.7288, 2.30, 0.161, 276, 87, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
1560, 4l8cA, 0.7285, 2.32, 0.114, 275, 88, CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N3D PEPTIDE
1561, 3lkpA, 0.7285, 2.33, 0.170, 276, 88, CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1972 STRAIN
1562, 5xmfA, 0.7284, 2.33, 0.126, 275, 87, CRYSTAL STRUCTURE OF FELINE MHC CLASS I FOR 21 ANGSTROM
1563, 4o2fA, 0.7284, 2.43, 0.136, 274, 88, A PEPTIDE COMPLEXED WITH HLA-B*3901
1564, 1cg9A, 0.7283, 2.39, 0.170, 277, 88, COMPLEX RECOGNITION OF THE SUPERTYPIC BW6-DETERMINANT ON HLA-B AND-C MOLECULES BY THE MONOCLONAL ANTIBODY SFR8-B6
1565, 1zt1A, 0.7282, 2.42, 0.138, 273, 87, CRYSTAL STRUCTURE OF CLASS I MHC H-2KK IN COMPLEX WITH AN OCTAPEPTIDE
1566, 5wkhF, 0.7281, 2.33, 0.159, 274, 88, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS3
1567, 5d2lG, 0.7280, 2.32, 0.159, 270, 88, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
1568, 3lknA, 0.7280, 2.33, 0.170, 276, 88, CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1918 STRAIN
1569, 4l8cC, 0.7279, 2.36, 0.114, 275, 88, CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N3D PEPTIDE
1570, 1legA, 0.7279, 2.31, 0.138, 273, 87, CRYSTAL STRUCTURE OF H-2KB BOUND TO THE DEV8 PEPTIDE
1571, 5j6gC, 0.7278, 2.32, 0.138, 276, 87, RECOGNITION OF THE MHC CLASS IB MOLECULE H2-Q10 BY THE NATURAL KILLER CELL RECEPTOR LY49C
1572, 5j6gA, 0.7278, 2.30, 0.138, 272, 87, RECOGNITION OF THE MHC CLASS IB MOLECULE H2-Q10 BY THE NATURAL KILLER CELL RECEPTOR LY49C
1573, 5swzF, 0.7277, 2.42, 0.114, 277, 88, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1574, 4gknA, 0.7277, 2.26, 0.161, 276, 87, A2-MHC COMPLEX CARRYING FATGIGIITV
1575, 6gh1C, 0.7275, 2.33, 0.138, 274, 87, HLA-E*01:03 IN COMPLEX WITH MTB44 
1576, 5wjlG, 0.7275, 2.36, 0.159, 274, 88, CRYSTAL STRUCTURE OF HLA-A*11:01 WITH GTS1 PEPTIDE
1577, 1ldpH, 0.7275, 2.39, 0.136, 272, 88, CRYSTAL STRUCTURE OF MURINE MHC CLASS I H-2LD WITH A MIXTURE OF BOUND PEPTIDES
1578, 3ffcA, 0.7274, 2.38, 0.148, 277, 88, CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR
1579, 6gh4C, 0.7272, 2.32, 0.149, 274, 87, HLA-E*01:03 IN COMPLEX WITH THE MTB44 PEPTIDE VARIANT: MTB44*P2-GLN. 
1580, 3pabA, 0.7272, 2.45, 0.125, 279, 88, CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH A MUTANT OF THE CHICKEN OVALBUMIN EPITOPE OVA-E1
1581, 3ffcF, 0.7272, 2.38, 0.148, 276, 88, CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR
1582, 6ghnC, 0.7268, 2.37, 0.159, 272, 88, HLA-E*01:03 IN COMPLEX WITH THE MTB44 PEPTIDE VARIANT: MTB44*P9-PHE. 
1583, 5swzK, 0.7268, 2.44, 0.114, 277, 88, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1584, 1kprC, 0.7267, 2.34, 0.149, 274, 87, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1585, 3tbtJ, 0.7266, 2.45, 0.114, 268, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P Y4S)
1586, 5wlgA, 0.7263, 2.39, 0.114, 278, 88, CRYSTAL STRUCTURE OF H-2DB WITH THE GAP501 PEPTIDE (SQL)
1587, 1ktlC, 0.7263, 2.38, 0.159, 274, 88, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1588, 4l8cG, 0.7262, 2.33, 0.114, 275, 88, CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N3D PEPTIDE
1589, 3rwdA, 0.7262, 2.42, 0.159, 276, 88, RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-IW11
1590, 1zhkA, 0.7262, 2.37, 0.170, 276, 88, CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY
1591, 3qukD, 0.7261, 2.54, 0.114, 261, 88, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (Y4A)
1592, 1qvoD, 0.7261, 2.41, 0.159, 275, 88, STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE
1593, 1ktlA, 0.7259, 2.39, 0.159, 274, 88, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1594, 1a9eA, 0.7259, 2.38, 0.161, 277, 87, DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA- B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS
1595, 3rwhD, 0.7257, 2.44, 0.161, 276, 87, RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-MF8
1596, 3bzeC, 0.7257, 2.28, 0.138, 273, 87, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA- 2 E
1597, 3rwiA, 0.7256, 2.47, 0.159, 276, 88, RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-GW10
1598, 1t7xA, 0.7256, 2.42, 0.080, 273, 87, ZN-ALPHA-2-GLYCOPROTEIN; REFOLDED CHO-ZAG PEG 400
1599, 3tbyJ, 0.7255, 2.53, 0.114, 262, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P Y4F)
1600, 3cvhM, 0.7254, 2.39, 0.126, 274, 87, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
1601, 2bc4B, 0.7254, 2.23, 0.106, 191, 85, CRYSTAL STRUCTURE OF HLA-DM
1602, 3uttF, 0.7250, 2.30, 0.163, 275, 86, 1E6-A*0201-ALWGPDPAAA COMPLEX TRICLINIC
1603, 5j6hA, 0.7249, 2.38, 0.115, 275, 87, RECOGNITION OF THE MHC CLASS IB MOLECULE H2-Q10 BY THE NATURAL KILLER CELL RECEPTOR LY49C
1604, 5iroQ, 0.7248, 2.41, 0.136, 259, 88, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 4 E3- 19K PROTEIN AND MHC CLASS MOLECULE HLA-A2/TAX
1605, 4mvbA, 0.7248, 2.34, 0.140, 174, 86, 42F3 PCPB7/H-2LD COMPLEX
1606, 5iroM, 0.7246, 2.43, 0.136, 265, 88, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 4 E3- 19K PROTEIN AND MHC CLASS MOLECULE HLA-A2/TAX
1607, 3qulD, 0.7246, 2.33, 0.116, 262, 86, CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (Y4S)
1608, 5tjeA, 0.7245, 2.46, 0.114, 275, 88, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 AND T CELL RECEPTOR P14
1609, 3rwdD, 0.7245, 2.47, 0.159, 276, 88, RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-IW11
1610, 2nx5K, 0.7245, 2.31, 0.172, 276, 87, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
1611, 4n5eA, 0.7244, 2.24, 0.141, 174, 85, 42F3 TCR PCPA12/H-2LD COMPLEX
1612, 2nx5F, 0.7244, 2.34, 0.148, 276, 88, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
1613, 5tjeC, 0.7242, 2.46, 0.114, 274, 88, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 AND T CELL RECEPTOR P14
1614, 1kjvA, 0.7242, 2.32, 0.103, 276, 87, TAP-B-ASSOCIATED RAT MHC CLASS I MOLECULE
1615, 4nhuE, 0.7240, 2.18, 0.141, 186, 85, THE M33 TCR P3M33L/H-2 LD COMPLEX
1616, 1lekA, 0.7240, 2.35, 0.138, 273, 87, CRYSTAL STRUCTURE OF H-2KBM3 BOUND TO DEV8
1617, 6ghnA, 0.7236, 2.37, 0.148, 269, 88, HLA-E*01:03 IN COMPLEX WITH THE MTB44 PEPTIDE VARIANT: MTB44*P9-PHE. 
1618, 3tbtA, 0.7236, 2.47, 0.114, 263, 88, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P Y4S)
1619, 3sjvK, 0.7236, 2.41, 0.148, 277, 88, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
1620, 4i0pF, 0.7233, 2.23, 0.106, 187, 85, HLA-DO IN COMPLEX WITH HLA-DM
1621, 1kprA, 0.7229, 2.41, 0.159, 274, 88, THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
1622, 4mjiF, 0.7228, 2.52, 0.148, 275, 88, T CELL RESPONSE TO A HIV REVERSE TRANSCRIPTASE EPITOPE PRESENTED BY THE PROTECTIVE ALLELE HLA-B*51:01
1623, 2bc4D, 0.7228, 2.25, 0.106, 197, 85, CRYSTAL STRUCTURE OF HLA-DM
1624, 4i0pB, 0.7226, 2.23, 0.106, 186, 85, HLA-DO IN COMPLEX WITH HLA-DM
1625, 4mxqA, 0.7224, 2.24, 0.141, 174, 85, 42F3 TCR PCPC5/H-2LD COMPLEX
1626, 2nx5A, 0.7223, 2.33, 0.148, 276, 88, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
1627, 6bj8A, 0.7222, 2.50, 0.159, 274, 88, TCR55 IN COMPLEX WITH PEP20/HLA-B35 
1628, 5iroA, 0.7218, 2.40, 0.136, 264, 88, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 4 E3- 19K PROTEIN AND MHC CLASS MOLECULE HLA-A2/TAX
1629, 6bj2A, 0.7217, 2.43, 0.170, 273, 88, TCR589 IN COMPLEX WITH HIV(POL448-456)/HLA-B35 
1630, 4jrxA, 0.7216, 2.45, 0.159, 276, 88, CRYSTAL STRUCTURE OF CA5 TCR-HLA B*3505-LPEP COMPLEX
1631, 3tfkA, 0.7216, 2.34, 0.140, 174, 86, 42F3-P4B10/H2-LD
1632, 1fzjA, 0.7215, 2.35, 0.138, 273, 87, MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
1633, 6bj3A, 0.7212, 2.49, 0.159, 275, 88, TCR55 IN COMPLEX WITH HIV(POL448-456)/HLA-B35 
1634, 4mjiA, 0.7210, 2.37, 0.149, 276, 87, T CELL RESPONSE TO A HIV REVERSE TRANSCRIPTASE EPITOPE PRESENTED BY THE PROTECTIVE ALLELE HLA-B*51:01
1635, 2nx5Q, 0.7210, 2.39, 0.170, 276, 88, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
1636, 5w69G, 0.7208, 2.14, 0.181, 268, 83, HLA-C*06:02 PRESENTING ARFNDLRFV
1637, 1fzmA, 0.7208, 2.34, 0.138, 273, 87, MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN
1638, 1a9bD, 0.7206, 2.46, 0.170, 277, 88, DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA- B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS
1639, 1a9bA, 0.7206, 2.46, 0.170, 277, 88, DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA- B3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS
1640, 4jryA, 0.7204, 2.50, 0.182, 276, 88, CRYSTAL STRUCTURE OF SB47 TCR-HLA B*3505-LPEP COMPLEX
1641, 4nhuG, 0.7203, 2.25, 0.141, 185, 85, THE M33 TCR P3M33L/H-2 LD COMPLEX
1642, 3hujC, 0.7200, 2.23, 0.108, 274, 83, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
1643, 5iroI, 0.7196, 2.46, 0.136, 252, 88, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 4 E3- 19K PROTEIN AND MHC CLASS MOLECULE HLA-A2/TAX
1644, 3qq4A, 0.7194, 2.54, 0.136, 275, 88, CRYSTAL STRUCTURE OF SWINE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I SLA-1 0401 AND IDENTIFICATION OF 2009 PANDEMIC SWINE-ORIGIN INFLUENZA A H1N1 VIRUS CYTOTOXIC T LYMPHOCYTE EPITOPE PEPTIDES
1645, 3kxfC, 0.7193, 2.45, 0.159, 276, 88, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE  RESTRICTION TRIAD  MUTANT HLA-B*3508-13MER
1646, 3sjvA, 0.7192, 2.37, 0.149, 277, 87, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
1647, 4fqxD, 0.7191, 2.24, 0.106, 191, 85, CRYSTAL STRUCTURE OF HLA-DM BOUND TO HLA-DR1
1648, 4x6cA, 0.7187, 2.28, 0.145, 263, 83, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
1649, 3tbtD, 0.7187, 2.15, 0.118, 263, 85, CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P Y4S)
1650, 3sjvP, 0.7185, 2.46, 0.136, 277, 88, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
1651, 5c9jA, 0.7184, 2.31, 0.157, 281, 83, HUMAN CD1C WITH LIGANDS IN A  AND F  CHANNEL
1652, 4ms8A, 0.7180, 2.09, 0.145, 162, 83, 42F3 TCR PCPB9/H-2LD COMPLEX
1653, 1fzkA, 0.7176, 2.37, 0.138, 273, 87, MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN
1654, 1lqvB, 0.7174, 2.27, 0.155, 173, 84, CRYSTAL STRUCTURE OF THE ENDOTHELIAL PROTEIN C RECEPTOR WITH PHOSPHOLIPID IN THE GROOVE IN COMPLEX WITH GLA DOMAIN OF PROTEIN C.
1655, 4n8vA, 0.7172, 2.41, 0.159, 274, 88, CRYSTAL STRUCTURE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR KIR2DS2 IN COMPLEX WITH HLA-A
1656, 3sjvF, 0.7172, 2.47, 0.136, 277, 88, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
1657, 4n8vD, 0.7170, 2.42, 0.159, 274, 88, CRYSTAL STRUCTURE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR KIR2DS2 IN COMPLEX WITH HLA-A
1658, 1tmcA, 0.7170, 2.26, 0.140, 175, 86, THE THREE-DIMENSIONAL STRUCTURE OF A CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE MISSING THE ALPHA3 DOMAIN OF THE HEAVY CHAIN
1659, 4gbxD, 0.7166, 2.25, 0.106, 191, 85, CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX AT PH 6.5
1660, 1kcgC, 0.7165, 2.53, 0.143, 170, 84, NKG2D IN COMPLEX WITH ULBP3
1661, 1zt4C, 0.7155, 2.28, 0.120, 278, 83, THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA- GALACTOSYLCERAMIDE
1662, 4nt6A, 0.7154, 2.51, 0.159, 274, 88, HLA-C*0801 CRYSTAL STRUCTURE
1663, 3jtcB, 0.7146, 2.33, 0.129, 173, 85, IMPORTANCE OF MG2+ IN THE CA2+-DEPENDENT FOLDING OF THE GAMMA- CARBOXYGLUTAMIC ACID DOMAINS OF VITAMIN K-DEPENDENT CLOTTING AND ANTICLOTTING PROTEINS
1664, 4n0cE, 0.7141, 2.32, 0.141, 174, 85, 42F3 TCR PCPE3/H-2LD COMPLEX
1665, 5iroU, 0.7131, 2.47, 0.136, 246, 88, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 4 E3- 19K PROTEIN AND MHC CLASS MOLECULE HLA-A2/TAX
1666, 3u0pA, 0.7124, 2.21, 0.120, 273, 83, CRYSTAL STRUCTURE OF HUMAN CD1D-LYSOPHOSPHATIDYLCHOLINE
1667, 4lhuA, 0.7120, 2.27, 0.108, 272, 83, CRYSTAL STRUCTURE OF 9C2 TCR BOUND TO CD1D
1668, 3eryB, 0.7120, 1.95, 0.162, 149, 80, DIFFERENT THERMODYNAMIC BINDING MECHANISMS AND PEPTIDE FINE SPECIFICITIES ASSOCIATED WITH A PANEL OF STRUCTURALLY SIMILAR HIGH-AFFINITY T CELL RECEPTORS
1669, 1nezA, 0.7117, 2.71, 0.138, 274, 87, THE CRYSTAL STRUCTURE OF A TL/CD8AA COMPLEX AT 2.1A RESOLUTION:IMPLICATIONS FOR MEMORY T CELL GENERATION CO-RECEPTOR PREFERENCE AND AFFINITY
1670, 1hdmB, 0.7102, 2.24, 0.095, 183, 84, HISTOCOMPATIBILITY ANTIGEN HLA-DM
1671, 3hujA, 0.7096, 2.29, 0.108, 275, 83, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
1672, 3gmnA, 0.7095, 2.37, 0.143, 268, 84, STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C10PH
1673, 3gmoA, 0.7094, 2.38, 0.143, 268, 84, STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PHF
1674, 4x6cC, 0.7088, 2.35, 0.133, 249, 83, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
1675, 5iroE, 0.7087, 2.54, 0.136, 268, 88, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 4 E3- 19K PROTEIN AND MHC CLASS MOLECULE HLA-A2/TAX
1676, 4n0cA, 0.7081, 2.40, 0.140, 173, 86, 42F3 TCR PCPE3/H-2LD COMPLEX
1677, 3gmlA, 0.7081, 2.21, 0.145, 268, 83, STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C6PH
1678, 3gmqA, 0.7079, 2.36, 0.143, 267, 84, STRUCTURE OF MOUSE CD1D EXPRESSED IN SF9 CELLS NO LIGAND ADDED
1679, 3gmpA, 0.7076, 2.39, 0.143, 268, 84, STRUCTURE OF MOUSE CD1D IN COMPLEX WITH PBS-25
1680, 3u0pC, 0.7066, 2.31, 0.108, 274, 83, CRYSTAL STRUCTURE OF HUMAN CD1D-LYSOPHOSPHATIDYLCHOLINE
1681, 1zt4A, 0.7065, 2.28, 0.120, 272, 83, THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA- GALACTOSYLCERAMIDE
1682, 2akrC, 0.7064, 2.40, 0.143, 269, 84, STRUCTURAL BASIS OF SULFATIDE PRESENTATION BY MOUSE CD1D
1683, 3gmmA, 0.7058, 2.40, 0.143, 268, 84, STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH
1684, 4wwkC, 0.7056, 2.26, 0.108, 270, 83, CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV12-3 BETA CHAIN-TRBV6- 5 ANTIGEN-PRESENTING MOLECULE CD1D AND BETA-2-MICROGLOBULIN
1685, 4wo4A, 0.7050, 2.35, 0.108, 273, 83, THE MOLECULAR BASES OF DELTA/ALPHA BETA T CELL-MEDIATED ANTIGEN RECOGNITION.
1686, 2po6A, 0.7050, 2.34, 0.108, 275, 83, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
1687, 2gazA, 0.7050, 2.38, 0.143, 269, 84, MYCOBACTERIAL LIPOGLYCAN PRESENTATION BY CD1D
1688, 1onqA, 0.7049, 2.38, 0.143, 274, 84, CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE
1689, 4ww2C, 0.7045, 2.37, 0.096, 275, 83, CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV21-TRAJ8 BETA CHAIN- TRBV7-8 ANTIGEN-PRESENTING GLYCOPROTEIN CD1D AND BETA-2- MICROGLOBULIN
1690, 2po6E, 0.7044, 2.31, 0.108, 272, 83, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
1691, 1mwaI, 0.7043, 2.54, 0.125, 274, 88, 2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX
1692, 3au1A, 0.7042, 2.41, 0.143, 267, 84, CRYSTAL STRUCTURE OF MOUSE CD1D IN COMPLEX WITH GANGLIOSIDE GD3
1693, 1onqC, 0.7041, 2.40, 0.143, 273, 84, CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE
1694, 4mngC, 0.7039, 2.31, 0.108, 273, 83, STRUCTURE OF THE DP10.7 TCR WITH CD1D-SULFATIDE
1695, 4x6dC, 0.7037, 2.54, 0.141, 218, 85, CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR
1696, 3t8xC, 0.7034, 2.43, 0.119, 277, 84, CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH SYNTHETIC ANTIGENIC DIACYLSULFOGLYCOLIPID SGL12 AND ENDOGENOUS SPACER
1697, 4x6dA, 0.7032, 2.42, 0.143, 267, 84, CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR
1698, 3tzvC, 0.7031, 2.39, 0.096, 263, 83, CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE
1699, 4f7eA, 0.7030, 2.38, 0.071, 271, 84, CRYSTAL STRUCTURE OF BOVINE CD1D WITH BOUND C16:0-ALPHA-GALACTOSYL CERAMIDE
1700, 2akrA, 0.7026, 2.36, 0.133, 269, 83, STRUCTURAL BASIS OF SULFATIDE PRESENTATION BY MOUSE CD1D
1701, 4mngA, 0.7024, 2.32, 0.108, 273, 83, STRUCTURE OF THE DP10.7 TCR WITH CD1D-SULFATIDE
1702, 3sdxA, 0.7020, 2.36, 0.108, 275, 83, CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
1703, 3sdxC, 0.7019, 2.36, 0.108, 268, 83, CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
1704, 3ma7A, 0.7012, 2.42, 0.143, 273, 84, CRYSTAL STRUCTURE OF CARDIOLIPIN BOUND TO MOUSE CD1D
1705, 4v3eB, 0.7011, 2.23, 0.159, 167, 82, THE CIDRA DOMAIN FROM IT4VAR07 PFEMP1 BOUND TO ENDOTHELIAL PROTEIN C RECEPTOR
1706, 1cd1C, 0.7009, 2.34, 0.145, 273, 83, CD1(MOUSE) ANTIGEN PRESENTING MOLECULE
1707, 1zhnA, 0.7004, 2.34, 0.145, 270, 83, CRYSTAL STRUCTURE OF MOUSE CD1D BOUND TO THE SELF LIGAND PHOSPHATIDYLCHOLINE
1708, 4s0uC, 0.6998, 2.64, 0.140, 175, 86, CRYSTAL STRUCTURE OF NKG2D IN COMPLEX WITH ULBP6
1709, 4y4fA, 0.6997, 2.30, 0.145, 267, 83, CRYSTAL STRUCTURE OF THE MCD1D/GCK127/INKTCR TERNARY COMPLEX
1710, 5l2kA, 0.6996, 2.47, 0.131, 276, 84, CRYSTAL STRUCTURE OF GEM42 TCR-CD1B-GMM COMPLEX
1711, 5fkpA, 0.6996, 2.30, 0.134, 265, 82, CRYSTAL STRUCTURE OF THE MOUSE CD1D IN COMPLEX WITH THE P99 PEPTIDE
1712, 2fikA, 0.6995, 2.42, 0.143, 265, 84, STRUCTURE OF A MICROBIAL GLYCOSPHINGOLIPID BOUND TO MOUSE CD1D
1713, 4y2dE, 0.6994, 2.30, 0.145, 243, 83, CRYSTAL STRUCTURE OF THE MCD1D/7DW8-5/INKTCR TERNARY COMPLEX
1714, 2q7yC, 0.6991, 2.29, 0.145, 269, 83, STRUCTURE OF THE ENDOGENOUS INKT CELL LIGAND IGB3 BOUND TO MCD1D
1715, 3gmrA, 0.6990, 2.47, 0.143, 273, 84, STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH DIFFERENT SPACE GROUP
1716, 3quzA, 0.6986, 2.30, 0.145, 266, 83, STRUCTURE OF THE MOUSE CD1D-NU-ALPHA-GALCER-INKT TCR COMPLEX
1717, 5tw5A, 0.6985, 2.27, 0.145, 273, 83, STRUCTURE OF MOUSE CD1D WITH BOUND GLYCOSPHINGOLIPID JJ112
1718, 4zakA, 0.6985, 2.31, 0.145, 267, 83, CRYSTAL STRUCTURE OF THE MCD1D/DB06-1/INKTCR TERNARY COMPLEX
1719, 4mx7A, 0.6985, 2.44, 0.143, 273, 84, STRUCTURE OF MOUSE CD1D IN COMPLEX WITH DIOLEOYL-PHOSPHATIDIC ACID
1720, 1gzqA, 0.6983, 2.45, 0.119, 277, 84, CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL
1721, 4y2dA, 0.6980, 2.29, 0.145, 249, 83, CRYSTAL STRUCTURE OF THE MCD1D/7DW8-5/INKTCR TERNARY COMPLEX
1722, 3quxA, 0.6980, 2.31, 0.145, 266, 83, STRUCTURE OF THE MOUSE CD1D-ALPHA-C-GALCER-INKT TCR COMPLEX
1723, 4v3dB, 0.6979, 2.19, 0.136, 169, 81, THE CIDRA DOMAIN FROM HB3VAR03 PFEMP1 BOUND TO ENDOTHELIAL PROTEIN C RECEPTOR
1724, 1cd1A, 0.6978, 2.34, 0.145, 273, 83, CD1(MOUSE) ANTIGEN PRESENTING MOLECULE
1725, 4y16A, 0.6974, 2.32, 0.145, 268, 83, CRYSTAL STRUCTURE OF THE MCD1D/NC-AGC/INKTCR TERNARY COMPLEX
1726, 3ta3A, 0.6968, 2.31, 0.145, 267, 83, STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2-INKT TCR COMPLEX
1727, 3quyA, 0.6966, 2.31, 0.145, 268, 83, STRUCTURE OF THE MOUSE CD1D-BNNH-GSL-1 -INKT TCR COMPLEX
1728, 1gzpA, 0.6963, 2.46, 0.119, 276, 84, CD1B IN COMPLEX WITH GM2 GANGLIOSIDE
1729, 1lqvA, 0.6961, 2.27, 0.146, 172, 82, CRYSTAL STRUCTURE OF THE ENDOTHELIAL PROTEIN C RECEPTOR WITH PHOSPHOLIPID IN THE GROOVE IN COMPLEX WITH GLA DOMAIN OF PROTEIN C.
1730, 3jtcA, 0.6958, 2.27, 0.159, 172, 82, IMPORTANCE OF MG2+ IN THE CA2+-DEPENDENT FOLDING OF THE GAMMA- CARBOXYGLUTAMIC ACID DOMAINS OF VITAMIN K-DEPENDENT CLOTTING AND ANTICLOTTING PROTEINS
1731, 3rugC, 0.6955, 2.47, 0.143, 285, 84, CRYSTAL STRUCTURE OF VALPHA10-VBETA8.1 NKT TCR IN COMPLEX WITH CD1D- ALPHAGLUCOSYLCERAMIDE (C20:2)
1732, 3rzcA, 0.6949, 2.32, 0.145, 268, 83, STRUCTURE OF THE SELF-ANTIGEN IGB3 BOUND TO MOUSE CD1D AND IN COMPLEX WITH THE INKT TCR
1733, 3d2uE, 0.6949, 2.49, 0.093, 279, 86, STRUCTURE OF UL18 A PEPTIDE-BINDING VIRAL MHC MIMIC BOUND TO A HOST INHIBITORY RECEPTOR
1734, 3ubxA, 0.6947, 2.29, 0.145, 275, 83, CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX
1735, 4irjA, 0.6945, 2.33, 0.145, 267, 83, STRUCTURE OF THE MOUSE CD1D-4CLPHC-ALPHA-GALCER-INKT TCR COMPLEX
1736, 1p1zA, 0.6945, 2.18, 0.136, 255, 81, X-RAY CRYSTAL STRUCTURE OF THE LECTIN-LIKE NATURAL KILLER CELL RECEPTOR LY-49C BOUND TO ITS MHC CLASS I LIGAND H-2KB
1737, 3d2uA, 0.6944, 2.48, 0.105, 281, 86, STRUCTURE OF UL18 A PEPTIDE-BINDING VIRAL MHC MIMIC BOUND TO A HOST INHIBITORY RECEPTOR
1738, 3ubxD, 0.6942, 2.29, 0.145, 276, 83, CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX
1739, 5vcjA, 0.6940, 2.35, 0.145, 267, 83, STRUCTURE OF ALPHA-GALACTOSYLPHYTOSPHINGOSINE BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR
1740, 4irsA, 0.6939, 2.33, 0.145, 268, 83, STRUCTURE OF THE MOUSE CD1D-PYRC-ALPHA-GALCER-INKT TCR COMPLEX
1741, 3rugA, 0.6939, 2.31, 0.145, 286, 83, CRYSTAL STRUCTURE OF VALPHA10-VBETA8.1 NKT TCR IN COMPLEX WITH CD1D- ALPHAGLUCOSYLCERAMIDE (C20:2)
1742, 2h26A, 0.6939, 2.22, 0.122, 283, 82, HUMAN CD1B IN COMPLEX WITH ENDOGENOUS PHOSPHATIDYLCHOLINE AND SPACER
1743, 5efiA, 0.6931, 2.30, 0.136, 263, 81, CRYSTAL STRUCTURE OF MOUSE CD1D IN COMPLEX WITH THE P99P LIPOPEPTIDE
1744, 4y4hE, 0.6930, 2.35, 0.145, 267, 83, CRYSTAL STRUCTURE OF THE MCD1D/GCK152/INKTCR TERNARY COMPLEX
1745, 4y4hA, 0.6926, 2.35, 0.145, 267, 83, CRYSTAL STRUCTURE OF THE MCD1D/GCK152/INKTCR TERNARY COMPLEX
1746, 3rtqA, 0.6925, 2.34, 0.145, 268, 83, STRUCTURE OF THE MOUSE CD1D-HS44-INKT TCR COMPLEX
1747, 2q7yA, 0.6925, 2.38, 0.145, 269, 83, STRUCTURE OF THE ENDOGENOUS INKT CELL LIGAND IGB3 BOUND TO MCD1D
1748, 4ei5E, 0.6924, 2.49, 0.143, 280, 84, CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
1749, 5wkeA, 0.6923, 2.21, 0.122, 279, 82, CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH PS
1750, 1xz0C, 0.6922, 2.47, 0.133, 270, 83, CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETIC MYCOBACTIN LIPOPEPTIDE
1751, 6bmhC, 0.6921, 2.36, 0.133, 273, 83, CRYSTAL STRUCTURE OF MHC-I LIKE PROTEIN
1752, 4y4kA, 0.6920, 2.36, 0.145, 268, 83, CRYSTAL STRUCTURE OF THE MCD1D/EF77/INKTCR TERNARY COMPLEX
1753, 3sddA, 0.6920, 2.35, 0.145, 290, 83, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE
1754, 4y4fE, 0.6917, 2.33, 0.145, 267, 83, CRYSTAL STRUCTURE OF THE MCD1D/GCK127/INKTCR TERNARY COMPLEX
1755, 4en3C, 0.6916, 2.30, 0.099, 257, 81, CRYSTAL STRUCTURE OF A HUMAN VALPHA24(-) NKT TCR IN COMPLEX WITH CD1D/ALPHA-GALACTOSYLCERAMIDE
1756, 3sdaA, 0.6916, 2.35, 0.145, 290, 83, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
1757, 3o8xA, 0.6912, 2.35, 0.145, 268, 83, RECOGNITION OF GLYCOLIPID ANTIGEN BY INKT CELL TCR
1758, 6bnlE, 0.6908, 2.35, 0.145, 260, 83, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
1759, 5l2jA, 0.6906, 2.44, 0.120, 280, 83, CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH C36-GMM
1760, 5wkgA, 0.6903, 2.31, 0.120, 280, 83, CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH PA
1761, 1i1aA, 0.6903, 2.51, 0.143, 265, 84, CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC
1762, 6bnkE, 0.6899, 2.38, 0.145, 272, 83, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
1763, 1uqsA, 0.6897, 2.33, 0.120, 280, 83, THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A BOUND BACTERIAL GLYCOLIPID
1764, 1xz0A, 0.6896, 2.51, 0.143, 271, 84, CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETIC MYCOBACTIN LIPOPEPTIDE
1765, 5tw2A, 0.6895, 2.23, 0.136, 267, 81, STRUCTURE OF MOUSE CD1D WITH BOUND ALPHA-GALACTOSYLSPHINGAMIDE JG168
1766, 6bmhG, 0.6894, 2.38, 0.133, 273, 83, CRYSTAL STRUCTURE OF MHC-I LIKE PROTEIN
1767, 6bnlA, 0.6893, 2.36, 0.145, 255, 83, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
1768, 4ei5A, 0.6892, 2.36, 0.145, 295, 83, CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
1769, 3o9wA, 0.6892, 2.37, 0.145, 274, 83, RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR
1770, 3tvmA, 0.6889, 2.39, 0.145, 268, 83, STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX
1771, 3ilqC, 0.6889, 2.16, 0.137, 262, 80, STRUCTURE OF MCD1D WITH BOUND GLYCOLIPID BBGL-2C FROM BORRELIA BURGDORFERI
1772, 6bnkA, 0.6881, 2.38, 0.145, 272, 83, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
1773, 3ilpA, 0.6877, 2.34, 0.136, 266, 81, STRUCTURE OF MCD1D WITH BOUND GLYCOLIPID BBGL-2F FROM BORRELIA BURGDORFERI
1774, 3scmA, 0.6875, 2.38, 0.145, 289, 83, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE
1775, 3l9rG, 0.6874, 2.48, 0.108, 275, 83, CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS
1776, 3arbA, 0.6873, 2.39, 0.145, 295, 83, TERNARY CRYSTAL STRUCTURE OF THE NKT TCR-CD1D-ALPHA-GALACTOSYLCERAMIDE ANALOGUE-OCH
1777, 3ma7C, 0.6866, 2.41, 0.146, 265, 82, CRYSTAL STRUCTURE OF CARDIOLIPIN BOUND TO MOUSE CD1D
1778, 3sdcA, 0.6865, 2.39, 0.145, 289, 83, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-GLOBOTRIHEXOSYLCERAMIDE
1779, 4n0fH, 0.6863, 2.61, 0.143, 264, 84, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
1780, 4n0uA, 0.6861, 2.58, 0.143, 264, 84, TERNARY COMPLEX BETWEEN NEONATAL FC RECEPTOR SERUM ALBUMIN AND FC
1781, 4gupC, 0.6861, 2.68, 0.140, 258, 86, STRUCTURE OF MHC-CLASS I RELATED MOLECULE MR1
1782, 4n0fA, 0.6860, 2.60, 0.143, 264, 84, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
1783, 4v3dD, 0.6858, 2.21, 0.137, 168, 80, THE CIDRA DOMAIN FROM HB3VAR03 PFEMP1 BOUND TO ENDOTHELIAL PROTEIN C RECEPTOR
1784, 4n0fE, 0.6858, 2.61, 0.143, 264, 84, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
1785, 3t8xA, 0.6856, 2.50, 0.120, 275, 83, CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH SYNTHETIC ANTIGENIC DIACYLSULFOGLYCOLIPID SGL12 AND ENDOGENOUS SPACER
1786, 4n0fK, 0.6855, 2.61, 0.143, 264, 84, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
1787, 4elmC, 0.6854, 2.44, 0.134, 269, 82, CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX
1788, 4f7cC, 0.6847, 2.23, 0.089, 263, 79, CRYSTAL STRUCTURE OF BOVINE CD1D WITH BOUND C12-DI-SULFATIDE
1789, 6c15A, 0.6846, 2.24, 0.152, 271, 79, CD1C IN COMPLEX WITH PHOSPHATIDYLCHOLINE
1790, 4k71B, 0.6846, 2.42, 0.145, 264, 83, CRYSTAL STRUCTURE OF A HIGH AFFINITY HUMAN SERUM ALBUMIN VARIANT BOUND TO THE NEONATAL FC RECEPTOR
1791, 3qi9A, 0.6846, 2.41, 0.145, 290, 83, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR
1792, 1z5lA, 0.6846, 2.36, 0.136, 265, 81, STRUCTURE OF A HIGHLY POTENT SHORT-CHAIN GALACTOSYL CERAMIDE AGONIST BOUND TO CD1D
1793, 5wl1A, 0.6835, 2.57, 0.119, 280, 84, CRYSTAL STRUCTURE OF HUMAN CD1B IN COMPLEX WITH PG
1794, 4k71E, 0.6832, 2.61, 0.143, 264, 84, CRYSTAL STRUCTURE OF A HIGH AFFINITY HUMAN SERUM ALBUMIN VARIANT BOUND TO THE NEONATAL FC RECEPTOR
1795, 6c97A, 0.6830, 2.57, 0.143, 265, 84, CRYSTAL STRUCTURE OF FCRN AT PH3 
1796, 4apqA, 0.6828, 2.39, 0.145, 290, 83, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-SULFATIDE
1797, 3m17G, 0.6827, 2.74, 0.141, 263, 85, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A MONOMERIC PEPTIDE INHIBITOR
1798, 6bmhE, 0.6826, 2.45, 0.155, 273, 84, CRYSTAL STRUCTURE OF MHC-I LIKE PROTEIN
1799, 5bjtC, 0.6825, 2.55, 0.143, 263, 84, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A PEPTIDE INHIBITOR AT MULTIPLE SITES
1800, 6bmhA, 0.6824, 2.47, 0.155, 273, 84, CRYSTAL STRUCTURE OF MHC-I LIKE PROTEIN
1801, 5bjtG, 0.6824, 2.61, 0.143, 263, 84, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A PEPTIDE INHIBITOR AT MULTIPLE SITES
1802, 4f7cA, 0.6823, 2.29, 0.075, 269, 80, CRYSTAL STRUCTURE OF BOVINE CD1D WITH BOUND C12-DI-SULFATIDE
1803, 3m1bA, 0.6818, 2.73, 0.141, 263, 85, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR
1804, 6c97C, 0.6817, 2.46, 0.145, 265, 83, CRYSTAL STRUCTURE OF FCRN AT PH3 
1805, 4elmA, 0.6816, 2.29, 0.136, 266, 81, CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX
1806, 6bmkA, 0.6809, 2.47, 0.155, 272, 84, CRYSTAL STRUCTURE OF MHC-I LIKE PROTEIN
1807, 3g08A, 0.6807, 2.40, 0.136, 262, 81, CRYSTAL STRUCTURE OF THE ALPHA-GALACTOSYLCERAMIDE ANALOG OCH IN COMPLEX WITH MOUSE CD1D
1808, 6bmkC, 0.6805, 2.49, 0.155, 272, 84, CRYSTAL STRUCTURE OF MHC-I LIKE PROTEIN
1809, 3m17A, 0.6801, 2.61, 0.143, 263, 84, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A MONOMERIC PEPTIDE INHIBITOR
1810, 3he6A, 0.6801, 2.39, 0.146, 286, 82, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA8.2 NKT TCR
1811, 3tn0A, 0.6799, 2.46, 0.145, 293, 83, STRUCTURE OF MOUSE VA14VB8.2NKT TCR-MOUSE CD1D-A-C-GALACTOSYLCERAMIDE COMPLEX
1812, 3t1fA, 0.6798, 2.38, 0.137, 263, 80, CRYSTAL STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2 COMPLEX
1813, 3arfA, 0.6795, 2.42, 0.134, 293, 82, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-C20:2
1814, 3l9rE, 0.6788, 2.54, 0.120, 275, 83, CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS
1815, 3l9rA, 0.6783, 2.53, 0.120, 275, 83, CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS
1816, 5bxfA, 0.6782, 2.57, 0.143, 263, 84, APO FCRN STRUCTURE AT PH 4.5
1817, 3m1bG, 0.6782, 2.44, 0.145, 263, 83, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR
1818, 6c99A, 0.6777, 2.76, 0.141, 265, 85, CRYSTAL STRUCTURE OF FCRN BOUND TO UCB-303 
1819, 3l9rC, 0.6777, 2.58, 0.108, 274, 83, CRYSTAL STRUCTURE OF BOVINE CD1B3 WITH ENDOGENOUSLY BOUND LIGANDS
1820, 3areA, 0.6776, 2.43, 0.134, 292, 82, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-4 DEOXY-ALPHA- GALACTOSYLCERAMIDE
1821, 1z5lC, 0.6776, 2.38, 0.137, 266, 80, STRUCTURE OF A HIGHLY POTENT SHORT-CHAIN GALACTOSYL CERAMIDE AGONIST BOUND TO CD1D
1822, 5bxfC, 0.6775, 2.64, 0.143, 263, 84, APO FCRN STRUCTURE AT PH 4.5
1823, 3u0pE, 0.6773, 2.24, 0.101, 228, 79, CRYSTAL STRUCTURE OF HUMAN CD1D-LYSOPHOSPHATIDYLCHOLINE
1824, 6c98A, 0.6770, 2.62, 0.143, 262, 84, CRYSTAL STRUCTURE OF FCRN BOUND TO UCB-84 
1825, 6c98C, 0.6767, 2.62, 0.143, 262, 84, CRYSTAL STRUCTURE OF FCRN BOUND TO UCB-84 
1826, 3m1bE, 0.6753, 2.81, 0.141, 263, 85, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR
1827, 1l8jA, 0.6749, 2.45, 0.136, 170, 81, CRYSTAL STRUCTURE OF THE ENDOTHELIAL PROTEIN C RECEPTOR AND BOUND PHOSPHOLIPID MOLECULE
1828, 5bjtE, 0.6739, 2.74, 0.141, 263, 85, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A PEPTIDE INHIBITOR AT MULTIPLE SITES
1829, 3ardA, 0.6739, 2.46, 0.134, 294, 82, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-3 DEOXY-ALPHA- GALACTOSYLCERAMIDE
1830, 1je6A, 0.6735, 2.81, 0.141, 275, 85, STRUCTURE OF THE MHC CLASS I HOMOLOG MICB
1831, 3m17C, 0.6734, 2.62, 0.155, 263, 84, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A MONOMERIC PEPTIDE INHIBITOR
1832, 5bjtA, 0.6721, 2.64, 0.155, 263, 84, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A PEPTIDE INHIBITOR AT MULTIPLE SITES
1833, 3vwjA, 0.6713, 2.25, 0.103, 252, 78, TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-C20:2 COMPLEX
1834, 3m17E, 0.6692, 2.66, 0.143, 263, 84, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A MONOMERIC PEPTIDE INHIBITOR
1835, 3m1bC, 0.6684, 2.83, 0.141, 263, 85, CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR
1836, 3fruA, 0.6680, 2.50, 0.145, 269, 83, NEONATAL FC RECEPTOR PH 6.5
1837, 3fruE, 0.6670, 2.51, 0.145, 269, 83, NEONATAL FC RECEPTOR PH 6.5
1838, 3to4A, 0.6668, 2.35, 0.137, 289, 80, STRUCTURE OF MOUSE VALPHA14VBETA2-MOUSECD1D-ALPHA-GALACTOSYLCERAMIDE
1839, 3tvmE, 0.6658, 2.37, 0.139, 209, 79, STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX
1840, 3argA, 0.6655, 2.47, 0.136, 290, 81, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-ALPHA- GLUCOSYLCERAMIDE(C20:2)
1841, 3he7A, 0.6653, 2.37, 0.137, 281, 80, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA7 NKT TCR
1842, 3fruC, 0.6634, 2.52, 0.145, 269, 83, NEONATAL FC RECEPTOR PH 6.5
1843, 4x6fA, 0.6633, 2.18, 0.145, 263, 76, CD1A BINARY COMPLEX WITH SPHINGOMYELIN
1844, 1frtA, 0.6611, 2.54, 0.145, 269, 83, CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC
1845, 5j1aA, 0.6607, 2.20, 0.145, 270, 76, ANTIGEN PRESENTING MOLECULE
1846, 4x6eA, 0.6581, 2.22, 0.145, 266, 76, CD1A BINARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE
1847, 1zs8I, 0.6575, 2.77, 0.110, 261, 82, CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5
1848, 1zs8G, 0.6575, 2.77, 0.110, 261, 82, CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5
1849, 1zs8E, 0.6575, 2.77, 0.110, 261, 82, CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5
1850, 1zs8C, 0.6575, 2.77, 0.110, 261, 82, CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5
1851, 1zs8A, 0.6575, 2.77, 0.110, 261, 82, CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5
1852, 2wy3A, 0.6568, 2.71, 0.145, 173, 83, STRUCTURE OF THE HCMV UL16-MICB COMPLEX ELUCIDATES SELECT BINDING OF A VIRAL IMMUNOEVASIN TO DIVERSE NKG2D LIGANDS
1853, 2wy3C, 0.6532, 2.52, 0.146, 167, 82, STRUCTURE OF THE HCMV UL16-MICB COMPLEX ELUCIDATES SELECT BINDING OF A VIRAL IMMUNOEVASIN TO DIVERSE NKG2D LIGANDS
1854, 1exuA, 0.6509, 2.71, 0.145, 256, 83, CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR
1855, 6c99C, 0.6450, 2.70, 0.150, 260, 80, CRYSTAL STRUCTURE OF FCRN BOUND TO UCB-303 
1856, 1hyrC, 0.6342, 2.96, 0.116, 275, 86, CRYSTAL STRUCTURE OF HUMAN MICA IN COMPLEX WITH NATURAL KILLER CELL RECEPTOR NKG2D
1857, 1jfmB, 0.6150, 2.87, 0.062, 174, 81, CRYSTAL STRUCTURE OF MURINE NK CELL LIGAND RAE-1 BETA
1858, 5whkA, 0.6148, 2.81, 0.125, 254, 80, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY DX-2507 BOUND TO FCRN- B2M
1859, 4pp8C, 0.6097, 2.98, 0.089, 146, 79, CRYSTAL STRUCTURE OF MURINE NK CELL LIGAND RAE-1 BETA IN COMPLEX WITH NKG2D
1860, 1jfmA, 0.6093, 3.03, 0.061, 174, 82, CRYSTAL STRUCTURE OF MURINE NK CELL LIGAND RAE-1 BETA
1861, 4pp8D, 0.6068, 3.14, 0.061, 150, 82, CRYSTAL STRUCTURE OF MURINE NK CELL LIGAND RAE-1 BETA IN COMPLEX WITH NKG2D
1862, 1jfmE, 0.6068, 2.87, 0.090, 174, 78, CRYSTAL STRUCTURE OF MURINE NK CELL LIGAND RAE-1 BETA
1863, 1b3jA, 0.6009, 3.09, 0.104, 264, 77, STRUCTURE OF THE MHC CLASS I HOMOLOG MIC-A A GAMMADELTA T CELL LIGAND
1864, 1c16E, 0.5990, 3.70, 0.120, 254, 83, CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/DELTA T CELL LIGAND T22
1865, 3it8J, 0.5973, 2.97, 0.053, 299, 76, CRYSTAL STRUCTURE OF TNF ALPHA COMPLEXED WITH A POXVIRUS MHC-RELATED TNF BINDING PROTEIN
1866, 3it8E, 0.5972, 2.97, 0.053, 299, 76, CRYSTAL STRUCTURE OF TNF ALPHA COMPLEXED WITH A POXVIRUS MHC-RELATED TNF BINDING PROTEIN
1867, 3it8K, 0.5971, 2.97, 0.053, 299, 76, CRYSTAL STRUCTURE OF TNF ALPHA COMPLEXED WITH A POXVIRUS MHC-RELATED TNF BINDING PROTEIN
1868, 3it8F, 0.5971, 2.97, 0.053, 299, 76, CRYSTAL STRUCTURE OF TNF ALPHA COMPLEXED WITH A POXVIRUS MHC-RELATED TNF BINDING PROTEIN
1869, 3it8D, 0.5971, 2.97, 0.053, 299, 76, CRYSTAL STRUCTURE OF TNF ALPHA COMPLEXED WITH A POXVIRUS MHC-RELATED TNF BINDING PROTEIN
1870, 3it8L, 0.5970, 2.97, 0.053, 299, 76, CRYSTAL STRUCTURE OF TNF ALPHA COMPLEXED WITH A POXVIRUS MHC-RELATED TNF BINDING PROTEIN
1871, 4g59B, 0.5957, 3.19, 0.100, 163, 80, CRYSTAL STRUCTURE OF THE MURINE CYTOMEGALOVIRUS MHC-I HOMOLOG M152 WITH LIGAND RAE-1 GAMMA
1872, 4mq7A, 0.5954, 3.25, 0.095, 268, 84, STRUCTURE OF HUMAN CD1D-SULFATIDE
1873, 1ypzC, 0.5950, 3.11, 0.101, 260, 79, IMMUNE RECEPTOR
1874, 1r3hE, 0.5938, 3.49, 0.086, 247, 81, CRYSTAL STRUCTURE OF T10
1875, 1pqzA, 0.5913, 3.31, 0.051, 238, 79, MURINE CYTOMEGALOVIRUS IMMUNOMODULATORY PROTEIN M144
1876, 1c16A, 0.5909, 3.49, 0.111, 260, 81, CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/DELTA T CELL LIGAND T22
1877, 1r3hG, 0.5905, 3.51, 0.125, 245, 80, CRYSTAL STRUCTURE OF T10
1878, 3s6cA, 0.5902, 2.99, 0.072, 372, 83, STRUCTURE OF HUMAN CD1E
1879, 1c16C, 0.5902, 3.52, 0.111, 260, 81, CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/DELTA T CELL LIGAND T22
1880, 1c16G, 0.5888, 3.68, 0.110, 260, 82, CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/DELTA T CELL LIGAND T22
1881, 4g59A, 0.5867, 3.34, 0.086, 162, 81, CRYSTAL STRUCTURE OF THE MURINE CYTOMEGALOVIRUS MHC-I HOMOLOG M152 WITH LIGAND RAE-1 GAMMA
1882, 6c09A, 0.5849, 2.87, 0.099, 269, 81, TERNARY CRYSTAL STRUCTURE OF THE 3C8 TCR-CD1C-MONOACYLGLYCEROL COMPLEX
1883, 1r3hC, 0.5846, 3.49, 0.125, 248, 80, CRYSTAL STRUCTURE OF T10
1884, 1jfmD, 0.5842, 3.06, 0.076, 174, 79, CRYSTAL STRUCTURE OF MURINE NK CELL LIGAND RAE-1 BETA
1885, 5wkiA, 0.5823, 2.96, 0.087, 267, 80, CRYSTAL STRUCTURE OF PG90 TCR-CD1B-PG COMPLEX
1886, 1ypzA, 0.5823, 3.75, 0.120, 260, 83, IMMUNE RECEPTOR
1887, 3vwkA, 0.5808, 3.07, 0.098, 249, 82, TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-4 DEOXY-ALPHA- GALACTOSYLCERAMIDE COMPLEX
1888, 1jfmC, 0.5788, 3.10, 0.076, 174, 79, CRYSTAL STRUCTURE OF MURINE NK CELL LIGAND RAE-1 BETA
1889, 1r3hA, 0.5740, 3.70, 0.111, 248, 81, CRYSTAL STRUCTURE OF T10
1890, 4pdcE, 0.5719, 3.11, 0.070, 150, 71, CRYSTAL STRUCTURE OF COWPOX VIRUS CPXV018 (OMCP) BOUND TO HUMAN NKG2D
1891, 4pdcF, 0.5711, 3.35, 0.055, 150, 73, CRYSTAL STRUCTURE OF COWPOX VIRUS CPXV018 (OMCP) BOUND TO HUMAN NKG2D
1892, 1u58A, 0.5697, 3.32, 0.051, 222, 78, CRYSTAL STRUCTURE OF THE MURINE CYTOMEGALOVIRUS MHC-I HOMOLOG M144
1893, 4ffeZ, 0.5667, 3.33, 0.082, 150, 73, THE STRUCTURE OF COWPOX VIRUS CPXV018 (OMCP)
1894, 4ffeX, 0.5557, 3.31, 0.080, 150, 75, THE STRUCTURE OF COWPOX VIRUS CPXV018 (OMCP)
1895, 4ffeY, 0.5539, 3.32, 0.080, 150, 75, THE STRUCTURE OF COWPOX VIRUS CPXV018 (OMCP)
1896, 2o5nA, 0.5319, 3.02, 0.116, 264, 69, CRYSTAL STRUCTURE OF A VIRAL GLYCOPROTEIN
1897, 4g59D, 0.5240, 2.98, 0.103, 264, 68, CRYSTAL STRUCTURE OF THE MURINE CYTOMEGALOVIRUS MHC-I HOMOLOG M152 WITH LIGAND RAE-1 GAMMA
1898, 2o5nB, 0.5232, 3.10, 0.116, 267, 69, CRYSTAL STRUCTURE OF A VIRAL GLYCOPROTEIN
1899, 4g59C, 0.5215, 2.98, 0.103, 264, 68, CRYSTAL STRUCTURE OF THE MURINE CYTOMEGALOVIRUS MHC-I HOMOLOG M152 WITH LIGAND RAE-1 GAMMA
1900, 2nykA, 0.5111, 3.12, 0.076, 237, 66, CRYSTAL STRUCTURE OF M157 FROM MOUSE CYTOMEGALOVIRUS
